Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,wide pore channel activity (GO:0022829),0.8462724079750938,1.9673131450062782,0.0,0.0,0.0,8/23,9.88%,PANX3;PRF1;GJD2;GJB2;GJB6;GJD3;GJC1;PANX1
prerank,gap junction channel activity (GO:0005243),0.8350261353915392,1.9363707186595238,0.0,0.0009416345294207889,0.001,7/22,9.88%,PANX3;GJD2;GJB2;GJB6;GJD3;GJC1;PANX1
prerank,metallocarboxypeptidase activity (GO:0004181),0.7738057616711427,1.8014631176526268,0.0,0.027935157706150075,0.074,8/26,7.82%,CPA4;CPA3;CPXM2;AGBL2;CPA6;AEBP1;AGBL1;CPM
prerank,triglyceride lipase activity (GO:0004806),-0.5809716530602056,-1.7623840251909275,0.005263157894736842,1.0,0.577,4/20,4.94%,DDHD2;DAGLB;LIPH;PLA2G15
prerank,water transmembrane transporter activity (GO:0005372),0.8732867259954269,1.7610153991837676,0.0,0.05838134082408891,0.197,4/11,9.91%,SLC5A1;AQP11;PDPN;AQP4
prerank,nuclear import signal receptor activity (GO:0061608),-0.6257192714030737,-1.7464372949110036,0.01639344262295082,0.7254380513474467,0.624,8/15,14.06%,KPNA3;IPO5;TNPO2;HIKESHI;IPO9;KPNA4;RANBP6;KPNB1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.7583686215714905,1.7049354990053442,0.0,0.15687631260150342,0.511,4/19,1.52%,CD24;NRG1;ANGPT4;CCL5
prerank,tropomyosin binding (GO:0005523),0.787109538201945,1.699943291051836,0.007782101167315175,0.14297150938372313,0.547,4/16,9.42%,TNNT3;S100A6;NEBL;TMOD2
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.8482618292679145,1.6992268934314119,0.0014265335235378032,0.12443027710203282,0.553,3/10,2.81%,CYBA;CYBB;NCF1
prerank,serine-type endopeptidase activity (GO:0004252),0.6434480388585968,1.699208736450847,0.0,0.10887649246427872,0.553,17/80,11.22%,MMP8;GZMB;GZMA;MMP9;HP;HPR;TMPRSS4;RHBDF1;PRSS53;DPP4;CD5L;KLK1;PLAU;CLPP;PCSK7;PIK3IP1;MMP2
prerank,carboxypeptidase activity (GO:0004180),0.6908369789439011,1.6848747885528028,0.0,0.1268067832953329,0.647,9/35,8.09%,CPA4;CPA3;CPXM2;AGBL2;CPA6;AEBP1;AGBL1;CPM;CTSZ
prerank,MHC protein binding (GO:0042287),0.7396125729828373,1.6842993415058607,0.0012437810945273632,0.11516190294816248,0.651,4/20,1.89%,CD8B;CD4;CD8A;CD74
prerank,cytokine receptor activity (GO:0004896),0.6292633963900438,1.6691809268116518,0.0,0.13465373770717284,0.733,18/83,8.59%,IL2RB;IL18RAP;IL18R1;CD4;OSMR;CCR2;IL27RA;IL31RA;GHR;CD74;IL1R2;IL20RA;IL7R;CXCR3;CD44;IFNGR1;IL2RG;IL3RA
prerank,chemokine binding (GO:0019956),0.7017455369343149,1.6680010073732487,0.0011574074074074073,0.12578667922179373,0.74,9/30,10.31%,CXCR2;CCR2;PLP2;ITGA4;HMGB1;CXCR3;ITGB1;PDPN;CXCR4
prerank,Toll-like receptor binding (GO:0035325),0.81328845840713,1.6527411665031202,0.0,0.15138585896072684,0.825,2/11,0.03%,S100A8;S100A9
prerank,CCR chemokine receptor binding (GO:0048020),0.6902207769354834,1.643861794900531,0.0059594755661501785,0.16095224492171056,0.858,3/28,1.85%,CCR2;CCL5;CCL7
prerank,serine-type peptidase activity (GO:0008236),0.6130645770302481,1.6371601402755636,0.0,0.167485394966311,0.875,19/96,11.22%,MMP8;GZMB;GZMA;TMPRSS2;MMP9;HP;HPR;TMPRSS4;RHBDF1;PRSS53;DPP4;CD5L;KLK1;PLAU;CLPP;PCSK7;TMPRSS7;PIK3IP1;MMP2
prerank,"DNA binding, bending (GO:0008301)",0.765133601363733,1.623981547120286,0.0053475935828877,0.18973935767828898,0.917,4/14,6.36%,LEF1;HMGB1;HMGB3;HMGB2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.6072028717217466,-1.6155475952859637,0.041811846689895474,1.0,0.927,5/13,15.38%,SLC9A9;SLC11A1;SLC9A6;LETM1;SLC9A7
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.653543059798129,1.6091364356942384,0.00776914539400666,0.21812686922700394,0.952,8/38,11.17%,HRG;TFPI2;SERPINB8;SERPINB9;SPINK5;SERPING1;TFPI;SERPINE1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.7525058257844923,1.6038501132571008,0.012064343163538873,0.2228011922668411,0.959,3/14,2.81%,CYBA;CYBB;NCF1
prerank,endopeptidase inhibitor activity (GO:0004866),0.6097680226703736,1.6033529125661923,0.0,0.21206600796797667,0.959,21/82,14.28%,LTF;HRG;TFPI2;SERPINB8;SERPINB9;SPINK5;TIMP4;SERPING1;TIMP3;CAST;BIRC6;CST7;TIMP1;PRNP;TFPI;SERPINE1;ROCK1;CARD16;CSTB;UBE2Z;GAPDH
prerank,acetylcholine receptor activity (GO:0015464),-0.5139581192484233,-1.5951995625082807,0.016129032258064516,1.0,0.952,12/22,48.30%,CHRFAM7A;CHRNA7;ANXA9;CHRM3;CHRNA4;CHRNB2;CHRNA5;HRH3;CHRNA3;CHRNB4;CHRM1;CHRNB3
prerank,C-C chemokine receptor activity (GO:0016493),0.698333696715342,1.5936904391438076,0.007290400972053463,0.23060629625515122,0.971,5/21,10.31%,CXCR2;CCR2;CXCR3;GPR75;CXCR4
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.5735125731830892,-1.5836610803540414,0.04048582995951417,1.0,0.962,9/15,25.63%,LPCAT1;LPCAT2;AGPAT5;ABHD4;AGPAT4;AGPAT3;ABHD8;GPAT4;GPAT3
prerank,channel activity (GO:0015267),0.6318992805995216,1.5779443357538077,0.009988901220865706,0.2702939496832627,0.99,9/41,12.38%,PANX3;PRF1;BCL2;TMEM266;AQP11;PDPN;PANX1;AQP4;P2RX5
prerank,filamin binding (GO:0031005),0.7855159141758827,1.5745991065258247,0.008298755186721992,0.2687938565801161,0.99,6/11,11.56%,MICALL2;CEACAM1;NEBL;RFLNA;SYNPO2;RFLNB
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.5875867907137271,-1.5696623036887989,0.03745318352059925,0.9252239018786504,0.969,6/13,8.72%,PIP4K2A;PIK3CA;PIP5K1A;PIK3CG;PIK3CB;PIK3CD
prerank,lipase activator activity (GO:0060229),0.78144525681859,1.562846235694162,0.017804154302670624,0.29907131467038534,0.992,2/10,1.52%,LCK;CCL5
prerank,phospholipase activator activity (GO:0016004),0.7743122957205401,1.5569511952991297,0.01897810218978102,0.3081891345250124,0.995,2/10,1.52%,LCK;CCL5
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.6511937155006347,1.5477123962089987,0.014994232987312572,0.3307020467325811,0.995,10/30,12.97%,LTF;PRDX5;SERPINB9;BIRC5;CAST;BIRC6;CST7;CARD16;CSTB;UBE2Z
prerank,kinase activity (GO:0016301),-0.33029270284014867,-1.5458547317930391,0.0,0.9148755861534612,0.985,45/109,21.04%,PI4KB;LYN;CERK;DGKZ;ABL1;PI4KA;IRAK1;PIK3CA;DCAKD;AGK;PPIP5K2;ITPKB;LRRK2;MTOR;PIK3CG;CKB;CDK5;PIK3CB;PIK3CD;CAMK2A;DGKH;DGKD;PGM2L1;FCSK;COQ8B;IPPK;NEK1;GK5;PIK3C3;SEPHS1;CHKA;FN3K;BCKDK;CDK5R1;DGKQ;PAPSS1;PANK1;IPMK;PANK2;PRKD1;NADK2;DGKK;CCL3;MVK;CDKL5
prerank,receptor antagonist activity (GO:0048019),0.68598927897962,1.519562139757125,0.029411764705882353,0.43677355480056596,1.0,2/17,5.24%,CCL5;DKK3
prerank,chemokine receptor activity (GO:0004950),0.6525507825964115,1.5181785722861743,0.023923444976076555,0.4274323256511552,1.0,5/24,10.31%,CXCR2;CCR2;CXCR3;GPR75;CXCR4
prerank,MHC class II protein complex binding (GO:0023026),0.7452932268826149,1.5085334006017366,0.035919540229885055,0.4596857993804558,1.0,4/11,3.78%,CD4;ANXA11;CD74;HSPA8
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.6652201806724343,1.5051452197724533,0.04504504504504504,0.4609138670733827,1.0,4/18,8.78%,ANXA1;PDLIM1;S100A11;PAK4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.6495167695332833,1.5045125410780356,0.048327137546468404,0.44906550708077425,1.0,10/22,15.25%,EXOSC4;ILF3;RBMS3;ELAVL4;DHX36;ZFP36L2;NUDT21;CPEB3;KHSRP;ELAVL3
prerank,C-C chemokine binding (GO:0019957),0.6542322269577892,1.5043323268881983,0.027777777777777776,0.4355819081256166,1.0,4/22,10.31%,CXCR2;CCR2;CXCR3;CXCR4
prerank,retinoid binding (GO:0005501),0.6517914674970955,1.5014101987206419,0.03558282208588957,0.43427007453725014,1.0,3/22,5.91%,ABCA4;PTGDS;RARA
prerank,mRNA 5'-UTR binding (GO:0048027),0.6424330468092717,1.495607775241286,0.015457788347205707,0.4481609672449367,1.0,7/24,11.13%,RPS14;RPL41;RPS7;SHMT1;SYNCRIP;DHX36;NCL
prerank,iron ion binding (GO:0005506),0.5871987507050076,1.4904122554585881,0.013143483023001095,0.45882527202688855,1.0,8/48,3.27%,LCN2;LTF;ACP5;FTL;HEPH;SCD5;NFU1;DOHH
prerank,alanine transmembrane transporter activity (GO:0022858),0.719125769530614,1.486540819388169,0.0375,0.46333799616242366,1.0,3/12,4.97%,SLC6A14;SLC36A3;SLC3A2
prerank,MHC class I protein binding (GO:0042288),0.6984014588273622,1.4799976021615286,0.0506155950752394,0.4821168790634439,1.0,2/13,0.39%,CD8B;CD8A
prerank,SH2 domain binding (GO:0042169),0.6173830784494856,1.4781525920441672,0.03044496487119438,0.4767215677056815,1.0,7/31,9.03%,LCK;SKAP1;LAX1;DLC1;RACK1;NLK;JAK2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.6130227967070787,-1.4752589971409338,0.0891089108910891,1.0,0.996,5/10,7.27%,PHF8;KDM7A;KDM2A;KDM4A;KDM2B
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.6691538928116509,1.4732298548348584,0.039950062421972535,0.4870976301269592,1.0,3/18,7.33%,DHRS9;HSD11B1;HSD17B7
prerank,chemokine activity (GO:0008009),0.6102033691241369,1.4685251961595713,0.03440094899169632,0.4960965301540757,1.0,4/31,8.55%,CCL5;CCL7;CXCL10;CXCL16
prerank,chloride channel regulator activity (GO:0017081),-0.5393391301746497,-1.4611744719910862,0.07116104868913857,1.0,0.998,6/14,27.43%,WNK1;CHRNA7;STX8;WNK3;VAMP8;SGK3
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5727189011376558,1.4574233641784804,0.02654867256637168,0.5363550279580814,1.0,16/47,21.00%,SLC6A19;SLC6A14;SLC36A3;SLC7A11;SLC38A11;SLC3A2;PDPN;SLC7A1;SLC1A5;SLC7A5;SLC25A44;SLC43A2;SLC38A1;SLC7A6;SLC6A6;SLC16A2
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.5488993555455052,-1.452704195014132,0.08365019011406843,1.0,1.0,7/13,25.63%,LPCAT1;LPCAT2;AGPAT5;AGPAT4;AGPAT3;GPAT4;GPAT3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.4942188482877985,-1.4491100773315309,0.06666666666666667,1.0,1.0,4/18,5.57%,TGFBR1;BMPR2;ACVR1B;TGFBR2
prerank,phospholipid transfer activity (GO:0120014),-0.4723756546163441,-1.4481314081951633,0.06432748538011696,0.9355722176038397,1.0,9/21,15.02%,PLEKHA8;PRELID2;ABCA3;PITPNA;PLTP;CERT1;C2CD2L;PITPNB;MTTP
prerank,cytokine activity (GO:0005125),0.536132533398762,1.4473562529150215,0.0,0.5734324617214209,1.0,21/131,14.64%,FAM3D;NRG1;CCL5;WNT6;CCL7;TNFRSF11B;HMGB1;IL17D;MIF;TGFB2;CXCL10;BMP4;AIMP1;CXCL16;BMP6;TIMP1;CLCF1;TGFB3;GDF3;WNT3;KITLG
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.7224413282641252,1.4429884598085303,0.047954866008462625,0.5811006040013674,1.0,1/11,1.23%,SLC22A3
prerank,neurexin family protein binding (GO:0042043),0.7107646609754028,1.4334933645183803,0.08835904628330996,0.6167487182931883,1.0,2/10,4.73%,SYTL1;SYTL3
prerank,N-methyltransferase activity (GO:0008170),-0.48029799375944593,-1.430788065391853,0.07575757575757576,0.9425577368531826,1.0,6/20,13.43%,SETD3;METTL5;HNMT;TRMT1;TRMT11;TRMT1L
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.5508059674870502,1.427753444072705,0.030107526881720432,0.632500193568896,1.0,21/57,20.06%,COX7A1;NDUFA1;CYBRD1;NDUFS7;COX4I1;NDUFA10;UQCR11;NDUFA5;NDUFA9;NDUFB10;NDUFA4;UQCRQ;NDUFS6;COX8A;NDUFV3;NDUFA8;CYB5A;UQCRFS1;UQCRC1;NDUFA2;UQCRH
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6144092250754356,1.4259005563038383,0.052256532066508314,0.6287189126883783,1.0,4/26,4.27%,PPP1R9B;PPP1R14A;LMTK2;SAG
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.4778023192155486,-1.4219724366761772,0.07614213197969544,0.9171383374053249,1.0,9/20,25.63%,LPCAT1;LPCAT2;AGPAT5;PLA2G15;DGAT1;AGPAT4;AGPAT3;GPAT4;GPAT3
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5551173872437734,-1.4186248294667518,0.10801393728222997,0.8697653771963099,1.0,4/12,15.38%,SLC9A9;SLC9A6;LETM1;SLC9A7
prerank,muscle alpha-actinin binding (GO:0051371),0.6585911546745314,1.4176782966696906,0.072,0.6572199609039968,1.0,3/15,10.88%,PDLIM1;PDLIM2;SYNPO2
prerank,nucleotidase activity (GO:0008252),0.6523803707620508,1.4155978188986438,0.08300395256916997,0.6541555110663442,1.0,4/15,8.42%,BPNT1;NT5M;NT5C3A;ACP3
prerank,protein kinase inhibitor activity (GO:0004860),0.5646356474563891,1.411785085052972,0.03808487486398259,0.6607527962489795,1.0,13/42,14.95%,ITPRIP;HEXIM1;INKA2;SMCR8;RACK1;GSKIP;PARVA;YWHAB;NCK1;TAOK3;CIT;NPM1;CDKN1A
prerank,kinase inhibitor activity (GO:0019210),0.5832836979901378,1.4116329703152097,0.056753688989784334,0.6480751606160549,1.0,10/33,14.95%,ITPRIP;HEXIM1;SMCR8;GSKIP;PARVA;YWHAB;NCK1;TAOK3;NPM1;CDKN1A
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.499387019676351,-1.40995390123332,0.1125,0.8527064955085107,1.0,8/15,13.87%,PI4KB;PI4KA;PIK3CA;PIK3CG;PIK3CB;PIK3CD;PI4K2B;PIK3C3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4896003342598003,-1.4065681996514263,0.09090909090909091,0.8138770185114585,1.0,8/18,23.33%,HSD17B12;ALDH18A1;ALDH3A2;ALDH6A1;ALDH3B1;ALDH2;FAR2;ALDH1A2
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.31136957928198233,-1.4028753924920851,0.0,0.7846416807684271,1.0,27/100,11.77%,GAB2;SNX24;ADAP2;FCHSD2;ARAP1;GAP43;PLEKHA8;RUBCN;ARAP2;PLEKHB2;SNX27;OSBP;DAPP1;PLEKHN1;ZFYVE19;SNX13;SNX20;BTK;CLVS1;WIPI1;PLA2G4A;GOLPH3;WDR45B;MAPKAP1;ANKFY1;RUBCNL;CERT1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.5743856978965878,1.4000549379176692,0.06148491879350348,0.6972050382737406,1.0,10/32,19.74%,SLC6A19;SLC6A14;SLC36A3;SLC3A2;SLC1A5;SLC7A5;SFXN3;SLC43A2;SLC38A1;SLC6A6
prerank,GTPase inhibitor activity (GO:0005095),0.6704135122044419,1.3989774638246344,0.08119079837618404,0.6888333534045255,1.0,5/13,13.98%,RTKN;IQGAP1;ARL2;IQGAP2;CDC42SE1
prerank,phospholipase inhibitor activity (GO:0004859),0.6952618144541186,1.395804230232734,0.10678210678210678,0.6919565122735998,1.0,2/10,4.40%,ANXA1;APOC1
prerank,calcium ion binding (GO:0005509),0.5027616528317652,1.3949006538890532,0.0,0.6838931686980081,1.0,49/323,9.72%,S100A8;S100A9;ANXA1;PLSCR2;TPT1;SLC25A24;ANXA11;S100A6;SCIN;S100A7A;DHH;RASGRP1;MCTP2;DSG3;SELL;PRF1;FBLN1;CHP1;TKT;IQGAP1;ITPR3;RASGRP2;S100A11;MELK;CLEC6A;GJB2;ANXA6;ASPN;SYT4;RCN3;CLEC4E;CDH1;RCN2;MEX3B;HSPA5;CDH13;CLEC3B;CDH20;CDH19;CDH7;LCP1;STIM1;BAIAP3;CALB1;GSN;ESYT2;ITPR1;SYT7;SRI
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5483426431261124,1.3929991116802252,0.06397306397306397,0.6807145763888767,1.0,11/42,13.89%,ANXA1;PDLIM1;EMB;S100A11;DSCAM;CD47;PAK4;JAM3;BSG;NTNG1;NPTN
prerank,pseudouridine synthase activity (GO:0009982),0.6626250987924726,1.3859961625785682,0.1043115438108484,0.705626675092324,1.0,3/13,6.60%,PUS7;TRUB2;RPUSD4
prerank,potassium:proton antiporter activity (GO:0015386),-0.5628900559330756,-1.381496126844392,0.1377049180327869,0.8232413059832575,1.0,3/10,15.38%,SLC9A9;SLC9A6;SLC9A7
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.6616796345694009,1.3804579030322877,0.10273972602739725,0.7220991648472563,1.0,5/12,14.46%,RACK1;ATP2A3;APAF1;NOD1;CTSH
prerank,metalloaminopeptidase activity (GO:0070006),-0.4987016918764624,-1.3790219486624746,0.08979591836734693,0.7932934358883302,1.0,4/16,5.27%,RNPEP;NPEPPS;MMP16;MMP14
prerank,C2H2 zinc finger domain binding (GO:0070742),0.6887720840313521,1.3743790197696624,0.1106612685560054,0.7426688053445788,1.0,1/11,0.24%,LEF1
prerank,frizzled binding (GO:0005109),0.5670666316286466,1.3739672926532578,0.08352402745995423,0.7317474398285138,1.0,5/34,14.59%,CCDC88C;WNT6;ZNRF3;WNT3;SDCBP
prerank,symporter activity (GO:0015293),0.7001535369842461,1.3738046746141424,0.1274787535410765,0.7203823348214601,1.0,2/10,7.69%,SLC28A2;MFSD2A
prerank,SH3 domain binding (GO:0017124),0.5238402254621429,1.3691061532335114,0.0627027027027027,0.7331566446070263,1.0,9/62,7.58%,SKAP1;CD3E;PTPN22;CYBA;CBLB;NCF1;WAS;GPX1;PTPN12
prerank,proton transmembrane transporter activity (GO:0015078),0.5387777009962814,1.3605183632486915,0.08987485779294653,0.766922732634158,1.0,20/39,27.84%,COX7A1;COX4I1;UQCR11;SLC11A2;NDUFA4;UQCRQ;SLC33A1;COX8A;DMAC2L;CYB5A;ATP6V1F;UQCRFS1;UQCRC1;UQCRH;ATP6V1B2;CLCN4;COX15;UQCR10;COX5A;MFSD3
prerank,solute:sodium symporter activity (GO:0015370),0.5751314785122298,1.3567780653248007,0.10328638497652583,0.7747525905615046,1.0,3/27,8.69%,SLC5A1;SLC28A2;SLC20A1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.6606489952696835,1.3555657247103094,0.11789181692094314,0.7687324939233336,1.0,1/11,0.58%,SLC5A1
prerank,potassium ion leak channel activity (GO:0022841),-0.493233646312626,-1.3537016437581244,0.1210762331838565,0.8493463098994934,1.0,10/15,37.41%,KCNK12;KCNK13;KCNK9;KCNK6;TMEM175;KCNK5;KCNK3;KCNK4;KCNK1;KCNK7
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.6213272494061688,1.3533693952961412,0.10773130544993663,0.7676381240312539,1.0,3/18,4.49%,PRDX5;SERPINB9;BIRC5
prerank,sodium channel regulator activity (GO:0017080),0.5543775305132835,1.3525512016138967,0.07233065442020666,0.760420585905025,1.0,6/37,9.09%,RANGRF;FXYD5;FXYD1;NEDD4;ATP2B4;GPLD1
prerank,MAP kinase phosphatase activity (GO:0033549),0.65442938509834,1.3496388618949298,0.12637362637362637,0.7648355129271159,1.0,7/12,23.05%,DUSP5;DUSP6;DUSP2;DUSP16;DUSP4;DUSP3;DUSP10
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.5006244247396295,-1.3459106648607415,0.14545454545454545,0.8386743521770681,1.0,8/13,30.85%,DNASE1L1;DNA2;FAN1;SLX4;GEN1;DNASE1L2;EXO1;FEN1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.5410437234062561,1.3450678536464193,0.0795964125560538,0.7770593004727675,1.0,13/38,14.64%,CD3E;CD3G;DEDD2;SORBS1;STAP1;NCK2;SAV1;SHANK2;NCK1;G3BP2;IRS1;GRIP1;SHC1
prerank,metalloexopeptidase activity (GO:0008235),0.5256662051732922,1.34472893515986,0.08259911894273128,0.7675152268775978,1.0,9/51,10.32%,CPA4;CPA3;CPXM2;AGBL2;CPA6;AEBP1;AGBL1;CPM;LAP3
prerank,GABA receptor binding (GO:0050811),-0.5266569039800962,-1.344367794422913,0.10884353741496598,0.8081603018960088,1.0,7/11,19.55%,TRAK1;ARFGEF2;GABARAPL1;TRAK2;JAKMIP1;AKAP5;SHISA7
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.675617581177673,1.3434312328455658,0.12427745664739884,0.7516530371492205,1.0,5/10,15.26%,DUSP5;DUSP6;DUSP2;DUSP16;DUSP4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.675617581177673,1.3434312328455658,0.12427745664739884,0.7516530371492205,1.0,5/10,15.26%,DUSP5;DUSP6;DUSP2;DUSP16;DUSP4
prerank,protein phosphatase regulator activity (GO:0019888),0.5297712717309849,1.3430853850041236,0.09269356597600872,0.7427374443824288,1.0,22/53,22.91%,PPP1R9B;LMTK2;PPP1R15A;SAG;RCAN3;PPP2R2C;PPP2R2A;RCAN2;PPP2R1A;PTPA;PPP1R15B;LGALS3;CABIN1;PPP1R16B;PPP2R1B;CALM1;PPP2R3A;PPP2R2B;PPP6R1;CALM3;PPP2R5B;PPP2R5E
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.5220666708519054,-1.340999175761416,0.13962264150943396,0.7874223506401618,1.0,9/12,47.82%,OPN3;GPR88;RRH;ELOVL4;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,transferrin receptor binding (GO:1990459),-0.5338691591253809,-1.3378199327614455,0.1357615894039735,0.7682927498567406,1.0,5/10,18.66%,SNX2;CHUK;CD81;IKBKB;HFE
prerank,mannose binding (GO:0005537),0.6455875095044329,1.3345234056081625,0.14542936288088643,0.776089947845673,1.0,5/12,18.09%,CLEC6A;LMAN2;LMAN1;CLEC4D;MBL2
prerank,LRR domain binding (GO:0030275),0.6318189626452511,1.3326203510420327,0.13685636856368563,0.7744363544844566,1.0,6/14,12.58%,DAPK3;PAWR;ROBO1;LRRFIP2;ERC1;ATF4
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.6213043176380386,1.3285068046992692,0.15416098226466576,0.7840761680250024,1.0,6/14,18.93%,AK7;CMPK1;NME1;AK9;NME6;NME4
prerank,lipase activity (GO:0016298),-0.34475090884758186,-1.3243907195019409,0.050505050505050504,0.7849936642964949,1.0,9/43,10.78%,DDHD2;ABHD12;DAGLB;LIPH;PLA2G15;MGLL;PITPNM3;PNPLA8;SMPD3
prerank,5'-nucleotidase activity (GO:0008253),0.6221795282045892,1.3235721117279056,0.148,0.7988325142523616,1.0,4/13,17.40%,NT5M;NT5C3A;ACP3;NT5DC1
prerank,sodium:proton antiporter activity (GO:0015385),-0.5252950723259504,-1.3233550061286803,0.15593220338983052,0.7597212469812368,1.0,8/11,41.92%,SLC9A9;SLC9A6;SLC9A7;SLC9B2;SLC9A2;SLC9A4;SLC9A8;SLC9A3
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6142695768888895,1.3229930084839623,0.14437086092715232,0.7913323126260049,1.0,2/15,4.03%,CCR2;CXCR3
prerank,cytochrome-c oxidase activity (GO:0004129),0.6100489781271411,1.3218968588111852,0.1395973154362416,0.7863871222649849,1.0,5/15,18.19%,COX7A1;COX4I1;NDUFA4;COX8A;CYB5A
prerank,GABA-A receptor activity (GO:0004890),0.5907615621942464,1.3191870190739312,0.13788659793814434,0.7896692030573417,1.0,4/18,9.37%,GABRP;GABRA4;GABRB1;GABRG1
prerank,translation initiation factor activity (GO:0003743),0.5417697170187118,1.3150459795694502,0.12249443207126949,0.8001867197924788,1.0,13/36,17.35%,EIF3L;EIF1B;EIF2A;EIF2S1;EIF3I;EIF2B4;EIF1;EIF3H;EIF4E3;EIF3E;EIF2D;EIF3G;AGO2
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.3802923138950325,-1.3144348902551575,0.12751677852348994,0.7612347761519278,1.0,13/32,14.33%,FTO;PHF8;PHYHD1;KDM7A;KDM2A;TMLHE;PHYH;KDM4A;KDM2B;EGLN2;TYW5;HIF1AN;EGLN1
prerank,chemorepellent activity (GO:0045499),0.5621377211420994,1.3143911795065564,0.11619718309859155,0.7935978109642232,1.0,8/25,20.85%,NRG1;DPP4;SEMA5A;EPHA7;SEMA3E;SEMA5B;SEMA3D;NRG3
prerank,E-box binding (GO:0070888),0.5423103954027182,1.3136507372237627,0.11595866819747416,0.7872064665957795,1.0,5/34,7.01%,TCF15;GATA3;TFAP4;AHR;PRMT5
prerank,peptidase inhibitor activity (GO:0030414),0.547408794458236,1.3110574674381061,0.12514092446448705,0.7904218040133141,1.0,7/33,14.90%,HRG;CAST;CST7;TIMP1;TFPI;CSTB;GPC3
prerank,voltage-gated sodium channel activity (GO:0005248),0.5760656445552503,1.3104728829697472,0.13995215311004786,0.7838029682966684,1.0,9/22,19.95%,SCN4A;SCN1A;SCN7A;CACNA1H;HCN3;SCN8A;CACNA1I;SCN3B;SCN1B
prerank,ferrous iron binding (GO:0008198),0.5796959349138752,1.3098470291234787,0.1433868974042027,0.7775322927994684,1.0,4/21,7.61%,ACP5;FTL;HEPH;FTH1
prerank,protein phosphatase 1 binding (GO:0008157),0.5790566169864818,1.3088323297159332,0.13819095477386933,0.7732591975070646,1.0,5/21,17.78%,PPP1R9B;PPP1R15A;AKAP11;PPP1R16B;LILRB1
prerank,actin binding (GO:0003779),0.47845805441899686,1.3086881371913595,0.025050100200400802,0.7648043241865361,1.0,30/170,11.67%,TMSB4X;TNNT3;PDLIM1;ABLIM1;SCIN;TPM2;TMSB10;FXYD5;CAP2;SORBS1;CEACAM1;PDLIM2;UTRN;FERMT2;ALDOA;PAWR;ITGB1;SPTBN4;PHACTR2;MLPH;LCP1;SYNE1;IQGAP2;PARVA;ARPC1A;GSN;DMD;CXCR4;SYNPO2;MAPT
prerank,pyrophosphatase activity (GO:0016462),0.5104530894105943,1.3077011986344254,0.09051724137931035,0.76046188128315,1.0,13/50,15.85%,CILP;NUDT1;ENTPD5;DOLPP1;NUDT15;RNGTT;NUDT4;ENTPD2;NUDT16L1;PRUNE1;ENTPD3;NUDT16;PPA2
prerank,copper ion binding (GO:0005507),0.5171881645480888,1.3045829118799046,0.11147540983606558,0.7666082112646999,1.0,5/42,4.01%,HEPH;RNF7;SOD3;ATP7A;ATOX1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6308042661269063,1.3045515099834402,0.17287234042553193,0.7581004374897505,1.0,10/13,33.03%,PRKAR1B;PRKAR1A;EZR;GSK3A;SOX9;GSK3B;CSK;RYR2;PRKAR2A;PRKAR2B
prerank,phospholipase binding (GO:0043274),0.6178910576975851,1.3031078482682015,0.17310252996005326,0.7566556574190162,1.0,2/13,3.26%,LCK;WAS
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5057460340042446,1.299518692944607,0.11617806731813246,0.7651970529245926,1.0,18/55,21.00%,SLC6A14;SLC36A3;SLC38A11;SLC16A9;SLC16A1;SLC13A3;SLC16A4;PDPN;SLC7A1;SLC25A10;ABCC1;SLC7A5;SLC19A2;SLC38A1;SLC19A1;SLC7A6;SLC6A6;SLC16A2
prerank,peptide hormone receptor binding (GO:0051428),-0.5060891399874451,-1.2973197928260023,0.14634146341463414,0.7923124942076949,1.0,7/11,49.41%,PSMC5;CCK;PTHLH;GNRH1;VIP;ADCYAP1;GHRH
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4943419130960404,1.2965648890938624,0.08633093525179857,0.7707380974888443,1.0,10/73,10.23%,FPR2;LTB4R;F2R;EDNRA;SORCS2;S1PR2;MC5R;GPR84;TSHR;LGR4
prerank,DNA polymerase binding (GO:0070182),0.5883887366211467,1.2952589830176937,0.14612452350698857,0.7689104064381088,1.0,9/18,21.23%,RTEL1;HMGB1;LONP1;POLG2;HSP90AA1;FANCD2;PCNA;PTGES3;HSP90AB1
prerank,solute:anion antiporter activity (GO:0140323),0.6032762373371634,1.2943126324521983,0.1926729986431479,0.7651281420974453,1.0,2/14,8.76%,SLC7A11;SLC26A6
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.579046347963541,1.2927928828260584,0.17454068241469817,0.7639134019206337,1.0,7/17,18.93%,CLP1;AK7;CMPK1;NME1;AK9;NME6;NME4
prerank,peptidoglycan binding (GO:0042834),0.6440686795653462,1.29256108765623,0.1649782923299566,0.7570251181892403,1.0,5/10,15.00%,JCHAIN;PGLYRP2;HK1;NOD1;PGLYRP1
prerank,amyloid-beta binding (GO:0001540),0.49192311055911164,1.2917718129066755,0.09109730848861283,0.7528125373407502,1.0,31/79,21.07%,FPR2;CD74;CLU;APOE;ITM2C;HSPG2;PFDN5;GRIA1;TGFB2;IAPP;FZD6;ATP1A3;COL25A1;CD36;PRNP;EPHB2;PFDN1;SORL1;GRIA2;APBB3;TREM2;AGER;PFDN4;ITGB2;CRYAB;LILRB3;LILRB1;GRIA3;LDLR;CACNA1B;VBP1
prerank,chemokine receptor binding (GO:0042379),0.5265768319359629,1.291387649948432,0.1282051282051282,0.7467353988618983,1.0,4/35,8.55%,CCL5;CCL7;CXCL10;CXCL16
prerank,metallopeptidase activity (GO:0008237),0.4750683991612312,1.2908192596189687,0.06802030456852792,0.7415990164081766,1.0,27/113,19.28%,MMP8;MMP9;ECEL1;ADAMTS14;BMP1;ADAM19;THSD4;COPS6;ADAMTSL1;ADAMTSL4;LAP3;PRPF8;MMP2;EIF3H;ADAM23;MMP12;ADAMTS2;LNPEP;NUDT16;PSMD7;MMP15;METAP2;ECE1;MYSM1;ADAMTSL3;OMA1;ADAM12
prerank,metal ion binding (GO:0046872),0.4647130757285033,1.290254007044141,0.002,0.7368196029264731,1.0,81/477,12.82%,S100A8;S100A9;ANXA1;PLSCR2;TPT1;SLC25A24;ANXA11;S100A6;SCIN;HRG;S100A7A;DHH;RASGRP1;THG1L;MCTP2;DSG3;SELL;PRF1;FBLN1;CHP1;FIGNL1;DUT;TKT;IQGAP1;ITPR3;SRPK1;RASGRP2;MTHFD2;S100A11;MELK;CLEC6A;GJB2;ANXA6;ASPN;SYT4;RCN3;CLEC4E;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;APOE;ADPRH;CDH1;RCN2;NT5C3A;MEX3B;HSPA5;CDH13;CLEC3B;CDH20;CDH19;CDH7;LCP1;STIM1;BAIAP3;NLK;CALB1;GSN;ESYT2;NME1;ITPR1;SYT7;SRI;DHX36;IDH3A;CDC42BPG;PAPOLG;PRNP;SRR;SIK3;CISD3;S100A16;MMP12;NIM1K;CDH5;TPM4
prerank,metalloendopeptidase activity (GO:0004222),0.48503595280283834,1.2899508374383537,0.09937888198757763,0.7308668877711278,1.0,11/76,12.47%,MMP8;MMP9;ECEL1;ADAMTS14;ADAM19;THSD4;ADAMTSL1;ADAMTSL4;MMP2;MMP12;ADAMTS2
prerank,death domain binding (GO:0070513),0.6433443879740096,1.287790492081675,0.16666666666666666,0.7326932127111742,1.0,6/11,18.71%,DAPL1;BCL2;RACK1;DAP;RIPK1;MCL1
prerank,protein kinase activator activity (GO:0030295),0.501504410780068,1.2871789548675798,0.10656620021528525,0.7281211853953276,1.0,13/60,15.02%,LTF;CD24;NRG1;GPRC5C;DAXX;IQGAP1;RPLP1;FAM20A;ETAA1;AGAP2;STK4;CDKN1A;ABI1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.49394031869367166,-1.2854742795081788,0.1848184818481848,0.8049300113262471,1.0,5/12,5.23%,GAB2;BLNK;PIK3R1;SH2B3;SH2B2
prerank,chemoattractant activity (GO:0042056),0.5516400399079397,1.28331210040101,0.14164648910411623,0.7381962001750609,1.0,8/26,14.35%,CCL5;HMGB1;HMGB2;MIF;CXCL10;BMP4;LGALS3;FGF7
prerank,G protein-coupled receptor activity (GO:0004930),0.4652142113321637,1.2812131254178751,0.021021021021021023,0.7405103618844076,1.0,33/239,13.90%,FPR2;CXCR2;GPR174;GPR83;LTB4R;ADGRB1;ADGRG5;GPR171;ADGRG7;ADORA2A;F2R;LPAR1;P2RY1;ADGRE5;GPR45;S1PR4;ADGRL4;S1PR2;GPR75;MTNR1A;MC5R;GPR84;TSHR;C3AR1;LGR4;CXCR4;ADGRG2;GPR176;GPR141;ADGRL2;CNR2;XPR1;MRGPRE
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.5207156308851224,-1.2795171511386825,0.16666666666666666,0.7987073967223051,1.0,7/11,47.95%,CHRNA7;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,protease binding (GO:0002020),0.47584735357467367,1.2789997906144013,0.08094262295081968,0.7427275600975731,1.0,23/99,13.18%,SELL;CD28;SERPINB9;BCL2;DPP4;TIMP4;PTEN;COL1A2;ITGB1;TIMP3;STIM1;INSL3;SRI;TIMP1;ADAMTSL4;AMFR;PRNP;SERPINE1;COL1A1;CARD16;COL3A1;CSTB;POLG
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.382897297842616,-1.2782272890410085,0.11949685534591195,0.7781827830283855,1.0,4/27,8.20%,SLC8A1;SLC9A9;SLC9A6;SLC8B1
prerank,phosphatase inhibitor activity (GO:0019212),0.5718562026793168,1.2781442367953444,0.17515527950310558,0.7397991281846601,1.0,5/20,14.96%,PPP1R9B;LMTK2;SAG;LGALS3;CABIN1
prerank,anion channel activity (GO:0005253),0.4864743961443699,1.2777419142777258,0.13685344827586207,0.7347016227423352,1.0,11/61,10.91%,LRRC8C;GABRP;FXYD1;CLCC1;GABRA4;GABRB1;VDAC3;ANO4;GABRG1;VDAC2;ANO5
prerank,nucleotide diphosphatase activity (GO:0004551),0.604737909648945,1.2754598910575115,0.16464237516869096,0.738301943008155,1.0,2/14,9.10%,CILP;NUDT4
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.48763841573165234,-1.2752549772356478,0.1875,0.7633562768710992,1.0,4/13,9.87%,PDGFA;ITGA5;ITGB3;VEGFA
prerank,alpha-actinin binding (GO:0051393),0.5381534405142626,1.2719811685506528,0.1927710843373494,0.7471356372119732,1.0,5/24,12.83%,PDLIM1;PDLIM2;RARA;SYNPO2;DAG1
prerank,actin monomer binding (GO:0003785),0.5560400154285615,1.270362508484087,0.16585365853658537,0.7472421398561279,1.0,2/22,1.56%,TMSB4X;TMSB10
prerank,hyaluronic acid binding (GO:0005540),0.6366632693514154,1.269224777880207,0.20365168539325842,0.7449926543437992,1.0,3/10,7.70%,CHODL;CEMIP;CD44
prerank,protein kinase C binding (GO:0005080),0.5097983760221606,1.2688284100570855,0.1444568868980963,0.7401664053694047,1.0,15/43,18.51%,PRKCSH;HDAC9;HDAC7;NELL2;RACK1;PRKD2;ADCY6;CAVIN2;DACT3;IRS1;TIRAP;PKN1;TWF2;CCDC88A;TOP2B
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.4937998153406278,-1.268548402147673,0.19081272084805653,0.7606943779117767,1.0,3/12,5.57%,TGFBR1;BMPR2;TGFBR2
prerank,transition metal ion binding (GO:0046914),0.4541580904340051,1.2672691794270445,0.004,0.7403394988770642,1.0,82/397,16.35%,S100A8;S100A9;MMP8;LCN2;LTF;RNF125;CD4;HRG;DHH;MMP9;RASGRP1;FTL;HEPH;SCD5;CHORDC1;UPB1;CBLB;RNF7;BBOX1;SMPD1;SOD3;ATP7A;NFU1;DOHH;NEK4;TAB2;ATOX1;HHIP;SHMT1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;PIM1;SORD;RPS27;UHRF1;AFM;TIMM9;GDA;FTH1;TNFSF10;TRIM24;APIP;RPS29;CALB1;SMPDL3B;GYG1;SLC11A2;KDM4C;TIMP1;CRIP1;PHF5A;NAPEPLD;ZDHHC15;PRNP;GALT;MMP12;BLM;CDADC1;PPM1M;SUV39H2;ME1;SCD;JMJD6;LNPEP;ADH5;FBXL5;KDM5B;RBAK;SEC24D;SOD2;NUDT16;IKZF4;SLU7;ABL2;TIMM10;SAMHD1
prerank,CoA-ligase activity (GO:0016405),0.5830785271985562,1.2639934475591474,0.19591836734693877,0.747944400782104,1.0,3/14,14.68%,ACSBG1;ACSF3;ACSL1
prerank,cation transmembrane transporter activity (GO:0008324),0.4915688195858118,1.253734796507527,0.1540130151843818,0.7853637852321717,1.0,9/48,14.93%,SLC6A14;SLC36A3;SLC22A3;SLC3A2;SLC7A1;SLC1A5;SLC7A5;SLC39A1;SFXN3
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.6104527570146175,1.2521653339411993,0.18392370572207084,0.7854117272790203,1.0,4/12,16.62%,PDE4C;PDE7A;PDE3A;PDE7B
prerank,MAP kinase activity (GO:0004707),0.5877034220191312,1.2518013638045429,0.2274562584118439,0.7802240071615152,1.0,3/14,8.21%,MAPK13;MAPK9;NLK
prerank,damaged DNA binding (GO:0003684),0.4981116026720224,1.2505303829892755,0.16629955947136563,0.7790799232200221,1.0,20/44,24.41%,SDE2;HMGB1;ERCC4;RAD1;XPC;RPS3;HMGB2;APTX;ERCC1;PCNA;ERCC5;DDB2;RBBP8;SMC6;DDB1;MPG;DCLRE1B;CRY2;XPA;RAD18
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5180065582913559,1.2502134855996505,0.17006802721088435,0.7738901849588873,1.0,10/35,15.99%,LCK;ITK;TXK;MELK;ZAP70;MATK;FYN;BLK;PKDCC;ABL2
prerank,mannosyltransferase activity (GO:0000030),-0.38792422238919855,-1.2501800734623794,0.16853932584269662,0.797574561256856,1.0,10/21,23.29%,TMTC2;ALG2;PIGM;PIGB;POMT2;DPM1;DPY19L1;POMT1;ALG3;TMTC4
prerank,rRNA binding (GO:0019843),0.4966119664373892,1.2468927800600313,0.17094972067039105,0.7810663868956721,1.0,14/42,20.07%,RPS14;RPL11;RPL23;RPS9;RPS3;RPLP0;NOP53;ERI1;RPS5;PPAN;MRPS27;MRPS7;CAVIN1;MRPS18A
prerank,endopeptidase activity (GO:0004175),0.4502782878583013,1.2437422648250738,0.038,0.787877960071678,1.0,43/257,12.87%,MMP8;CTSW;GZMB;GZMA;MMP9;ECEL1;HP;HPR;ADAMTS14;TMPRSS4;NAPSA;ADAM19;RHBDF1;PRSS53;DPP4;CD5L;USP42;CTSE;MALT1;KLK1;PLAU;CLPP;PSMB5;THSD4;PCSK7;CTSZ;ADAMTSL1;USP1;ADAMTSL4;PIK3IP1;CASP4;PSMB4;USP46;TASP1;ESPL1;MMP2;PSMA7;MMP12;ADAMTS2;PSMB9;PSMA6;USP18;USP34
prerank,ribonuclease P activity (GO:0004526),-0.49055925364898556,-1.2428006738865824,0.21885521885521886,0.7985450301270997,1.0,6/11,22.88%,RPP14;RPP30;POP1;PRORP;RPP38;RPP40
prerank,aspartic-type peptidase activity (GO:0070001),0.6264129058507852,1.241819294320165,0.22443181818181818,0.7895873473978109,1.0,2/10,5.45%,NAPSA;CTSE
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5852478416256021,1.2410713850940978,0.22018348623853212,0.7866597110625675,1.0,3/14,9.76%,TIMP4;TIMP3;TIMP1
prerank,cAMP response element binding (GO:0035497),0.6181691463881508,1.2376112397622627,0.24104683195592286,0.7952743912438569,1.0,1/10,0.87%,NR4A3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.30396515590730616,-1.23301827223532,0.10526315789473684,0.8068946501969642,1.0,31/74,19.58%,PI4KB;DGKZ;HK2;ADK;PI4KA;PIK3CA;DCAKD;AGK;PKM;GNE;NOL9;PIK3CG;PIK3CB;PIK3CD;DGKH;DGKD;PGM2L1;FCSK;IPPK;GK5;PIK3C3;CHKA;FGGY;XYLB;DGKQ;PAPSS1;PANK1;IPMK;PANK2;NADK2;DGKK
prerank,protein kinase binding (GO:0019901),0.44236516859082364,1.2322413506663548,0.008,0.8112779334153379,1.0,109/480,16.94%,LCK;SKAP1;LAX1;CD3E;CD226;CD247;CD4;CD24;NR4A3;MAP4K2;CCND2;IL31RA;GHR;STAP1;DAXX;ACTB;RPS7;ACTA2;IQGAP1;PRKCSH;RPS6;CENPJ;CEACAM1;WAS;UTRN;FERMT2;FAM83H;HDAC9;HDAC7;PPP1R15A;INKA2;SMCR8;NELL2;TRIM21;PPP1R12A;RACGAP1;PRAM1;FBXO5;RACK1;ITGB1;PRKAR1B;RPS3;DCX;PRKD2;DUSP5;RARA;GSKIP;MSN;SLC12A7;KIF20A;DUSP6;PIN1;RAC2;EEF2;CAV1;BCAR1;JAK2;EEF1A1;CNKSR2;CDC42;SRCIN1;NSF;HSP90AA1;NEFH;APPL1;ADCY6;CAVIN2;DUSP2;RHOC;ILK;SMAD1;FRMD5;MAPT;DACT3;DUSP16;MAPKAPK3;SLC12A4;UNC5C;IRS1;CIT;ATF4;RPS19;CDH5;AGAP2;MAPKAPK2;NPM1;TRIM68;ARHGAP33;SIRT1;PRKAR1A;GDF3;CADPS;SHC1;TIRAP;EZR;CDKN1A;DUSP4;TICAM1;CKS2;PKN1;TREM2;MAPK4;KIF11;GSK3A;MAPRE3;NEDD9;ITGB2;CALM1;TWF2
prerank,hexose transmembrane transporter activity (GO:0015149),0.6002134061662171,1.2313370356580935,0.22054794520547946,0.8086045551934835,1.0,3/12,13.56%,SLC5A1;SLC2A1;SLC2A8
prerank,5'-3' exonuclease activity (GO:0008409),-0.4555006496187486,-1.2310263541832096,0.2222222222222222,0.7915294426492459,1.0,7/14,12.50%,DCLRE1C;CPSF3;DCP2;FAN1;EXOG;DCLRE1A;MRE11
prerank,protein phosphatase binding (GO:0019903),0.4548289539285039,1.2301230636732547,0.1094224924012158,0.8071132090693159,1.0,32/117,21.99%,LCK;SKAP1;PPP1R9B;KCNN4;IQGAP1;CEACAM1;PPP1R15A;RACK1;ATP2B4;PTPA;GRIN3A;CTNNB1;MAPT;FOXO1;MASTL;CDH5;LGALS3;AKAP11;EIF2AK3;PPP1R16B;STX17;ANK1;PPP3CB;LILRB1;JUP;MVP;TRAF3;PPP6R1;ITGA1;SMG7;JAK1;MET
prerank,glucose transmembrane transporter activity (GO:0005355),0.5626466721019813,1.2291849980805576,0.23741935483870968,0.8045938576739217,1.0,3/17,13.56%,SLC5A1;SLC2A1;SLC2A8
prerank,active ion transmembrane transporter activity (GO:0022853),0.4928341130634964,1.2286028137904468,0.2037037037037037,0.8006501103388948,1.0,14/37,20.06%,COX7A1;COX4I1;UQCR11;SLCO4C1;SLCO3A1;SLCO5A1;SLCO1C1;NDUFA4;UQCRQ;COX8A;CYB5A;UQCRFS1;UQCRC1;UQCRH
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.38456987254761466,-1.2273537855368364,0.192090395480226,0.7817933217566796,1.0,8/25,16.60%,GAB2;ADAP2;FCHSD2;DAPP1;PLEKHA2;MAPKAP1;HIP1R;PLA2G4E
prerank,ligand-gated ion channel activity (GO:0015276),0.5094547302070408,1.2262072785467328,0.19181286549707602,0.8046374874648285,1.0,10/30,19.99%,ANXA6;GABRB1;GRIA1;GRID2;GRIN3A;GRIA2;GRIK5;GRIA3;GRIK2;CNGB1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5863958854277609,1.225116023166669,0.23087621696801114,0.8031785856213337,1.0,3/12,7.04%,CDK6;CDK8;CDK1
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.4139660078058366,-1.2233881507813267,0.1932367149758454,0.7750782883108288,1.0,9/20,19.39%,SLC30A4;SLC30A5;SLC39A13;SLC39A8;SLC39A12;SLC39A10;SLC39A3;SLC30A1;SLC39A11
prerank,ligand-gated channel activity (GO:0022834),0.5094672787981717,1.2212363622352538,0.21219226260257915,0.8133810745301304,1.0,10/29,19.99%,ANXA6;GABRB1;GRIA1;GRID2;GRIN3A;GRIA2;GRIK5;GRIA3;GRIK2;CNGB1
prerank,chloride channel activity (GO:0005254),0.46628208773858576,1.221071811214441,0.19956850053937433,0.8079294533663908,1.0,9/59,10.91%,GABRP;CLCN1;FXYD1;CLCC1;GABRA4;GABRB1;ANO4;GABRG1;ANO5
prerank,poly(A) binding (GO:0008143),0.5359187440467769,1.2204913480974113,0.22021660649819494,0.8046022926430051,1.0,11/21,26.67%,RBMS3;ELAVL4;PABPC1;EIF4A3;DDX1;KHDRBS2;RBMS2;HNRNPU;TIA1;KHDRBS1;HNRNPDL
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.4580959143608263,-1.2196162968516628,0.21940928270042195,0.7677636413493778,1.0,8/13,21.82%,WDR4;TRMT1;FTSJ1;TRMT11;TRMT1L;TRMT10A;TRMT5;TRMT10C
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.5971256100266097,1.2183639081718967,0.24861878453038674,0.8074793041115448,1.0,5/11,16.91%,ITPR3;ITPR1;TRPC5;TRPC4;TRPC1
prerank,leucine zipper domain binding (GO:0043522),0.6106725911780954,1.2176572517570912,0.2532561505065123,0.804506423607109,1.0,4/10,12.58%,DAPK3;PAWR;ERC1;ATF4
prerank,double-stranded DNA binding (GO:0003690),0.43536407493720924,1.2164244877687507,0.009,0.8035690724041205,1.0,106/531,20.12%,BCL11B;LEF1;TCF7;TBX21;SATB1;EOMES;SOX3;IRF6;OVOL1;GATA3;IRX5;SOX7;RUNX3;RFX5;FOSB;TFAP4;PBX1;HOXA7;MYBL2;NHLH2;RARG;HOXB4;SPIB;H1-0;HMGB1;HMGB3;LHX4;TCF7L1;DMC1;PRRX2;AHR;HOXC4;SMAD2;ELF4;RPS3;SREBF1;RARA;RFX2;ZBTB7B;UHRF1;HMGB2;NFE2;NR4A2;POLG2;FOXP1;NR1D2;POU6F1;TCF12;NR4A1;HOXB2;NR6A1;HEY2;APTX;EGR3;GLI3;HOXC9;KLF13;MEIS2;KLF12;ELF1;MAPT;RFX1;HOXC8;ATF4;BCL6;HMBOX1;HSF2;HOXB9;ARNT2;HLF;MBNL2;DDX11;TARDBP;PCID2;ZFP41;ZBTB22;MSH6;KDM5B;RFX7;IRF4;RUNX2;RFX3;BATF3;CREB5;ERCC5;JDP2;CEBPB;ZBTB2;KLF2;BATF;TOP1;WDR48;SOX10;CGAS;HES1;HSF5;EGR2;YY1;MLX;KLF11;SNAI2;RBBP8;ZBTB33;SOX9;GLIS2;HES6
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.5685650773959141,1.2163337485223373,0.24296675191815856,0.7981063943500101,1.0,2/14,11.66%,DHRS9;RDH12
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.5280623933293985,1.2145807376451068,0.22616136919315402,0.799588960657663,1.0,6/23,17.26%,PDE4C;PDE6B;PDE7A;PDE3A;PDE7B;PDE1C
prerank,nuclear receptor binding (GO:0016922),0.45019275627018795,1.214124787337797,0.13034623217922606,0.7955676469563103,1.0,30/111,16.77%,LEF1;NR4A3;NCOR2;DAXX;TRIP6;ARID5A;RNF14;SMARCD3;NR4A2;FOXP1;NR4A1;OASL;KDM4C;MED30;STAT5B;CTNNB1;MED13;ASXL1;TRIM68;NCOR1;SIRT1;NCOA7;NCOA2;GRIP1;BAZ2A;PKN1;WBP2;PPARGC1B;NRIP1;HMGN3
prerank,kinase binding (GO:0019900),0.43628733659307267,1.2128907149823587,0.016,0.7948854298709154,1.0,78/435,13.15%,LCK;SKAP1;LAX1;CD3E;CD226;CD4;CD24;NR4A3;PTPN22;CCND2;IL31RA;GHR;CHP1;STAP1;DAXX;FLNA;ACTB;RPS7;ACTA2;IQGAP1;RPS6;CENPJ;CEACAM1;SP100;TRIP6;WAS;UTRN;FERMT2;FAM83H;HDAC7;PPP1R15A;INKA2;SMCR8;TRIM21;PPP1R12A;RACGAP1;PRAM1;FBXO5;RPS3;DCX;GADD45A;GSKIP;BARD1;MSN;SLC12A7;KIF20A;GSN;RAC2;LAPTM4B;EEF2;CAV1;BCAR1;JAK2;EEF1A1;CNKSR2;ATP1A4;CDC42;SRCIN1;PIK3IP1;NSF;NEFH;ADCY6;CTNNB1;RHOC;ILK;SMAD1;FRMD5;UBQLN1;MAPT;SLC12A4;UNC5C;CARD16;CIT;ATF4;RPS19;AGAP2;NPM1;TRIM68
prerank,protein tyrosine kinase binding (GO:1990782),0.46132440675642034,1.2123522986957094,0.1708595387840671,0.791670999539467,1.0,18/71,16.47%,CD247;CD4;NRG1;ANGPT4;CBLB;ANGPT1;CEACAM1;RACK1;ITGB1;NCK1;HSP90AA1;CDH5;GRB14;ITGAX;SHC1;TREM2;PCNA;NEDD9
prerank,secondary active transmembrane transporter activity (GO:0015291),0.47154362638480357,1.2090070373171675,0.21844127332601537,0.7992842372613365,1.0,15/51,15.80%,SLC28A2;SLC35D2;SLCO4C1;SLCO3A1;SLC25A16;MFSD2A;SLCO5A1;SLCO1C1;SLC20A1;SLC25A10;SLC35A1;SLC7A5;SLC25A14;SLC35E1;SLC25A30
prerank,histone deacetylase binding (GO:0042826),0.4470103961753789,1.208436347531141,0.1535312180143296,0.7957850818603648,1.0,21/88,18.76%,IKZF3;LEF1;NCOR2;TFAP4;HDAC9;HDAC1;NIPBL;YWHAB;HEY2;GLI3;DHX36;HSP90AA1;NUDT21;HSPA1A;NCOR1;PKN1;KAT2B;HDAC2;HES1;TOP2B;HDAC4
prerank,receptor ligand activity (GO:0048018),0.4378740541961134,1.207069173810946,0.05805805805805806,0.795378048436712,1.0,35/245,15.35%,FAM3D;NRG1;TAFA4;CCL5;WNT6;TNFRSF11B;DPP4;HMGB1;IL17D;SEMA5A;MDK;HMGB2;AMH;MIF;TGFB2;CXCL10;BMP4;GREM2;AIMP1;GREM1;BMP6;TIMP1;NBL1;CLCF1;LGALS3;EPHA7;TGFB3;GRN;TNFSF12;GDF3;FGF7;WNT3;KITLG;SEMA3E;CSPG5
prerank,chloride channel inhibitor activity (GO:0019869),-0.5039763166905349,-1.2051774384234302,0.2564935064935065,0.7906957974511909,1.0,4/10,26.05%,WNK1;STX8;WNK3;VAMP8
prerank,endopeptidase regulator activity (GO:0061135),0.4877718051462274,1.2044573978495472,0.21333333333333335,0.8002932648516072,1.0,7/40,15.06%,HRG;PSME1;CAST;CST7;TFPI;CSTB;ABCA2
prerank,sodium channel activity (GO:0005272),0.484869718528314,1.2035469705899435,0.2202247191011236,0.7984488193896075,1.0,10/37,19.95%,SCN4A;SCN1A;SCN7A;CACNA1H;HCN3;SCN8A;CACNA1I;GRIK5;GRIK2;SCN1B
prerank,antiporter activity (GO:0015297),0.5323514161400926,1.2023598376919644,0.25126262626262624,0.7978741114659962,1.0,8/20,15.80%,SLC35D2;SLC25A16;ATP1A3;SLC25A10;SLC35A1;SLC25A14;SLC35E1;SLC25A30
prerank,endoribonuclease activity (GO:0004521),-0.3412215358855997,-1.2021111092272578,0.21481481481481482,0.7826214590305877,1.0,12/32,21.95%,LACTB2;CPSF3;AGO1;INTS11;RCL1;EXOG;RIDA;ZC3H12A;ZC3H12B;SMG6;YBEY;ZC3H12C
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5572601712143133,1.2019742784340817,0.2621231979030144,0.7939485698264324,1.0,1/16,1.23%,SLC22A3
prerank,organic anion transmembrane transporter activity (GO:0008514),0.44058069498533803,1.2014860213290746,0.13779128672745694,0.7906362612393653,1.0,29/134,15.54%,SLC25A24;SLC6A14;SLC36A3;SLC22A3;SLC6A8;SLC35D2;SLC16A1;SLC3A2;SLC13A3;SLCO4C1;MPC2;SLCO3A1;MFSD2A;SLCO5A1;PDPN;SLCO1C1;SLC26A6;SLC7A1;CD36;SLC1A5;SLC27A1;SLC35A1;ABCC1;SLC7A5;SLC2A8;SLC19A2;SLC25A1;SFXN3;SFXN5
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.5325947621264847,1.2014503259289449,0.2525,0.7856019709173587,1.0,6/21,17.26%,PDE4C;PDE6B;PDE7A;PDE3A;PDE7B;PDE1C
prerank,nucleosomal DNA binding (GO:0031492),0.5312791383480966,1.2010180253689489,0.2469437652811736,0.7821597978760081,1.0,5/21,6.49%,ACTB;H1-0;SMARCC1;HDAC1;RCC1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.49652393578802867,1.1996401647016042,0.2410196987253766,0.7771765400920781,1.0,10/34,17.09%,NDUFA1;NDUFS7;NDUFA10;NDUFA5;NDUFA9;NDUFB10;NDUFA4;NDUFS6;NDUFV3;NDUFA8
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.49652393578802867,1.1996401647016042,0.2410196987253766,0.7771765400920781,1.0,10/34,17.09%,NDUFA1;NDUFS7;NDUFA10;NDUFA5;NDUFA9;NDUFB10;NDUFA4;NDUFS6;NDUFV3;NDUFA8
prerank,zinc ion binding (GO:0008270),0.43148270650658,1.199297869167013,0.047,0.7735105130877298,1.0,42/293,10.36%,S100A8;S100A9;MMP8;RNF125;CD4;HRG;DHH;MMP9;RASGRP1;CHORDC1;UPB1;CBLB;BBOX1;SMPD1;TAB2;HHIP;SHMT1;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;SORD;RPS27;UHRF1;AFM;TIMM9;GDA;TNFSF10;TRIM24;APIP;RPS29;CALB1;SMPDL3B;KDM4C;TIMP1;CRIP1;PHF5A;NAPEPLD
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.422407490422415,-1.197924128918571,0.22790697674418606,0.7596649296167459,1.0,3/16,7.54%,PTPRM;PTPRO;PTPRE
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.422407490422415,-1.197924128918571,0.22790697674418606,0.7596649296167459,1.0,3/16,7.54%,PTPRM;PTPRO;PTPRE
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5069972412084458,-1.1928212828304992,0.2832764505119454,0.7579429649829125,1.0,8/10,33.40%,DCLRE1C;TATDN1;DCLRE1A;MGME1;POLD1;EXO1;FEN1;APEX1
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5940666050444617,1.1903886375897172,0.2942008486562942,0.8014989193576251,1.0,1/11,0.90%,MAP4K2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5463091297769219,1.1903370859125995,0.2513020833333333,0.7966287716021989,1.0,7/16,20.05%,SLC13A3;SLC1A6;SLC1A5;SLC25A10;SLC25A14;SLC25A30;SLC25A22
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.5782611730723922,1.189566728922701,0.27595628415300544,0.7945381870198231,1.0,5/12,23.52%,SLC25A24;SLC19A1;SLC25A23;SLC17A9;SLC25A42
prerank,transcription cis-regulatory region binding (GO:0000976),0.42651935508242306,1.1892160487715282,0.033,0.790814103886623,1.0,93/406,20.91%,FOXN1;LEF1;TCF7;DEAF1;TBX21;SATB1;TCF15;GATA3;DACH1;ZNF395;PRDX5;SOX7;RUNX3;OTP;RFX5;TFAP4;PBX1;HMGB1;LHX4;ARID5A;AEBP1;AHR;ARID4B;XRN2;LONP1;SMAD2;RPS3;SREBF1;RARA;ZBTB7B;HDAC1;UHRF1;HMGB2;MAFK;CREBRF;NFE2;SOX5;FOXP1;ZBTB8A;ETS1;NFYB;PER2;TFDP2;MNT;TCF12;PSPC1;GLI3;DHX36;E2F6;HOXC8;MMP12;DR1;ATF4;HSF2;NPM1;ATMIN;SUV39H2;EPAS1;NCOR1;NPAS3;ZFP41;ZBTB22;CIC;RBAK;RFX3;DMTF1;PRDM5;CEBPB;NFIL3;SOX11;AGO2;PBX2;CALCOCO1;SOX10;TBP;PER1;HINFP;EGR2;RORA;HDAC4;YY1;ZFP37;MLX;BNC2;KLF11;SNAI2;RFXANK;SOX9;GLIS2;SNCA;BBX;ZNF35;LMX1B
prerank,cholesterol binding (GO:0015485),0.4674063343171739,1.1830728215451445,0.23626373626373626,0.8093611970146984,1.0,19/47,25.88%,SIDT1;STARD4;ANXA6;SOAT1;STARD3NL;GRAMD1B;CAV1;VDAC2;SYP;APOD;TSPO;SOAT2;OSBPL1A;OSBPL8;OSBPL6;GRAMD1C;PTCH1;STARD5;ERLIN1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5759524028495828,1.183026509558017,0.2923497267759563,0.8046034551547698,1.0,4/12,12.82%,ENTPD5;NUDT15;ENTPD2;ENTPD3
prerank,single-stranded DNA binding (GO:0003697),0.43890688704714004,1.1815828558096415,0.19421487603305784,0.8052361682296585,1.0,32/93,21.40%,JCHAIN;HMGB1;ERCC4;DMC1;MCM7;MCM2;FUBP1;LONP1;XPC;HMGB2;APTX;DHX36;NABP1;SUB1;MAPT;BLM;WBP11;ERCC1;DDX11;SAMHD1;ERCC5;TOP1;WDR48;MCM6;RBBP8;STN1;SMC6;PCBP1;MSH2;HNRNPU;CTC1;POLR2D
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.5591850423804876,1.180672214979876,0.28415300546448086,0.8037654542960818,1.0,5/14,14.46%,RACK1;ATP2A3;APAF1;NOD1;CTSH
prerank,platelet-derived growth factor binding (GO:0048407),0.5895995663508933,1.1783718246340926,0.28973277074542897,0.8078311162280628,1.0,4/11,12.67%,COL1A2;COL4A1;COL1A1;COL3A1
prerank,protein kinase regulator activity (GO:0019887),0.4426910491628414,1.1758589833580448,0.18782249742002063,0.812477441466681,1.0,20/95,14.95%,CCND2;GPRC5C;DAXX;ITPRIP;HEXIM1;SMCR8;PRKAR1B;RPLP1;GSKIP;CXCL10;PARVA;YWHAB;NCK1;TAOK3;CNPPD1;AGAP2;CCNY;NPM1;PRKAR1A;CDKN1A
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.5800525518412567,1.1743912684692654,0.3089887640449438,0.8136060646002595,1.0,5/11,23.52%,SLC25A24;SLC19A1;SLC25A23;SLC17A9;SLC25A42
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5020894728768365,1.1743542772200701,0.2613365155131265,0.8089593452188872,1.0,6/26,10.81%,SLC16A9;SLC16A1;MPC2;SLC16A4;SLC26A6;SLC27A1
prerank,phosphatase binding (GO:0019902),0.4350540475379782,1.1728863218975423,0.1808080808080808,0.8097276900745892,1.0,12/105,8.24%,LCK;SKAP1;KCNN4;SH2D4A;IQGAP1;CEACAM1;RCAN3;RACK1;SMAD2;SPTBN4;SH3YL1;CNST
prerank,pyridoxal phosphate binding (GO:0030170),0.5286418075908168,1.1695527757563298,0.26903553299492383,0.8175935667628528,1.0,7/20,20.02%,SHMT1;PYGB;PYGM;PYGL;SRR;OAT;PLPBP
prerank,GABA receptor activity (GO:0016917),0.5150887700066753,1.1693947033035859,0.2819875776397516,0.8134125410139874,1.0,4/21,9.37%,GABRP;GABRA4;GABRB1;GABRG1
prerank,titin binding (GO:0031432),-0.42756861621168796,-1.1689211628220582,0.2222222222222222,0.8145018663665414,1.0,2/13,2.01%,CAPN3;CALM2
prerank,signal sequence binding (GO:0005048),-0.3373637308213607,-1.1684764118437072,0.1810344827586207,0.7987474206557386,1.0,13/35,14.06%,KPNA3;BABAM2;IPO5;TNPO2;PEX5L;SEC61A1;KPNA4;AP2M1;KDELR1;RANBP6;CABP1;PEX5;KPNB1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.4760778125251106,-1.167899040273312,0.2871287128712871,0.784411813974587,1.0,6/10,20.89%,GNE;GALM;RENBP;GLCE;DSEL;GFUS
prerank,lysine N-methyltransferase activity (GO:0016278),-0.3873693763764556,-1.1636269892394557,0.2560386473429952,0.7819778694280111,1.0,8/20,14.90%,SETD3;ATPSCKMT;EHMT1;SETD4;KMT5A;SMYD2;EHMT2;EEF1AKMT1
prerank,monocarboxylic acid binding (GO:0033293),0.5311074089523766,1.162759933565905,0.26841448189762795,0.8334177285890405,1.0,3/18,10.36%,RARA;PYGL;NAPEPLD
prerank,calcium-activated potassium channel activity (GO:0015269),0.5729568171965607,1.1626227392311799,0.3141654978962132,0.8291173676162424,1.0,2/11,3.53%,KCNN4;KCNMB4
prerank,alkali metal ion binding (GO:0031420),0.5575691716745456,1.1624421069641717,0.29326287978863935,0.8250179634754522,1.0,5/13,18.76%,ADPRH;ACAT1;ATP1A1;ATP1A2;HDAC4
prerank,sulfate transmembrane transporter activity (GO:0015116),0.5395803408969924,1.1619902719090254,0.31769436997319034,0.8218962826596414,1.0,4/14,15.80%,SLC26A6;SLC25A10;SLC25A14;SLC25A30
prerank,actinin binding (GO:0042805),0.5059614546747766,1.16184285544318,0.2816020025031289,0.8177507366438664,1.0,5/21,12.83%,CSRP3;RARA;SYNPO2;CSRP2;DAG1
prerank,cGMP binding (GO:0030553),-0.4605368257043897,-1.1592807877165032,0.24422442244224424,0.7800120621286666,1.0,1/11,1.24%,PDE10A
prerank,snoRNA binding (GO:0030515),0.48773195567393085,1.154583169566028,0.2951388888888889,0.8399699200579005,1.0,5/30,10.29%,NUDT1;ISG20;BMS1;NUDT4;NUDT16L1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.479309972350367,1.1545585893032149,0.31058823529411766,0.8353567895552628,1.0,9/29,20.05%,SLC13A3;SLC1A6;SLC26A6;SLC1A5;SLC25A10;SLC25A14;SLC25A30;SLC19A1;SLC25A22
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.44193317064996485,-1.1539593775498527,0.26153846153846155,0.7811678741029595,1.0,3/12,8.56%,PAN3;CNOT8;CNOT7
prerank,beta-tubulin binding (GO:0048487),0.479082293461095,1.1533529318754614,0.28703703703703703,0.8349562801351791,1.0,7/31,10.38%,UXT;SMC3;GJB6;RACGAP1;DLEC1;ARL8B;APPL1
prerank,phosphatidylglycerol binding (GO:1901611),-0.44701672439447604,-1.1532204596042808,0.2755905511811024,0.7684371560800293,1.0,4/13,11.14%,OPA1;PLEKHN1;PITPNA;PLTP
prerank,phosphatidate phosphatase activity (GO:0008195),-0.42484391615097794,-1.1527169287061203,0.25,0.7557086347612656,1.0,5/13,13.68%,LPIN2;PLPPR4;PLPP1;PLPP5;LPIN1
prerank,thioesterase binding (GO:0031996),0.5662084699120548,1.152650454691339,0.33152909336941816,0.8330222177550421,1.0,2/11,9.79%,TRAF1;CDC42
prerank,lysophospholipase activity (GO:0004622),-0.37575268865871014,-1.1520297186195378,0.25380710659898476,0.7440650196527874,1.0,6/20,14.74%,ABHD12;PNPLA7;MGLL;ABHD4;PLA2G4A;LYPLA1
prerank,histone methyltransferase binding (GO:1990226),-0.45120797633632337,-1.151222430913056,0.292358803986711,0.7330182680411895,1.0,7/11,23.14%,CBX1;LCOR;CBX3;NOP56;PHF1;LCORL;PRDM4
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.5786673535303974,1.1509894383076305,0.3267605633802817,0.8344546698897001,1.0,3/10,14.05%,PRKAR1B;CXCL10;PRKAR1A
prerank,cytokine receptor binding (GO:0005126),0.4305030779700674,1.1499492129295361,0.25967413441955195,0.8338691139630658,1.0,17/83,16.29%,OSMR;IL27RA;CCL5;TRIP6;TLR9;SMAD2;MIF;TGFB2;JAK2;IL6ST;FKBP1A;TGFBR3;CLCF1;SDCBP;KITLG;USP15;IL27
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5649894997503283,1.1481750386556415,0.3347222222222222,0.8361766076695372,1.0,4/11,15.44%,NUDT1;NUDT4;NUDT16L1;NUDT16
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.429174150196195,-1.1470334265202042,0.2795275590551181,0.7324073252031864,1.0,6/14,22.88%,RPP14;RPP30;POP1;PRORP;RPP38;RPP40
prerank,PDZ domain binding (GO:0030165),0.4390860301845339,1.1465633490780731,0.26873661670235544,0.8377016182359693,1.0,13/61,12.42%,CCDC88C;GNG5;PTEN;SDC2;ATP2B4;GRIA1;GRID2;SLC26A6;NSF;SRR;TGFBR3;ERC1;CIT
prerank,retinoid X receptor binding (GO:0046965),0.570243071322603,1.1465077922011329,0.315086782376502,0.8333720081192744,1.0,3/11,6.59%,RARG;ARID5A;NR4A2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.46696257540543307,-1.1457290599737877,0.2921686746987952,0.722925617198826,1.0,5/10,18.02%,TNFAIP3;CYLD;OTUD4;STAMBPL1;YOD1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.41004744156935236,1.1452334027085571,0.032,0.8331946820003948,1.0,150/730,20.12%,IKZF3;BCL11B;LEF1;STAT4;TCF7;TBX21;SATB1;EOMES;SOX3;IRF6;TCF15;OVOL1;NR4A3;SIX5;ZKSCAN4;GATA3;ZBTB42;DACH1;ZNF395;IRX5;SOX7;RUNX3;RFX5;FOSB;TFAP4;EHF;PBX1;HOXA7;MYBL2;NHLH2;RARG;HOXB4;SPIB;TCF7L1;PRRX2;AHR;HOXC4;IKZF2;SMAD2;ZBTB39;MYB;ELF4;SREBF1;CHD2;RARA;RFX2;ZBTB7B;HDAC1;MAFK;NFE2;NR4A2;SOX5;NR1H2;FOXP1;PRMT5;NR1D2;DACH2;MXD4;ETS1;POU6F1;NFYB;TRIM24;ZFHX2;MNT;TCF12;NR4A1;HOXB2;NR6A1;HEY2;STAT5B;EGR3;GLI3;DHX36;ZNF18;ZBTB16;HOXC9;KLF13;CC2D1A;ZFP62;MEIS2;KLF12;EBF1;ELF1;HOXC5;ZBTB6;SMAD1;ZBTB24;GTF2IRD1;E2F6;PAX5;FOXP4;RFX1;FOXO1;ZBTB25;ATF4;HIVEP2;BCL6;HSF2;HOXB9;ARNT2;HLF;EBF2;MYT1L;RFX7;IRF4;IKZF4;RUNX2;RFX3;WBP2;BATF3;CREB5;DMTF1;ZSCAN22;PRDM5;JDP2;NRIP1;CEBPB;NKRF;ZBTB2;KLF2;BATF;NFIL3;TOP1;ZNF83;SOX11;PRRX1;ZSCAN18;PBX2;CALCOCO1;SOX10;HES1;PER1;HINFP;HSF5;EGR2;RORA;HDAC4;LYL1;YY1;MLXIPL;MLX;KLF11;SNAI2;ZBTB33;MECOM;PBX3;SOX9;ZNF383;GLIS2;HES6
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5532888567451837,1.1439034438556772,0.3204272363150868,0.8337594677962885,1.0,2/13,6.48%,EHHADH;MIF
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4085006100276076,1.1410183782622538,0.059,0.8395423133932148,1.0,136/597,23.32%,FOXN1;BCL11B;LEF1;TCF7;TBX21;EOMES;SOX3;IRF6;OVOL1;GATA3;IRX5;SOX7;RUNX3;RFX5;FOSB;TFAP4;PBX1;HOXA7;MYBL2;NHLH2;RARG;HOXB4;SPIB;HMGB1;LHX4;ARID5A;TCF7L1;PRRX2;AHR;MCM7;MCM2;ARID4B;HOXC4;ELF4;SREBF1;RARA;RFX2;ZBTB7B;HMGB2;MAFK;NFE2;NR4A2;SOX5;FOXP1;NR1D2;ETS1;POU6F1;NFYB;PER2;TCF12;NR4A1;HOXB2;NR6A1;HEY2;PSPC1;EGR3;GLI3;DHX36;HOXC9;KLF13;MEIS2;KLF12;ELF1;RFX1;HOXC8;ATF4;BCL6;HMBOX1;HSF2;HOXB9;ATMIN;SUV39H2;ARNT2;HLF;MBNL2;NCOR1;MLH3;DDX11;ZFP41;ZBTB22;KDM5B;RFX7;IRF4;RUNX2;RFX3;BATF3;CREB5;DMTF1;PRDM5;JDP2;CEBPB;ZBTB2;KLF2;BATF;SOX11;CALCOCO1;SOX10;HES1;TBP;PER1;HINFP;HSF5;MCM6;EGR2;HDAC4;YY1;MLX;BNC2;KLF11;SNAI2;ZBTB33;SOX9;GLIS2;HES6;SNCA;BBX;ZW10;HNRNPU;LMX1B;KLF6;ORC2;TEAD1;EGR1;SOX13;TBL1XR1;ERBB4;SMAD6;NFIB;ETV3;MBD2;YBX1;ARID4A;DDIT3;CRY2;THRB;XPA
prerank,sequence-specific DNA binding (GO:0043565),0.4077120873163414,1.140882205451492,0.054,0.8355536701592683,1.0,123/590,21.93%,IKZF3;BCL11B;LEF1;TCF7;TBX21;SATB1;EOMES;SOX3;IRF6;OVOL1;CSRNP1;GATA3;IRX5;SOX7;RUNX3;RFX5;FOSB;TFAP4;PBX1;BCL2;HOXA7;MYBL2;NHLH2;RARG;HOXB4;SPIB;LHX4;ARID5A;TLR9;TCF7L1;PRRX2;AHR;HOXC4;LONP1;CHCHD2;ELF4;SREBF1;RARA;RFX2;ZBTB7B;UHRF1;MAFK;NFE2;NR4A2;CSRNP3;FOXP1;PRMT5;NR1D2;SLTM;POU6F1;TCF12;NR4A1;HOXB2;NR6A1;HEY2;EGR3;GLI3;HOXC9;KLF13;MEIS2;KLF12;ELF1;NCL;MAPT;RFX1;HOXC8;MMP12;FOXO1;ATF4;BCL6;HMBOX1;HSF2;HOXB9;ARNT2;EPAS1;HLF;MBNL2;ZFP41;ZBTB22;KDM5B;RFX7;IRF4;RUNX2;RFX3;BATF3;CREB5;PRDM5;JDP2;CEBPB;ZBTB2;KLF2;BATF;CALCOCO1;HDAC2;SOX10;HES1;HSF5;EGR2;RORA;HDAC4;HLX;YY1;MLX;KLF11;SNAI2;ZBTB33;STN1;SOX9;GLIS2;HES6;BBX;HNRNPU;ZNF35;LMX1B;MECP2;CTC1;KLF6;SMG7;ZNF148;TEAD1;CXXC1;EGR1;SOX13
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.5483455496617365,1.1384884322402549,0.3397790055248619,0.8397496733374596,1.0,1/12,0.84%,B3GNT3
prerank,protein heterodimerization activity (GO:0046982),0.4136938205114762,1.1380702979953876,0.19578313253012047,0.8366546044496567,1.0,48/178,20.48%,CD3E;TPM2;CYBA;BCL2;CYBB;SDCBP2;SMC3;ABCG4;AHR;ITGB1;GADD45A;TENM2;RALGAPB;METTL3;RCC1;NR4A2;BARD1;PRMT5;ZHX2;PPP2R1A;NR4A1;BMP6;EXT2;ATP1A1;SRI;ATP1A2;HIP1;ATF4;TPM4;GCA;ARNT2;EPAS1;PPP2CA;NPAS3;SDCBP;KATNB1;PAFAH1B1;TRMT112;ATP1B2;LSM6;P4HB;TOP2B;MCL1;MLXIPL;MLX;PAFAH1B2;TENM4;UBA3
prerank,tubulin binding (GO:0015631),0.4118529122867117,1.1362132840235228,0.118,0.8389129918232973,1.0,68/296,16.68%,S100A8;S100A9;CCDC88C;FAM110C;CHP1;UXT;CENPJ;DIXDC1;SMC3;BIRC5;GJB6;KIF26B;ALDOA;RMDN3;RACGAP1;KIF5A;TTLL12;AGBL1;RPS3;DCX;KIF21A;HOOK1;SAXO2;POLB;DLEC1;ARL8B;KIF20A;MAP1LC3A;DNM3;MAPRE2;TBCA;ARL3;KIF22;TTLL11;RABGAP1;RAB11A;NEFH;APPL1;DLGAP5;ARL4C;PRNP;GPAA1;MAPT;PRUNE1;UNC5C;MACO1;CCSAP;DAG1;REEP1;NDRG1;EML5;GAPDH;KIF3B;MAP1B;NCALD;KIF5C;EZR;FYN;PAK1;KATNB1;B9D2;MTCL1;STMN2;KIFC1;MDM1;MAPRE3;PAFAH1B1;CCDC181
prerank,microtubule motor activity (GO:0003777),0.44343613790817693,1.133908381262629,0.28354978354978355,0.8427092355423645,1.0,15/51,16.23%,DNAH8;SMC3;KIF26B;KIF5A;KIF21A;KIF24;KIF20A;KIF22;DNAH3;KIFC3;KIF3B;DYNLRB1;KIF5C;KIF11;KIFC1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4875429290936186,1.1320318797397873,0.3075030750307503,0.845379094611801,1.0,12/24,25.83%,AK7;PMVK;CMPK1;NME1;AK9;PPIP5K1;NME6;NME4;IP6K2;IP6K1;AK4;AK3
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.47604928994633106,1.1288905669680842,0.34777376654632974,0.8522854848163128,1.0,8/29,17.60%,HEXIM1;INKA2;PRKAR1B;SFN;CIT;PRKAR1A;CDKN1A;KAT2B
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4033920787244918,1.1273859529331143,0.053,0.8532554028737234,1.0,149/731,20.12%,IKZF3;BCL11B;LEF1;STAT4;TCF7;TBX21;SATB1;EOMES;SOX3;IRF6;OVOL1;NR4A3;SIX5;ZKSCAN4;GATA3;ZBTB42;DACH1;ZNF395;IRX5;SOX7;RUNX3;RFX5;FOSB;TFAP4;EHF;PBX1;HOXA7;MYBL2;NHLH2;RARG;HOXB4;SPIB;TCF7L1;PRRX2;AHR;HOXC4;IKZF2;SMAD2;ZBTB39;MYB;ELF4;SREBF1;CHD2;RARA;RFX2;ZBTB7B;HDAC1;UHRF1;HMGB2;MAFK;NFE2;NR4A2;SOX5;NR1H2;FOXP1;NR1D2;DACH2;MXD4;ETS1;POU6F1;NFYB;ZFHX2;MNT;TCF12;NR4A1;HOXB2;NR6A1;HEY2;STAT5B;EGR3;GLI3;DHX36;ZNF18;ZBTB16;HOXC9;KLF13;CC2D1A;ZFP62;MEIS2;KLF12;EBF1;ELF1;HOXC5;ZBTB6;SMAD1;ZBTB24;GTF2IRD1;E2F6;PAX5;FOXP4;RFX1;FOXO1;ZBTB25;ATF4;HIVEP2;BCL6;HSF2;HOXB9;ARNT2;HLF;EBF2;MYT1L;RFX7;IRF4;IKZF4;RUNX2;RFX3;WBP2;BATF3;CREB5;DMTF1;ZSCAN22;PRDM5;JDP2;NRIP1;CEBPB;NKRF;ZBTB2;KLF2;BATF;NFIL3;TOP1;ZNF83;SOX11;PRRX1;ZSCAN18;PBX2;CALCOCO1;SOX10;HES1;PER1;HINFP;HSF5;EGR2;RORA;HDAC4;LYL1;YY1;MLXIPL;MLX;KLF11;SNAI2;ZBTB33;MECOM;PBX3;SOX9;ZNF383;GLIS2;HES6
prerank,RNA binding (GO:0003723),0.39980289070847663,1.126022452616385,0.02,0.8540003798654552,1.0,402/1321,22.64%,TMSB4X;FAU;RPS14;TPT1;ANXA11;RPS27A;GTPBP4;RPL36A;THG1L;SYF2;NUDT1;RPS12;MRPS12;RPL41;MEX3A;RPS25;MBNL3;RPL37;RPS24;RPL32;RPL27A;RPL28;AHNAK;RPS16;IFIT2;SIDT1;RBM11;RPS20;PUS7;RPL35A;RPL30;LGALS1;DUT;RPL9;RPL11;AGFG1;MRPL13;RPL13;FLNA;PLEC;RPS7;RPL23;MRPL23;RPL17;MRPL21;RPL18;RPS6;DCN;RPS23;CMSS1;DIAPH1;RPS9;SELENOH;DBR1;TRIP6;SRPK1;RPS18;RPS8;EIF3L;MSI2;YTHDF3;RTRAF;SEC61B;H1-0;HMGB1;RPL14;HSPA8;HMGB3;MRPL12;GPATCH8;HEXIM1;MRPL40;MRPL22;BICC1;RCAN3;RPL8;EIF1B;ILF3;PPIA;BMS1;EIF2A;EIF2S1;LBR;HELZ2;RPL38;ALDOA;RPS15;XRN2;MRPS14;RPL21;SLC3A2;FUBP1;LONP1;RACK1;RPL15;RPS26;NELFCD;SLC4A1AP;ACTN1;RPS3;RPL29;EIF3I;RPS2;HNRNPAB;CHD2;RPSA;TRUB2;NQO1;PTBP3;MEX3B;RPL34;RPL10A;RPS27;PRDX1;METTL3;HMGB2;ZYX;DHX57;CAST;POLR1G;NOC4L;RPUSD4;BARD1;RPL39;ESF1;DCP1A;RBMS3;RPL23A;RPL31;LSM3;MSN;ZCCHC9;MKRN1;NOL10;IMMT;RBM15;HEATR6;SLTM;SYNE1;NSA2;CSTF2;SNRPG;NVL;TARBP2;RPS4X;UBE2L3;AIMP1;NOC3L;TBCA;FTSJ3;EEF2;RPL27;MRPL15;NME1;WBP4;RPS28;NUDT4;EEF1A1;RPL19;OASL;PABPC1;RBM4B;VIM;EIF4A3;APTX;RPL18A;PSPC1;MRPL54;ARL6IP4;SYNCRIP;PCBP4;FASN;LUC7L2;DHX36;RPS21;CHERP;RPLP0;CCAR2;NUDT16L1;PHF5A;HSP90AA1;NOP53;SNRPA;ZFP36L2;DDX43;DRG2;SCAF4;NUDT21;FAM98A;PRPF8;G3BP2;MDH2;UTP11;EIF1;NCL;CPEB3;EIF3H;CWC22;SUB1;ZFR;MAPT;SUMO2;EXOSC1;NOL8;S100A16;MPHOSPH10;CSTF3;RPL35;CDC40;ERI1;YBX3;NYNRIN;RPS10;SF3B2;SF3B1;RBM10;RPL7;NOL7;RPS19;PTBP2;PSMA6;LGALS3;CSTB;GSPT1;SF3A3;MANF;NPM1;DDX1;ZCRB1;RPS5;ETF1;SNTB2;METTL14;FBL;MRPL4;SF3A2;WBP11;GRN;SAMD4A;TRMT6;RPL4;HSPA1A;MBNL2;JMJD6;SRSF7;FASTKD3;HNRNPF;PSMC1;KHSRP;RPS15A;DDX11;RPP25L;TARDBP;RBFOX1;POLDIP3;PCID2;CHCHD1;EIF3E;GANAB;KHDRBS2;BAZ2A;DDX51;RBM8A;TENT5A;EZR;CRKL;SRRM3;SNRPB;PPAN;NUDT16;CCDC86;AFF2;ZC3H18;RBM27;HELB;ZC3HAV1;FNDC3B;MTCL1;DROSHA;BTF3;ZC3H7B;RPS17;NSUN2;HUWE1;EIF3G;SAMHD1;PPARGC1B;MRPS27;RBMS2;CDK13;RAVER2;EDF1;NKRF;DARS1;DEK;DDX46;IREB2;NDUFV3;TWF2;RBFOX2;KHDRBS3;PRRC2B;RBM20;RPL37A;TOP1;AGO2;LSM6;RSRC2;YTHDC1;SCG3;RBM42;DDX50;CSRP1;SLBP;HDAC2;NAF1;FAM32A;TUFM;METAP2;RBM5;P4HB;RPL22;RPL10;RBM28;CORO1A;RRP12;RALYL;MRPS7;TRMT9B;EXOSC10;YY1;CAVIN1;RPS11;RPL7A;CLUH;RNASEL;CANX;TSNAX;SEC63;CKAP4;MBNL1;EIF1AX;EIF5B;MAP4;GAR1;NIP7;CSTF2T;COL14A1;PCBP1;HELZ;PCBP3;ANP32A;PRPF31;ASS1;YWHAZ;HNRNPU;RPL3;LSM4;PPIB;RIMS1;GRSF1;WDR36;RDX;MECP2;UTP20;SRSF4;SRP19;PEG10;HSP90AB1;BRIX1;DGCR8;POLR2D;YWHAG;PRPF6;EXOSC9;ZGRF1;SMG7;SUGP2;MKRN2;POP5;TRIM28;DIDO1;MRPL41;MRPL27;TUBB4B;PPRC1;RNMT;DDX17;DDX41;KARS1;HADHB;TIA1;DDX6;PRPF38B;TIAL1;SF3B6;BOP1;SARS1;SARS2;WDR43;PPP1R10;TFRC
prerank,glutamate receptor binding (GO:0035254),-0.3840897377427382,-1.125705395749751,0.2922374429223744,0.7664483084430858,1.0,11/17,24.48%,DLG4;HOMER1;SYNDIG1;HOMER3;CAMK2A;SHANK1;HOMER2;AKAP5;SHISA7;SHANK3;IGSF11
prerank,cadherin binding (GO:0045296),0.40361779881281434,1.1226785599769638,0.149,0.8615337699307164,1.0,106/315,23.35%,ANXA1;PDLIM1;PKP1;AHNAK;PRDX6;TAGLN2;FXYD5;DNAJB1;FLNA;EVPL;PLEC;CCT8;IQGAP1;PKP4;S100A11;RPL14;HSPA8;KDR;EIF2A;ALDOA;SLC3A2;RACK1;RPL15;RPS26;CDH1;ITGB1;RPL29;RPS2;HSPA5;RPL34;PRDX1;CAST;PLCB3;MPP7;CDH13;RPL23A;CDH20;CDH19;CDH7;PARVA;YWHAB;SH3GLB2;ESYT2;EEF2;SFN;PAK4;ANK3;FASN;BSG;NCK1;CC2D1A;EPS15L1;CTNNB1;UNC45A;ABCF3;CHMP5;ERC1;STK24;CDH5;TRPC4;MICALL1;HSPA1A;CAPG;NDRG1;CTNNA3;EIF3E;FNBP1L;EZR;CRKL;ABI1;VCL;EEF1D;RUVBL1;ZC3HAV1;MB21D2;PFKP;TWF2;JUP;TMPO;RARS1;AFDN;EPS8L1;RPL7A;CDH8;PCBP1;PSMB6;YWHAZ;CDH11;RDX;COBLL1;CDH12;OLA1;HSP90AB1;PPP1CA;CTNND2;STK38;DLG1;DDX6;STXBP6;BZW2;IDH1;GIGYF2;EHD1;CALD1;CDH4;SLK
prerank,protein tyrosine kinase activity (GO:0004713),0.41542926184953255,1.1204484740181904,0.2934560327198364,0.8652059820881025,1.0,37/108,24.52%,LCK;ITK;DDR2;TXK;LMTK2;MELK;KDR;KIT;HIPK1;JAK2;ZAP70;EPHB2;FLT3;EPHA7;MATK;EPHA5;FYN;HIPK3;BLK;PKDCC;ABL2;IGF1R;NTRK3;EPHA3;WEE1;JAK1;ROR1;DYRK2;MET;ERBB4;DDR1;FGFR1;INSR;FGFR3;TNK2;AXL;CSK
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.4419505037713385,-1.1194365707126153,0.3225806451612903,0.7714352587953285,1.0,7/11,25.54%,NAA25;NAA40;NAA10;NAA60;NAA30;NAA15;NAA80
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3999750404410722,1.118857909258435,0.059,0.8667510434686007,1.0,166/830,20.12%,IKZF3;BCL11B;LEF1;STAT4;TCF7;DEAF1;TBX21;SATB1;EOMES;SOX3;IRF6;TCF15;OVOL1;NR4A3;SIX5;ZKSCAN4;GATA3;ZBTB42;DACH1;ZNF395;IRX5;SOX7;RUNX3;OTP;RFX5;FOSB;TFAP4;EHF;PBX1;HOXA7;MYBL2;NHLH2;RARG;HOXB4;SPIB;LHX4;TCF7L1;AEBP1;PRRX2;HOXC4;IKZF2;SMAD2;ZBTB39;MYB;ELF4;RPS3;SREBF1;CHD2;RARA;RFX2;ZBTB7B;HDAC1;MAFK;CREBRF;NFE2;NR4A2;SOX5;NR1H2;FOXP1;NR1D2;DACH2;ZBTB8A;MXD4;ETS1;POU6F1;NFYB;TFDP2;ZFHX2;MNT;TCF12;NR4A1;HOXB2;NR6A1;HEY2;STAT5B;EGR3;GLI3;DHX36;ZNF18;ZBTB16;HOXC9;KLF13;CC2D1A;ZFP62;MEIS2;KLF12;EBF1;ELF1;HOXC5;ZBTB6;SMAD1;ZBTB24;GTF2IRD1;E2F6;PAX5;FOXP4;RFX1;HOXC8;FOXO1;ZBTB25;ATF4;HIVEP2;BCL6;HSF2;HOXB9;ARNT2;EPAS1;HLF;EBF2;NPAS3;ZFP41;ZBTB22;CIC;RBAK;MYT1L;RFX7;IRF4;TBPL1;IKZF4;RUNX2;RFX3;WBP2;BATF3;CREB5;DMTF1;ZSCAN22;PRDM5;JDP2;NRIP1;CEBPB;NKRF;ZBTB2;KLF2;BATF;NFIL3;TOP1;ZNF83;SOX11;PRRX1;ZSCAN18;PBX2;CALCOCO1;SOX10;HES1;TBP;PER1;HINFP;HSF5;EGR2;RORA;HDAC4;LYL1;YY1;ZFP37;MLXIPL;MLX;KLF11;SNAI2;ZBTB33;RFXANK;MECOM;PBX3;SOX9;ZNF383;GLIS2;HES6
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.40635145617178847,1.1141534423657624,0.22590361445783133,0.8799879186115942,1.0,49/188,23.25%,FOXN1;TCF7;TBX21;GATA3;SOX7;TFAP4;PBX1;HMGB1;ARID5A;AHR;ARID4B;HMGB2;MAFK;SOX5;ETS1;NFYB;PER2;TCF12;PSPC1;DHX36;ATF4;ATMIN;SUV39H2;NCOR1;RFX3;DMTF1;PRDM5;CEBPB;SOX11;CALCOCO1;SOX10;TBP;PER1;HINFP;EGR2;HDAC4;YY1;BNC2;KLF11;GLIS2;SNCA;EGR1;SOX13;TBL1XR1;ERBB4;SMAD6;ARID4A;DDIT3;CRY2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.46917457391840656,1.1128545897111792,0.3532863849765258,0.8804842236933538,1.0,8/27,15.57%,ATP2B4;ATP2A3;MAGT1;SLC11A2;ITPR1;KCNA1;TUSC3;ATP2B3
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5490993020235175,1.1127006832592194,0.3728129205921938,0.8766571082970135,1.0,3/12,10.78%,NDUFS7;NQO1;DCXR
prerank,androgen receptor binding (GO:0050681),0.4831231090347502,1.109354316484316,0.3563636363636364,0.8839917254825203,1.0,7/25,15.51%,DAXX;ARID5A;RNF14;FOXP1;KDM4C;TRIM68;PKN1
prerank,motor activity (GO:0003774),0.4283114508688505,1.1060558718760833,0.3233404710920771,0.8913053121580398,1.0,16/60,16.23%,DNAH8;SMC3;KIF26B;KIF5A;KIF21A;KIF24;KIF20A;PIN1;KIF22;DNAH3;KIFC3;KIF3B;DYNLRB1;KIF5C;KIF11;KIFC1
prerank,P-type ion transporter activity (GO:0015662),0.5446058918093519,1.105775188026895,0.363265306122449,0.8879065087469445,1.0,5/12,17.17%,ATP7A;ATP2B4;ATP2A3;ATP2B3;ATP2B2
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3458424100073807,-1.0998947343424181,0.3005464480874317,0.8138574676423972,1.0,7/25,14.26%,FER;GRB2;SNX2;CNOT9;ATXN2;EFEMP1;TGFA
prerank,ribosome binding (GO:0043022),0.43363742496308827,1.09762721863793,0.3530701754385965,0.9127167965535041,1.0,11/46,13.29%,YTHDF3;SEC61B;EIF2A;EIF2S1;RACK1;RPSA;EEF2;NAA16;CPEB3;ERI1;ETF1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.44908451107738023,-1.097554274924695,0.34057971014492755,0.8076591326425807,1.0,8/11,46.93%,KCND3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ3;KCNE2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.48251537097953257,1.0968672877500865,0.37752525252525254,0.9110630968381995,1.0,12/20,28.84%,AK7;CMPK1;AK9;DLG1;TJP2;DLG2;AK2;MAGI3;AK4;AK3;MPP1;CASK
prerank,ribonuclease P RNA binding (GO:0033204),-0.45423494883049076,-1.0957167871744318,0.3322475570032573,0.8000283892810991,1.0,5/10,22.88%,RPP14;RPP30;POP1;RPP38;RPP40
prerank,potassium channel regulator activity (GO:0015459),0.4292388498940575,1.0948135027876387,0.37923497267759565,0.9137954875198748,1.0,4/49,3.98%,CHP1;FLNA;KCNMB4;AMIGO1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5283739908380902,1.0944044961858386,0.3813443072702332,0.9109551796574697,1.0,4/12,18.14%,NAPSA;CTSE;BACE2;SPPL3
prerank,gated channel activity (GO:0022836),0.5164255989195173,1.0932681250490108,0.38088829071332436,0.9107569497569858,1.0,4/14,16.51%,PIEZO2;TMEM266;TMC7;TMC8
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.34188543470718274,-1.0918005220971574,0.3028571428571429,0.7977442676007457,1.0,10/24,22.78%,PLEKHA8;OSBP;PLA2G4A;GOLPH3;RUBCNL;CERT1;LANCL2;PLA2G4E;PLEKHA5;OSBPL5
prerank,G protein-coupled receptor binding (GO:0001664),0.3988190439410397,1.090668746656601,0.3424242424242424,0.9156551880878541,1.0,18/132,14.59%,CCDC88C;CCL5;WNT6;FLNA;HSPA8;SAG;S1PR2;NPB;RTP4;INSL3;GNAI2;ARHGEF12;ZNRF3;REEP1;HSPA1A;GNA13;WNT3;SDCBP
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5456849576943125,1.0903462103746946,0.4043795620437956,0.9124261757311968,1.0,4/10,8.67%,SLCO4C1;SLCO3A1;SLCO5A1;SLCO1C1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.5505579863042297,1.0903012562850114,0.3869047619047619,0.908307707337457,1.0,3/10,17.60%,HEXIM1;CDKN1A;KAT2B
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.40502741589725866,-1.0897239752555772,0.3493975903614458,0.7909297311190758,1.0,10/14,46.93%,KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5;KCNJ3;KCNA5;KCNE2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5482046685778892,1.0892305834157174,0.389196675900277,0.9079634305268958,1.0,1/11,2.17%,PPP1R14A
prerank,Hsp90 protein binding (GO:0051879),0.4456468784475525,1.0892268646618888,0.3850574712643678,0.9037904120601322,1.0,6/33,11.67%,CHORDC1;KDR;AHR;RPS3;UNC45A;MAPT
prerank,DNA binding (GO:0003677),0.3876300720789444,1.088023594983765,0.142,0.9037999143884394,1.0,155/694,20.75%,IKZF3;LEF1;TBX21;SATB1;EOMES;SOX3;IRF6;NR4A3;CSRNP1;GATA3;DEDD2;TRIM16;ZNF395;TFPT;OTP;RFX5;FOSB;TFAP4;EHF;SPATA24;PBX1;BCL2;HOXA7;RARG;JCHAIN;SDE2;H1-0;HMGB1;HMGB3;ERCC4;RAD1;LHX4;ARID5A;TCF7L1;DMC1;ING2;ILF3;AHR;MCM7;MCM2;RPS15;FUBP1;LONP1;CHCHD2;SMAD2;XPC;RPS3;SREBF1;CHD2;RFX2;RPS27;HMGB2;MAFK;NFE2;NR4A2;DNMT1;CSRNP3;POLG2;NR1H2;SLTM;ETS1;POU6F1;SYCP2;MSL3;NFYB;MLF1;WDR76;RLF;NR4A1;HOXB2;POLE;NR6A1;PDS5B;HEY2;OASL;APTX;TSHZ2;DHX36;ZBTB16;MEIS2;KLF12;NABP1;HP1BP3;ZBTB6;SUB1;GTF3C3;MAPT;MMP12;FOXO1;ATF4;RPL7;HIVEP2;BLM;BCL6;HMBOX1;POLG;WBP11;ERCC1;EPAS1;HLF;BRIP1;DDX11;TARDBP;PALB2;PCID2;TAF6;ZBTB22;MSH6;KDM5B;IRF4;PCNA;RFX3;HUWE1;PRDM5;SAMHD1;ERCC5;CEBPB;KLF2;BATF;TOP1;MBD5;WDR48;CALCOCO1;HDAC2;SOX10;RYBP;CGAS;DDB2;HES1;RBM5;HINFP;MCM6;EGR2;RORA;HDAC4;LYL1;HLX;YY1;MLXIPL;MLX;TSNAX;SNAI2;RBBP8;ZBTB33;MECOM;STN1;SOX9;SMC6;DDB1;PCBP1;CCNT1;MSH2;HNRNPU;MPG;ZNF35
prerank,BMP binding (GO:0036122),0.5349619140110822,1.087356395114746,0.40746054519368724,0.9021463511273723,1.0,3/11,11.27%,GREM2;GREM1;NBL1
prerank,phosphatase activity (GO:0016791),0.4083995164489496,1.086958895128013,0.37145855194123817,0.8992824741020914,1.0,14/73,11.94%,ACP5;CILP;PTPN22;PLPPR5;NT5M;DUSP5;ACP3;APTX;NUDT16L1;ENOPH1;ATP1A2;DUSP16;PRUNE1;PLPP6
prerank,aminopeptidase activity (GO:0004177),-0.3295185437141478,-1.0860465483951252,0.3314285714285714,0.7898510369838284,1.0,4/26,5.27%,RNPEP;NPEPPS;MMP16;MMP14
prerank,cell adhesion mediator activity (GO:0098631),0.4676005388752045,1.0849889637601333,0.3977832512315271,0.9021586418532983,1.0,7/24,13.89%,EMB;DSCAM;CD47;JAM3;BSG;NTNG1;NPTN
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5246527736250554,1.0844011021419087,0.4016282225237449,0.9001173943317564,1.0,1/12,1.39%,TRAF1
prerank,calcium channel regulator activity (GO:0005246),0.4464751721070779,1.0839675819172507,0.3829787234042553,0.89745829688062,1.0,10/37,16.77%,RRAD;CACNG7;STIM1;ITPR1;SRI;REM1;FKBP1A;INAFM1;INAFM2;CALM1
prerank,microtubule binding (GO:0008017),0.3949002097091406,1.081992288727311,0.2852852852852853,0.9003292874172276,1.0,49/222,17.32%,S100A8;S100A9;CCDC88C;CHP1;UXT;BIRC5;GJB6;KIF26B;RMDN3;RACGAP1;KIF5A;RPS3;DCX;KIF21A;HOOK1;SAXO2;POLB;KIF20A;MAP1LC3A;STIM1;DNM3;MAPRE2;ARL3;KIF22;RAB11A;NEFH;DLGAP5;PRNP;MAPT;MACO1;CCSAP;REEP1;CLIP4;NDRG1;EML5;GAPDH;KIF3B;MAP1B;KIF5C;EZR;KATNB1;MTCL1;KIFC1;MDM1;MAPRE3;PAFAH1B1;CCDC181;HAUS4;CLIP3
prerank,mRNA 3'-UTR binding (GO:0003730),0.4065308184793962,1.0819751873906116,0.3507853403141361,0.89638142357608,1.0,19/79,16.54%,RPL41;RPS7;EXOSC4;ILF3;RBMS3;ELAVL4;BOLL;PABPC1;PCBP4;DHX36;ZFP36L2;NUDT21;CPEB3;YBX3;KHSRP;TARDBP;ELAVL3;ANGEL2;RBMS2
prerank,MAP-kinase scaffold activity (GO:0005078),0.532061587318328,1.0815064369751424,0.3904494382022472,0.8939878222320972,1.0,3/11,12.85%,IQGAP1;KSR1;AKAP13
prerank,heme binding (GO:0020037),0.4136410178682275,1.0777943278134539,0.38266384778012685,0.9025233642540946,1.0,5/65,4.33%,HRG;SLC48A1;CYP2A6;CYBB;STEAP4
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4287446184171577,1.0774349319758454,0.36210762331838564,0.8998707565476238,1.0,11/42,15.99%,LCK;STAP1;NCK2;NEDD4;YWHAB;PIN1;ZAP70;IRS1;SHC1;CRKL;ABL2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4080460928348081,-1.0749271480708984,0.3443223443223443,0.8075279649725159,1.0,7/12,17.59%,PIK3CA;PIK3R6;PIK3CG;PIK3CB;PIK3CD;PIK3C3;IPMK
prerank,ATPase binding (GO:0051117),0.4050621454201943,1.0709014440224551,0.382010582010582,0.917573289208484,1.0,20/71,19.74%,LCK;ATP1B3;DNAJB1;CLPP;NR1H2;CAV1;METTL21A;FBL;RALB;EZR;ATP6V0A2;SLC2A13;ANK1;TRPC1;ATP1B2;DERL1;RALA;S100A1;SELENOS;ATP6V1G1
prerank,poly-purine tract binding (GO:0070717),0.4589422411739615,1.0696839317317466,0.4122497055359246,0.9177277034205599,1.0,11/27,24.29%,RBMS3;ELAVL4;PABPC1;EIF4A3;ATXN1;DDX1;KHDRBS2;RBMS2;HNRNPU;TIA1;KHDRBS1
prerank,cation:chloride symporter activity (GO:0015377),0.5389907081092054,1.069295403773563,0.4198250728862974,0.9149535197328095,1.0,3/10,12.04%,SLC12A7;SLC12A5;SLC12A4
prerank,single-stranded DNA helicase activity (GO:0017116),0.476923637346677,1.0665033138347448,0.4005037783375315,0.9205313174778823,1.0,6/19,18.49%,RFC4;MCM7;MCM2;RFC5;HELB;MCM6
prerank,lipoprotein particle binding (GO:0071813),0.4819359665014841,1.0643322387984762,0.4190715181932246,0.923844942599878,1.0,7/20,19.70%,COLEC12;CDH13;CD36;MAPT;SORL1;TREM2;LDLR
prerank,CXCR chemokine receptor binding (GO:0045236),0.5216867097077367,1.0632820657093525,0.40221914008321774,0.9232989248715094,1.0,1/11,7.50%,CXCL10
prerank,galactosyltransferase activity (GO:0008378),0.5302386862887611,1.0613390747945697,0.42105263157894735,0.9259044038844391,1.0,2/11,10.59%,B3GALT6;B4GALT3
prerank,inward rectifier potassium channel activity (GO:0005242),0.45519127114515057,1.0610904743205003,0.4147521160822249,0.9227016649462646,1.0,2/24,3.58%,KCNJ10;KCNJ15
prerank,solute:proton symporter activity (GO:0015295),0.4898126322146309,1.0590421359338498,0.41365461847389556,0.9255948226060788,1.0,4/16,15.90%,SLC36A3;SLC11A2;SLC33A1;SLC2A13
prerank,Hsp70 protein binding (GO:0030544),0.44198340000476627,1.0569211392650089,0.397887323943662,0.928769497326846,1.0,6/31,12.95%,SPN;DNAJB1;RPS3;SACS;DNAJB2;METTL21A
prerank,GTPase activity (GO:0003924),0.3863191654416293,1.056444838332481,0.37537537537537535,0.9264536399695807,1.0,40/192,16.69%,GIMAP7;GTPBP4;ABCA4;ARHGDIB;GNG5;RAB8A;BMS1;ARL2;RASL12;GBP2;MRAS;GPN3;RHOJ;ARL8B;MMUT;HBS1L;DNM3;RAC2;EEF2;GNAI2;EEF1A1;CDC42;RAB11A;DRG2;RAB5B;RHOC;RAB5C;AGAP2;GSPT1;RALB;RHOU;RAB2A;GNA13;SAR1B;NKIRAS2;RAP2A;RHEB;ATL1;GBP3;GNAQ
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.46012957520189884,1.0558476582724572,0.4222222222222222,0.9245432717277874,1.0,3/23,6.54%,CCL5;EDNRA;PLCB3
prerank,potassium ion antiporter activity (GO:0022821),-0.38521235782220103,-1.0542959779371373,0.376984126984127,0.8538851227047021,1.0,3/15,4.93%,SLC24A3;SLC9A9;SLC9A6
prerank,calcium-dependent phospholipid binding (GO:0005544),0.41374178834616504,1.0529488794394595,0.44091903719912473,0.9300288838456778,1.0,6/49,9.45%,ANXA1;MCTP2;ANXA6;SYT4;ESYT2;SYT7
prerank,glutamate receptor activity (GO:0008066),0.46568487966899597,1.0527030808432607,0.418227215980025,0.9269590966718076,1.0,6/19,19.45%,GRIA1;GRID2;GRIA2;GRM1;GRIK5;GRIK2
prerank,pre-mRNA binding (GO:0036002),-0.3057157494914641,-1.0487776399601083,0.4155844155844156,0.8578175258905281,1.0,10/28,15.00%,DDX5;U2AF2;RNPC3;RBM4;TRA2B;HNRNPL;CELF2;PTBP1;CELF4;CELF5
prerank,low-density lipoprotein particle binding (GO:0030169),0.49119019111645523,1.0421340025878991,0.45595854922279794,0.9574944564535127,1.0,6/16,19.70%,COLEC12;CDH13;CD36;SORL1;TREM2;LDLR
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3954518268447703,1.0384321320880694,0.43184183142559834,0.9657217731857256,1.0,14/75,14.18%,DHRS9;SORD;EHHADH;UGDH;HSD17B7;ME2;BDH1;DCXR;MDH2;RDH12;HADHA;HADH;ME1;ADH5
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.5037510401347789,1.0379180725054116,0.4528301886792453,0.9634233349663208,1.0,3/13,12.78%,BMP4;BMP6;CDH5
prerank,retinoic acid receptor binding (GO:0042974),0.47856443259741144,1.0373048295058789,0.4547738693467337,0.9615433737571142,1.0,9/17,27.89%,RARG;ARID5A;NR4A2;ASXL1;NRIP1;NCOA6;ACTN4;PPARG;CNOT1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.37182529602120706,1.0339644690070804,0.4064064064064064,0.9684060412044027,1.0,36/254,13.65%,LEF1;NR4A3;GATA3;ZNF395;RFX5;TFAP4;EHF;HOXA7;MYBL2;SPIB;LHX4;HOXC4;SMAD2;MYB;ELF4;SMARCD3;CREBRF;NR4A2;NR1H2;ETS1;NFYB;RLF;TFDP2;TCF12;NR4A1;HOXB2;ZBTB16;ZFP62;MEIS2;ELF1;SMAD1;FOXO1;ATF4;HSF2;ATMIN;HLF
prerank,four-way junction DNA binding (GO:0000400),0.47842963393317306,1.0333029818626023,0.4593548387096774,0.9667117437306267,1.0,8/17,23.53%,HMGB1;HMGB3;HMGB2;BLM;MSH6;YY1;MSH2;WRN
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.35623562056875907,-1.0327019803156,0.375,0.8927730319252583,1.0,7/17,20.46%,ABCA3;PITPNA;PLTP;PITPNB;MTTP;ABCA1;ATP10B
prerank,ribosomal small subunit binding (GO:0043024),0.4699881455497666,1.0288804537136302,0.47530864197530864,0.9770369501962705,1.0,5/17,13.11%,EIF1B;PIM1;NME1;EIF1;NPM1
prerank,phosphoric diester hydrolase activity (GO:0008081),0.41501975349493453,1.0284189658928993,0.45875706214689266,0.9746522445869452,1.0,10/35,17.87%,SMPD1;PLCB3;SMPDL3B;GPLD1;GDPD1;NAPEPLD;PLCXD2;PLD3;GDPD3;GPCPD1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3146462219264705,-1.0278424586396933,0.4010416666666667,0.8949225818750567,1.0,12/23,29.18%,CLVS1;WIPI1;WDR45B;MAPKAP1;HIP1R;PLA2G4E;SNX14;KIF16B;PLEKHA5;PHLDA3;GBF1;SH3PXD2B
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4505894140673323,1.0276869564553468,0.4628501827040195,0.9692495563971493,1.0,4/21,10.12%,CDK6;CDK8;CDK1;CDK2
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4505894140673323,1.0276869564553468,0.4628501827040195,0.9692495563971493,1.0,4/21,10.12%,CDK6;CDK8;CDK1;CDK2
prerank,ephrin receptor binding (GO:0046875),-0.32783319073647504,-1.02759490740296,0.3870967741935484,0.8830738743925481,1.0,7/21,13.79%,LYN;ABL1;GRB2;CRK;PIK3CG;EFNA5;PTPN1
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.45392937073910977,1.026856707535117,0.4560099132589839,0.967974139729865,1.0,3/22,5.61%,CLU;APOE;HSPG2
prerank,deoxyribonuclease activity (GO:0004536),0.4838925055970826,1.0229596462567367,0.46866840731070497,0.9765085038898514,1.0,4/14,16.40%,ERCC4;RPS3;NME1;ERCC5
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.513190455107047,1.0195035026778514,0.48516320474777447,0.9834705359739921,1.0,4/10,16.96%,DAXX;LAPTM5;DNAJB2;ANKRD13A
prerank,vinculin binding (GO:0017166),0.5071165103692958,1.018938124098756,0.4914772727272727,0.9814195114599246,1.0,4/11,12.83%,UTRN;ACTN1;DMD;DAG1
prerank,BMP receptor binding (GO:0070700),0.5037590569373664,1.0184130264216769,0.4781420765027322,0.97929623233774,1.0,3/12,12.78%,BMP4;BMP6;CDH5
prerank,phospholipase C activity (GO:0004629),0.43501770792058325,1.0168028884617903,0.4800483675937122,0.9805603085669619,1.0,3/25,6.54%,CCL5;EDNRA;PLCB3
prerank,mRNA binding (GO:0003729),0.3672352819864252,1.0154675052968276,0.463855421686747,0.9809787938671305,1.0,99/249,27.90%,RPS14;RPL41;MRPL13;RPS7;YTHDF3;EIF2A;SHMT1;FUBP1;RPS26;SLC4A1AP;RPS3;RPS2;HNRNPAB;PTBP3;METTL3;DCP1A;RBMS3;ELAVL4;RBM15;CSTF2;BOLL;PABPC1;RBM4B;EIF4A3;SYNCRIP;PCBP4;LUC7L2;DHX36;NUDT21;G3BP2;NCL;CPEB3;CSTF3;RPL35;YBX3;NYNRIN;SF3B1;RPL7;PTBP2;RPS5;ETF1;METTL14;SAMD4A;KHSRP;TARDBP;RBFOX1;KHDRBS2;RBM8A;SRRM3;TYMS;NUDT16;ANGEL2;RBMS2;IREB2;RBFOX2;KHDRBS3;RBM20;AGO2;YTHDC1;SLBP;RBM5;MRPS7;CLUH;CSTF2T;PCBP1;PCBP3;HNRNPU;GRSF1;SRSF4;DDX6;SF3B6;RC3H1;TUT1;RNF20;PURB;KHDRBS1;HNRNPC;ZC3H12D;CNBP;CELF1;SHMT2;CELF6;SRSF6;NCBP3;AQR;CALR;HDLBP;MARF1;KHNYN;RNF40;HNRNPA2B1;SRBD1;ZFP36;HNRNPR;EIF4G1;DENR;PUM1;SNRNP35;NUP98
prerank,FMN binding (GO:0010181),-0.410027078066177,-1.0138512951050371,0.4084967320261438,0.9114907582534133,1.0,6/11,28.62%,PPCDC;MTRR;NDOR1;PNPO;NOS1;DUS2
prerank,N-acetyltransferase activity (GO:0008080),-0.33296855781097234,-1.0120453206856421,0.41037735849056606,0.9050809310048541,1.0,8/19,25.54%,SAT1;SMARCE1;NAT8L;NAT10;NAA10;NAT2;SAT2;NAA80
prerank,adenylate cyclase binding (GO:0008179),0.5047198663365652,1.0118523343723005,0.48034934497816595,0.9882290781816261,1.0,5/10,22.74%,CAP2;AKAP6;CALM1;CAP1;CALM3
prerank,Notch binding (GO:0005112),0.44221753961933535,1.0092169629792636,0.4708798017348203,0.9925117673796475,1.0,6/22,22.15%,NCOR2;CUL3;JAG1;AAK1;CCN3;KCTD10
prerank,ubiquitin binding (GO:0043130),-0.2379612880885314,-1.0073962032266903,0.3888888888888889,0.9063435054331012,1.0,19/73,15.14%,OTULINL;RNF185;USP16;GGA3;N4BP1;NBR1;TNFAIP3;ASCC2;MVB12B;SMAD3;MDM2;TOM1L1;DDI2;UBAP1L;USP13;UCHL1;UBAP1;UBXN11;RAE1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.47753043299493564,1.0073777832226478,0.48314606741573035,0.994250613624133,1.0,5/13,24.14%,ARHGDIB;GPSM2;CCDC88A;SH3BP4;ITGB1BP1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.2842472148268971,-1.0069490778769894,0.39814814814814814,0.8956850736942356,1.0,18/35,28.62%,FTO;TRIT1;DTWD2;FTSJ1;DUS3L;PTRH2;GATC;TRMT12;LCMT2;QRSL1;TRMT5;BCDIN3D;TRDMT1;MRPL58;TYW3;PUS10;AARS2;DUS2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3950412547969132,1.006127015890855,0.48511576626240355,0.9942834004951597,1.0,13/49,17.10%,PTPN22;SMPD1;DUSP5;ACP3;SMPDL3B;GDPD1;PLCXD2;ATP1A2;DUSP16;PRUNE1;DUSP4;SAMHD1;GDPD3
prerank,protein homodimerization activity (GO:0042803),0.3616643646571935,1.0061039710928001,0.473,0.9905493999186856,1.0,159/590,23.60%,IKZF3;CD4;S100A6;GZMA;GIMAP7;TPM2;NR4A3;RBM44;CCL5;CLCN1;GHR;RBM11;GLIPR2;UPB1;TFAP4;TKT;BCL2;FLNA;PECAM1;NECTIN1;JCHAIN;CEACAM1;S100A11;DPP4;IL17D;SDCBP2;TMEM192;TLR9;ABCG4;B2M;TRIM21;AHR;SHMT1;HSD11B1;DAPK3;APOE;RACK1;ACTN1;GADD45A;GBP2;FBLN5;ZBTB7B;TENM2;HOOK1;TMEM266;BARD1;TPD52L1;KIT;ABCB7;ABCD3;STARD3NL;TIMM9;TGFB2;MMUT;ZHX2;SYNE1;PTPA;TARBP2;ACP3;AIMP1;GREM1;TARS2;CST7;GYG1;NR6A1;EXT2;ZBTB16;NUDT16L1;HSP90AA1;APPL1;JAML;NUDT21;SRR;S100A16;HIP1;NOD1;SNF8;NFS1;ZDHHC2;TPM4;BLM;CDADC1;NPM1;STK4;TRIM68;GCA;RIPK1;DEFA6;MSH6;EFEMP2;S100A10;NUDT16;MAPK4;MTCL1;DROSHA;PSMD7;TIMM10;GBP3;ERCC5;S100A13;CEBPB;STK26;CRYAB;RAB11FIP4;FAP;RPE;LILRB1;JUP;SPPL3;HES1;CEP43;CCDC88A;ECE1;CRPPA;CORO1A;MCL1;MKLN1;S100A1;KYAT1;TAP1;BNIP3;PTH1R;MLXIPL;MLX;HMGCS1;TYROBP;GLB1;PAFAH1B2;TENM4;HSD17B4;XPNPEP3;DNM1L;MSH2;MID1;MTHFD1L;PDCD6IP;TENM3;HSP90AB1;MFF;DGCR8;MME;KARS1;ERBB4;SARS1;TFRC;DCLRE1B;IDH1;DDIT3;FGFR1;MTMR1;XPA;STK10;SLK;ERN1;WRN;ODC1;EPRS1;CENPF;ZNF318
prerank,GTP binding (GO:0005525),0.3677799010552667,1.0017366464450317,0.5155466399197592,1.0,1.0,34/172,16.37%,GIMAP7;GTPBP4;THG1L;RAB8A;RRAD;ANXA6;BMS1;ARL2;RASL12;GBP2;MRAS;RHOJ;ARL8B;RAC2;ARL3;NME1;EEF1A1;TUBD1;CDC42;DRG2;ARL4C;RHOC;REM1;AGAP2;SCG5;RALB;ARL6;RHOU;RAB2A;RAP2A;NUDT16;RHEB;ATL1;GBP3
prerank,myosin V binding (GO:0031489),0.46668346128947913,1.0001505863334583,0.5012953367875648,1.0,1.0,3/15,9.79%,RAB8A;RAB3D;RAB11A
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.29363156068171664,-0.9947926029934839,0.460431654676259,0.9202074509214888,1.0,8/29,15.74%,HPSE;HEXD;ACER3;NEU1;HPSE2;GLA;GBA2;GALC
prerank,exopeptidase activity (GO:0008238),0.3867813726896656,0.9944255402979185,0.4940152339499456,1.0,1.0,19/50,26.01%,CNDP2;DPP4;GGH;CPM;CTSZ;LAP3;LNPEP;CTSH;NUDT16;FAP;METAP2;DPP3;XPNPEP3;MME;DPP10;DPEP2;XPNPEP1;CTSA;BLMH
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.28723294933808136,-0.9929934893319481,0.47368421052631576,0.9142420158029394,1.0,15/34,21.45%,SETD3;ATPSCKMT;KMT5B;DOT1L;EHMT1;SETD4;SMYD3;KMT5A;SMYD2;EHMT2;EEF1AKMT1;SUV39H1;CAMKMT;ANTKMT;MEN1
prerank,phosphatidic acid binding (GO:0070300),-0.324013304045368,-0.9919025885612645,0.4312796208530806,0.9058933229561903,1.0,6/19,11.14%,OPA1;PLEKHN1;MARK1;SMPD3;MAPKAP1;PLTP
prerank,calcium:sodium antiporter activity (GO:0005432),-0.40373263148101557,-0.9915874314207516,0.4602649006622517,0.8954249763924423,1.0,2/10,0.36%,SLC8A1;SLC24A3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.492400404714297,0.989469714227155,0.5148936170212766,1.0,1.0,2/11,9.31%,ITPR3;ITPR1
prerank,sterol binding (GO:0032934),0.38521786430925126,0.9891212958103208,0.5129032258064516,1.0,1.0,21/56,25.88%,SIDT1;STARD4;ANXA6;SOAT1;STARD3NL;GRAMD1B;CAV1;VDAC2;SYP;APOD;TSPO;RORA;SOAT2;OSBPL1A;GPR183;OSBPL8;OSBPL6;GRAMD1C;PTCH1;STARD5;ERLIN1
prerank,hexosaminidase activity (GO:0015929),-0.3797168605079867,-0.9888107290788443,0.4468864468864469,0.8919419038358084,1.0,3/12,7.88%,HEXB;NAGA;HEXD
prerank,ATP binding (GO:0005524),0.3582746677035108,0.9887057994848362,0.5405405405405406,1.0,1.0,58/266,17.21%,MAP4K2;GCK;THG1L;RUNX3;MLKL;ATP7A;RTEL1;SRPK1;P2RY1;CDK6;LMTK2;HSPA8;CLP1;DAPK3;LONP1;PIM1;SMC4;HSPA5;ABCD3;PTPA;STK17B;NVL;RPS6KA5;NLK;PMVK;NME1;EIF4A3;PYGL;ATP1A3;ATP1A1;DHX36;HSP90AA1;ATP5F1D;CDC42BPG;SRR;ZAP70;SIK3;ATP1A2;HSPA4;GALK1;KSR1;ABCF3;P2RX5;NIM1K;AGAP2;BLM;STK4;SYN3;PPIP5K1;HSPA1A;MSH6;ABCA2;MAP4K5;KIFC1;PFKP;STK26;TWF2;TOP1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4342638391255229,0.9871888971814566,0.5259259259259259,1.0,1.0,8/22,23.21%,DUSP5;DUSP6;DUSP2;DUSP16;DUSP4;DUSP3;DUSP10;SBF1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.35831659535713034,0.9833950597051654,0.557,1.0,1.0,48/248,16.69%,GIMAP7;GTPBP4;ABCA4;ARHGDIB;CLU;GNG5;RAB8A;ABCG4;BMS1;ARL2;KIF5A;RASL12;GBP2;MRAS;GPN3;RHOJ;ARL8B;MMUT;HBS1L;DNM3;PIN1;RAC2;EEF2;GNAI2;EEF1A1;CDC42;RAB11A;VWA8;HSP90AA1;DRG2;RAB5B;RHOC;RAB5C;AGAP2;GSPT1;RALB;HSPA1A;RHOU;RAB2A;GNA13;SAR1B;NKIRAS2;RAP2A;RHEB;RUVBL1;ATL1;GBP3;GNAQ
prerank,Wnt-activated receptor activity (GO:0042813),-0.3526495259605662,-0.9828499385354065,0.4475806451612903,0.8974910338525585,1.0,2/15,1.62%,LRP5;PKD1
prerank,glycine binding (GO:0016594),0.4860536570683187,0.981630297010704,0.5007194244604316,1.0,1.0,3/11,14.74%,GRIN3A;SRR;GLRB
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3536831991337716,0.9811475681813842,0.584,1.0,1.0,89/431,16.94%,GIMAP7;GTPBP4;MAP4K2;GCK;THG1L;RUNX3;MLKL;ATP7A;RTEL1;SRPK1;P2RY1;CDK6;LMTK2;RAB8A;HSPA8;CLP1;RRAD;ANXA6;BMS1;DAPK3;ARL2;LONP1;PIM1;RASL12;GBP2;SMC4;HSPA5;MRAS;ABCD3;RHOJ;ARL8B;PTPA;STK17B;NVL;RPS6KA5;NLK;PMVK;RAC2;ARL3;NME1;EEF1A1;EIF4A3;TUBD1;PYGL;ATP1A3;ATP1A1;CDC42;DHX36;HSP90AA1;ATP5F1D;DRG2;ARL4C;CDC42BPG;RHOC;REM1;SRR;ZAP70;SIK3;ATP1A2;HSPA4;GALK1;KSR1;ABCF3;P2RX5;NIM1K;PSMA6;AGAP2;BLM;SCG5;STK4;SYN3;RALB;PPIP5K1;HSPA1A;ARL6;RHOU;RAB2A;MSH6;ABCA2;RAP2A;NUDT16;RHEB;MAP4K5;KIFC1;ATL1;GBP3;PFKP;STK26;TWF2
prerank,gamma-tubulin binding (GO:0043015),0.43681970469710996,0.9808634037181646,0.5213154689403167,1.0,1.0,6/22,15.80%,CENPJ;DIXDC1;RACGAP1;NDRG1;PAK1;B9D2
prerank,R-SMAD binding (GO:0070412),-0.33581412394946697,-0.9808046292085442,0.4697674418604651,0.8924487224205334,1.0,4/18,6.68%,LDLRAD4;DDX5;SMAD3;SMURF1
prerank,DNA secondary structure binding (GO:0000217),0.40968461147321306,0.9804092456282096,0.5186046511627908,1.0,1.0,14/31,25.21%,HMGB1;HMGB3;XPC;HMGB2;MAPT;BLM;MSH6;ERCC5;YY1;RBBP8;MSH2;WRN;RAD18;KMT2A
prerank,RNA polymerase binding (GO:0070063),0.4400231923137804,0.9795074259293769,0.5112219451371571,1.0,1.0,4/18,8.28%,NEDD4;PHRF1;ANP32B;STOM
prerank,GTPase binding (GO:0051020),0.3562322664136963,0.9781407611432322,0.5645645645645646,1.0,1.0,67/195,24.98%,RANGRF;RTKN;ARHGDIB;RABGAP1L;FLNA;IQGAP1;WAS;RAB8A;RAF1;RGP1;BIRC5;DAPK3;AP3M1;RCC1;MLPH;LCP1;IQGAP2;AIMP1;SPHK2;CAV1;RAPGEF4;RAPGEF6;BICDL1;ATP6AP1;RABGAP1;HSP90AA1;RANBP2;SORL1;YBX3;ERC1;NCKAP1;AKAP13;MICALL1;NDRG1;KIF3B;FNBP1L;PKN1;PAK1;RAB11FIP4;BRAF;RIN3;GGA1;RNF152;RANBP9;OCRL;AFDN;SIKE1;BNIP3;ATG14;CYFIP1;DNM1L;RIMS1;CCDC186;PPP6R1;TBC1D20;SH3BP4;ATG16L1;YBX1;EHD1;EPRS1;RRAGB;AP1G1;CHML;EXOC2;STOML2;EVI5L;ENO1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4024728537366037,0.9769855035067442,0.5097813578826237,1.0,1.0,9/34,20.33%,LTF;IQGAP1;FAM20A;ETAA1;STK4;CKS2;CALM1;CCNT1;CAB39L
prerank,fatty acid synthase activity (GO:0004312),0.4976401393636789,0.9768975712911843,0.5256588072122053,1.0,1.0,3/10,12.45%,ELOVL7;ELOVL1;ELOVL6
prerank,GDP binding (GO:0019003),0.3777740544357743,0.9767277801311386,0.5399568034557235,1.0,1.0,28/63,30.82%,RAB8A;RASL12;MRAS;ARL8B;ARL3;RAB5B;RAB5C;RALB;RAB2A;RAP2A;RHEB;RAB9B;GNAI1;RALA;RAB27A;RAP1B;RASEF;RAB29;RIT1;KRAS;NRAS;RRAS2;RAB7A;RAB22A;GNAI3;RRAGC;RAB11B;HRAS
prerank,serotonin receptor activity (GO:0099589),0.4250468330955538,0.974713335596387,0.5229244114002478,1.0,1.0,2/22,7.12%,HTR7;HTR4
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.4250468330955538,0.974713335596387,0.5229244114002478,1.0,1.0,2/22,7.12%,HTR7;HTR4
prerank,G protein-coupled amine receptor activity (GO:0008227),0.4250468330955538,0.974713335596387,0.5229244114002478,1.0,1.0,2/22,7.12%,HTR7;HTR4
prerank,cardiolipin binding (GO:1901612),-0.40449543831931567,-0.9739159177175277,0.45751633986928103,0.9013594186756632,1.0,2/10,6.10%,OPA1;PLEKHN1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.4133929801380555,0.9738601696972126,0.5310262529832935,1.0,1.0,3/27,8.39%,RNF125;RNF14;DCUN1D5
prerank,I-SMAD binding (GO:0070411),-0.3628455484402262,-0.9727736413875598,0.486013986013986,0.8938559580537973,1.0,4/13,6.68%,TGFBR1;SMAD7;SMAD3;SMURF1
prerank,N-acyltransferase activity (GO:0016410),-0.2772367089215973,-0.9706785503745017,0.5241935483870968,0.8893706959964097,1.0,10/32,16.62%,SIRT7;NMT1;SAT1;SMARCE1;NAT8L;CERS5;NAT10;TGM2;PLA2G4E;CERS2
prerank,calcium activated cation channel activity (GO:0005227),0.43799251007301143,0.970515081791467,0.5123859191655802,1.0,1.0,2/17,3.53%,KCNN4;KCNMB4
prerank,methylated histone binding (GO:0035064),0.37719937169204854,0.9704297911522177,0.5457481162540366,1.0,1.0,14/62,14.55%,CHD5;ATRX;ING3;ING2;TTLL12;UHRF1;ING5;MSL3;TRIM24;PYGO1;L3MBTL1;NCAPD3;WDR5;MSH6
prerank,voltage-gated anion channel activity (GO:0008308),0.4522323397881331,0.9704163749319421,0.5287817938420348,1.0,1.0,3/15,9.62%,CLCN1;VDAC3;VDAC2
prerank,SUMO transferase activity (GO:0019789),0.4420800038277298,0.9699956095840399,0.5236842105263158,1.0,1.0,7/16,21.69%,MUL1;RANBP2;PIAS1;CBX4;EGR2;HDAC4;TRIM28
prerank,store-operated calcium channel activity (GO:0015279),0.4880044605146432,0.9671611042861079,0.5355113636363636,1.0,1.0,5/10,22.76%,TRPC5;TRPC4;ORAI2;TRPC1;STIM2
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3924794990474326,0.9669674332602696,0.5507246376811594,1.0,1.0,4/32,10.31%,KCNQ5;KCNA4;KCNC4;KCNA1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3491304663956516,0.9667312509879733,0.613,1.0,1.0,53/291,13.73%,MAP4K2;GCK;THG1L;RUNX3;MLKL;ATP7A;RTEL1;SRPK1;P2RY1;CDK6;LMTK2;HSPA8;CLP1;DAPK3;LONP1;PIM1;SMC4;HSPA5;ABCD3;PTPA;STK17B;NVL;RPS6KA5;NLK;PMVK;RAPGEF4;NME1;EIF4A3;PYGL;ATP1A3;ATP1A1;DHX36;HSP90AA1;ATP5F1D;CDC42BPG;SRR;ZAP70;SIK3;ATP1A2;HSPA4;GALK1;KSR1;ABCF3;P2RX5;NIM1K;AGAP2;BLM;STK4;SYN3;COQ8A;PPIP5K1;HSPA1A;ME1
prerank,phosphotyrosine residue binding (GO:0001784),0.3894117103302217,0.966679486554528,0.5345413363533409,1.0,1.0,3/37,2.83%,LCK;STAP1;NCK2
prerank,ubiquitin protein ligase binding (GO:0031625),0.34679410419771717,0.9655622756987587,0.6196196196196196,0.9995370185558549,1.0,78/254,24.82%,RPS27A;PTPN22;TRAF1;PRDX6;ACTG1;RPL11;BCL2;DAXX;RPL23;CLU;HSPA8;UBA52;LAPTM5;CCT2;SMAD2;HSPA5;MAP1LC3A;NLK;GPI;UBE2L3;LAPTM4B;FZD6;CXCR4;HSP90AA1;NFKBIA;FANCL;SUMO2;MUL1;UBB;FOXO1;SPART;RALB;HSPA1A;PRKAR1A;RIPK1;TNFRSF14;UBE2B;CDKN1A;CUL3;VCL;SHPRH;GLMN;DERL1;PER1;EGR2;RALA;FZD8;UQCRC1;FAF2;BAG1;SMC6;PRR5L;DNM1L;GSK3B;YWHAZ;UBE2D1;MID1;TRAF3;HSP90AB1;TXNIP;TRIM28;JAK1;GABARAP;SMAD6;DBT;PSMA3;MAP1LC3B;DNAJA1;UBE2W;SCAMP3;TUBB;TNK2;RNF20;RAD18;UBXN7;EIF4E2;SPOPL;FBXW7
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.32272774388204456,-0.965524121167339,0.5,0.8934215832495855,1.0,8/21,18.84%,AKAP8L;WASF2;ACBD3;WASF1;AKAP7;ARFGEF2;AKAP1;AKAP5
prerank,amino acid:sodium symporter activity (GO:0005283),-0.3832351967135448,-0.9654269123162943,0.5016393442622951,0.8834562564980398,1.0,1/11,0.70%,SLC1A3
prerank,small GTPase binding (GO:0031267),0.35305931978437205,0.9652383526269256,0.5901803607214429,0.9970084048600951,1.0,48/170,21.15%,RANGRF;RTKN;ARHGDIB;RABGAP1L;FLNA;IQGAP1;WAS;RAB8A;RAF1;RGP1;BIRC5;DAPK3;AP3M1;RCC1;MLPH;IQGAP2;SPHK2;CAV1;RAPGEF4;RAPGEF6;BICDL1;ATP6AP1;RABGAP1;RANBP2;SORL1;YBX3;ERC1;NCKAP1;AKAP13;MICALL1;NDRG1;KIF3B;PKN1;PAK1;RAB11FIP4;BRAF;RIN3;GGA1;RNF152;RANBP9;OCRL;AFDN;SIKE1;CYFIP1;DNM1L;RIMS1;CCDC186;PPP6R1
prerank,guanyl ribonucleotide binding (GO:0032561),0.35215271189180697,0.9645039874062747,0.6088264794383149,0.9955758240400497,1.0,61/196,26.23%,GIMAP7;GTPBP4;THG1L;RAB8A;RRAD;ANXA6;BMS1;ARL2;RASL12;GBP2;MRAS;RHOJ;ARL8B;RAC2;ARL3;NME1;EEF1A1;TUBD1;CDC42;DRG2;RAB5B;ARL4C;RHOC;REM1;RAB5C;AGAP2;SCG5;RALB;ARL6;RHOU;RAB2A;RAP2A;NUDT16;RHEB;ATL1;GBP3;RAB9B;RANBP17;SLC19A1;GNAI1;RALA;CNGB1;ARL1;RAB27A;TUBB4B;RAP1B;INSR;RRAGB;TUBB;RHOA;RHOD;EIF2B2;RASEF;ARF3;RAB29;RHOG;RIT1;NMUR2;RHOT2;KRAS;NRAS
prerank,transforming growth factor beta receptor binding (GO:0005160),0.43447095262752156,0.9644000156064702,0.5484276729559748,0.9924986999981843,1.0,7/18,15.59%,FERMT2;SMAD2;TGFB2;FKBP1A;TGFBR3;TGFB3;USP15
prerank,histone deacetylase activity (GO:0004407),0.4322784706213749,0.9642581145908599,0.5280612244897959,0.9895374119292694,1.0,6/19,18.76%,HDAC9;HDAC11;HDAC1;SIRT1;HDAC2;HDAC4
prerank,miRNA binding (GO:0035198),-0.2923178188082529,-0.9641506316337587,0.5294117647058824,0.8768328900502205,1.0,6/30,14.59%,AGO4;PNPT1;AGO1;RBM4;ZC3H12A;PUM2
prerank,disordered domain specific binding (GO:0097718),0.41740738496498664,0.9639890346016413,0.5337423312883436,0.9868898640864417,1.0,11/23,26.69%,SMAD2;KCNA1;HSP90AA1;HSPA1A;GAPDH;FYN;CALM1;HSP90AB1;CALM3;DFFB;FN1
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.4618730693592382,0.9627130012243041,0.5336194563662375,0.9868739274647007,1.0,3/12,9.37%,GABRA4;GABRB1;GABRG1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.37322178213637186,0.9612502432011423,0.5720384204909285,0.9875297963847581,1.0,5/60,5.99%,LCK;PDP2;PTEN;CTDNEP1;PPM1L
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.40714122788533114,0.9610125530684566,0.555952380952381,0.9848621238644316,1.0,2/28,4.93%,TRAF1;BID
prerank,histone acetyltransferase activity (GO:0004402),-0.29249004086428665,-0.9609895923967847,0.48175182481751827,0.8754393516687606,1.0,12/30,29.41%,KAT6B;TADA3;ARRB1;NAA40;EPC2;KAT8;NAA60;MCM3AP;CREBBP;TAF9;NCOA3;KAT14
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.3997748584273049,-0.9609646498383848,0.4965034965034965,0.8659166113746788,1.0,6/10,25.54%,NAA25;NAA10;NAA60;NAA30;NAA15;NAA80
prerank,myosin binding (GO:0017022),0.3770029906337583,0.9609353514303718,0.5729499467518637,0.9817787167263937,1.0,17/55,24.57%,LMTK2;RAB8A;RAB3D;MLPH;GSN;DMD;RAB11A;CXCR4;KIRREL1;STXBP5L;CORO1A;RALA;SPATA6;NCKIPSD;STXBP5;CALD1;RHOA
prerank,5'-3' RNA polymerase activity (GO:0034062),-0.2927564508975029,-0.959674907179589,0.5272727272727272,0.8600304310278578,1.0,15/27,34.83%,TENT2;POLR3B;POLR2G;POLR3K;POLRMT;POLR1C;POLR3A;POLR2C;POLR2J;POLR3F;POLR2L;POLR2E;POLR2I;POLR2B;POLR1B
prerank,Tat protein binding (GO:0030957),0.48461070208102774,0.9592592043196618,0.5272459499263623,0.9827525705388299,1.0,2/10,13.11%,ACTB;NPM1
prerank,tau protein binding (GO:0048156),0.3802997197419062,0.9584471978021646,0.5554323725055432,0.9817314339712894,1.0,15/40,21.23%,ACTB;CLU;APOE;SMAD2;PIN1;HSP90AA1;ROCK1;PPP2CA;FYN;GSK3A;MAP2;MARK3;SNCA;GSK3B;HSP90AB1
prerank,cation channel activity (GO:0005261),-0.2291999208185956,-0.9561189909186664,0.52,0.8597209027359946,1.0,26/94,20.63%,CACNA1D;SLC24A3;PKD1;MCOLN1;ANO6;TRPM4;CUL5;TRPV2;ANXA2;HVCN1;CHRNA7;TMEM63A;SEC61A1;TRPM7;TRPM2;TMEM38A;TRPV4;UNC80;KCNA2;KCNK9;PKD1L2;PSEN1;PKD2L2;ANXA9;TMEM175;CACNB2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.45967595878226264,0.9549709576004906,0.5572005383580081,0.9876850888989547,1.0,2/14,7.68%,SLC7A11;SLC1A6
prerank,RNA polymerase II complex binding (GO:0000993),0.39515794044288244,0.9516872441078918,0.5609756097560976,0.9925166436167785,1.0,15/32,24.84%,RTRAF;PAF1;CCAR2;ELOF1;CTR9;ERCC5;AGO2;CDC73;SCAF1;HNRNPU;RPRD1B;BRD4;WDR43;URI1;RPRD2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3674290001616606,0.9512086076131263,0.5712742980561555,0.9905075085471435,1.0,13/54,18.76%,UPB1;HDAC9;HDAC11;NAAA;HDAC1;PM20D1;FAAH;SIRT1;ASPA;NADSYN1;DARS1;HDAC2;HDAC4
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.4160737865093319,0.9505334044132852,0.5642256902761105,0.9890525539380502,1.0,10/24,24.43%,ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;ZDHHC14;ZDHHC18;GOLGA7B;ZDHHC21;ZDHHC7
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.2844827184061727,-0.9499941212130489,0.4968152866242038,0.866265912026194,1.0,12/30,19.39%,SLC40A1;SLC11A1;SLC30A4;SLC30A5;SLC39A13;SLC39A8;SLC25A28;SLC39A12;SLC39A10;SLC39A3;SLC30A1;SLC39A11
prerank,glycerophospholipid flippase activity (GO:0140333),0.46591780730421106,0.9494832467567579,0.5450762829403606,0.988594361454363,1.0,1/11,0.93%,ABCA4
prerank,estrogen receptor binding (GO:0030331),0.3913872482686525,0.9468465124526622,0.5535307517084282,0.9919269258840793,1.0,6/32,16.59%,LEF1;ARID5A;CTNNB1;WBP2;PPARGC1B;NRIP1
prerank,FAD binding (GO:0071949),-0.2968959114292896,-0.9455290256630187,0.5290697674418605,0.869098461037866,1.0,9/24,20.82%,SQOR;MTHFR;AGPS;MTRR;MICAL3;AIFM1;NQO2;KMO;NDOR1
prerank,syntaxin binding (GO:0019905),-0.23901441715565114,-0.9440214881556527,0.5344827586206896,0.8638467741718523,1.0,12/61,11.89%,ABL1;STX16;LRRK2;SYT2;NAPA;SNAP29;SNAP25;STXBP4;CPLX1;SYT10;STX8;VPS18
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.3053098815157157,-0.9423559498786486,0.5759162303664922,0.8589515723269918,1.0,6/20,18.02%,OTULINL;SENP5;UFSP2;USP21;SENP2;YOD1
prerank,ATPase activator activity (GO:0001671),0.41616480947698886,0.9402385630407863,0.5591531755915318,1.0,1.0,3/20,5.24%,ATP1B3;DNAJB1;DNAJC15
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3299401786015929,-0.9393877313217761,0.5063829787234042,0.8486258864706174,1.0,7/16,22.85%,ATP6V0A1;TCIRG1;ATP6V1D;ATP6V1A;ATP6V1C1;ATP6V0E2;ATP6V0D2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3299401786015929,-0.9393877313217761,0.5063829787234042,0.8486258864706174,1.0,7/16,22.85%,ATP6V0A1;TCIRG1;ATP6V1D;ATP6V1A;ATP6V1C1;ATP6V0E2;ATP6V0D2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3321350957338722,-0.939289564421746,0.5454545454545454,0.8404437413741617,1.0,8/15,23.57%,HS3ST4;HS3ST5;HS6ST1;NDST4;NDST2;HS2ST1;HS3ST3A1;HS6ST2
prerank,receptor tyrosine kinase binding (GO:0030971),0.3609682427626554,0.9384880615606593,0.6004273504273504,1.0,1.0,12/56,15.76%,NRG1;ANGPT4;CBLB;STAP1;ANGPT1;RACK1;NCK1;IRS1;GRB14;ITGAX;SHC1;PCNA
prerank,1-phosphatidylinositol binding (GO:0005545),0.43903853293397876,0.9376779991205136,0.5806010928961749,1.0,1.0,1/15,0.55%,SCIN
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.46300486410226865,0.9368683084484679,0.5700416088765603,1.0,1.0,4/11,17.12%,PTDSS2;SGMS1;GNPTAB;DPAGT1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3855089806343449,0.936624158675277,0.596551724137931,1.0,1.0,4/33,8.39%,RNF125;RNF14;RPS3;DCUN1D5
prerank,cholesterol transfer activity (GO:0120020),0.4362997078706872,0.9346271420174066,0.5727272727272728,1.0,1.0,2/16,7.57%,STARD4;GRAMD1B
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3352926971744959,0.9334717660616425,0.7007007007007007,1.0,1.0,80/269,24.82%,RPS27A;PTPN22;TRAF1;PRDX6;ACTG1;RPL11;BCL2;DAXX;RPL23;CLU;HSPA8;UBA52;LAPTM5;CCT2;SMAD2;HSPA5;PTPRN;MAP1LC3A;NLK;GPI;UBE2L3;LAPTM4B;FZD6;CXCR4;HSP90AA1;NFKBIA;FANCL;SUMO2;MUL1;UBB;FOXO1;SPART;RALB;HSPA1A;PRKAR1A;RIPK1;TNFRSF14;UBE2B;CDKN1A;CUL3;VCL;SHPRH;GLMN;DERL1;PER1;EGR2;RALA;FZD8;UQCRC1;FAF2;BAG1;SMC6;PRR5L;DNM1L;GSK3B;YWHAZ;UBE2D1;MID1;TRAF3;HSP90AB1;TXNIP;TRIM28;JAK1;GABARAP;SMAD6;DBT;PSMA3;MAP1LC3B;DNAJA1;UBE2W;SCAMP3;TUBB;TNK2;RNF20;PRR7;RAD18;UBXN7;EIF4E2;SPOPL;FBXW7
prerank,lipoprotein particle receptor binding (GO:0070325),0.39930661427462555,0.9331269212375591,0.5802615933412604,0.999995142440771,1.0,3/27,5.61%,CLU;APOE;HSPG2
prerank,dynactin binding (GO:0034452),0.4540067806690799,0.9330018793727889,0.5802816901408451,0.997146689170906,1.0,5/12,23.62%,BICDL1;MAPT;PAFAH1B1;GSK3B;HTT
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3049962011723388,-0.9317743035420456,0.5416666666666666,0.8506779726164319,1.0,5/19,10.87%,MCOLN1;P2RX4;TRPM4;GRIN2A;TRPM2
prerank,ADP binding (GO:0043531),0.3977417183268685,0.9309671720511916,0.5908529048207664,0.9986946392957843,1.0,10/25,23.41%,LONP1;ATP5F1D;COQ8A;ME1;MSH6;TAP1;MSH2;PGK1;PRKAG1;ERN1
prerank,amino acid binding (GO:0016597),0.3799101160606659,0.92976853317161,0.580046403712297,0.998329141726445,1.0,9/31,25.68%,SHMT1;GRIN3A;SRR;PADI4;GLRB;ASS1;GRIN1;SHMT2;CASTOR2
prerank,diacylglycerol kinase activity (GO:0004143),-0.3707685342945307,-0.9296748872315983,0.5451505016722408,0.8476425913098551,1.0,6/11,19.58%,DGKZ;AGK;DGKH;DGKD;DGKQ;DGKK
prerank,protein phosphatase activator activity (GO:0072542),0.4461223917126444,0.929548928894793,0.5704607046070461,0.9957083309224032,1.0,6/13,22.91%,PPP1R15A;PTPA;CALM1;CALM3;PPP2R5B;PPP2R5E
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3841419431286496,0.9284318171586515,0.5921205098493627,0.995214408727986,1.0,14/33,24.84%,RTRAF;PAF1;MAF1;CCAR2;ELOF1;CTR9;ERCC5;AGO2;CDC73;HNRNPU;RPRD1B;WDR43;URI1;RPRD2
prerank,phospholipase A2 activity (GO:0004623),0.3951588832531253,0.9279312210987302,0.580335731414868,0.9933750217889318,1.0,3/26,15.47%,PRDX6;PLAAT3;PLA2G12A
prerank,mitogen-activated protein kinase binding (GO:0051019),0.39027313259465796,0.927500129185123,0.5884476534296029,0.9913122698560161,1.0,9/29,17.95%,DUSP5;DUSP6;DUSP2;DUSP16;MAPKAPK3;MAPKAPK2;SIRT1;DUSP4;TNIP1
prerank,mechanosensitive ion channel activity (GO:0008381),0.449195666795809,0.9270909095148752,0.5864453665283541,0.9891639655607247,1.0,3/12,16.51%,PIEZO2;TMC7;TMC8
prerank,adrenergic receptor binding (GO:0031690),0.41348059655351577,0.9180731194909943,0.5918884664131813,1.0,1.0,2/16,6.37%,NEDD4;SAV1
prerank,retinoic acid binding (GO:0001972),0.4510536175531341,0.9180106829646523,0.5933147632311978,1.0,1.0,2/12,19.97%,RARA;CYP26B1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.2988134525644338,-0.9179301454229145,0.5739644970414202,0.8683727526588523,1.0,9/22,22.85%,ATP6V0A1;ATP2C1;TCIRG1;ATP6V1D;ATP6V1A;ATP2A2;ATP6V1C1;ATP6V0E2;ATP6V0D2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3510989561198086,0.915327006637031,0.6335470085470085,1.0,1.0,21/60,25.46%,DDR2;LMTK2;KDR;KIT;EPHB2;FLT3;EPHA7;EPHA5;IGF1R;IGF2R;NTRK3;EPHA3;ROR1;MET;ERBB4;DDR1;FGFR1;INSR;FGFR3;AXL;PDGFRA
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.3733463799463252,-0.9136862750204238,0.5743243243243243,0.8705865818429479,1.0,5/10,13.87%,PIK3CA;PIK3CG;PIK3CB;PIK3CD;PIK3C3
prerank,voltage-gated chloride channel activity (GO:0005247),0.4573608015838915,0.9132135472826287,0.5885797950219619,1.0,1.0,1/10,1.62%,CLCN1
prerank,calcium-release channel activity (GO:0015278),0.41374707047285364,0.912323557892349,0.6013071895424836,1.0,1.0,3/17,9.31%,ITPR3;MCOLN2;ITPR1
prerank,nuclear localization sequence binding (GO:0008139),-0.32075127903601025,-0.9120204693747143,0.5853658536585366,0.8662053152267113,1.0,7/18,14.06%,KPNA3;IPO5;TNPO2;KPNA4;RANBP6;CABP1;KPNB1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.37754723899235443,0.9119945696251542,0.5962219598583235,1.0,1.0,5/27,15.80%,SLC26A6;SLC25A10;XPR1;SLC25A14;SLC25A30
prerank,ribonuclease activity (GO:0004540),-0.2294479427973874,-0.9097583825339254,0.711864406779661,0.8632575338222711,1.0,20/56,20.49%,LACTB2;N4BP1;CPSF3;DIS3L2;AGO1;RNASE12;EXOSC7;INTS11;RCL1;EXOG;CNOT7;EXOSC8;ZC3H12A;ZC3H12B;RNASE7;EXOSC3;SMG6;RNASE4;RNASEH2A;YBEY
prerank,palmitoyltransferase activity (GO:0016409),0.3895412821510841,0.9084387209692845,0.6158323632130385,1.0,1.0,11/28,25.43%,ZDHHC17;ZDHHC23;ZDHHC15;ZDHHC12;ZDHHC2;ZDHHC14;ZDHHC18;GOLGA7B;ZDHHC21;ZDHHC7;ZDHHC5
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.3351352603507219,-0.9074259888605932,0.5814977973568282,0.8612530338700473,1.0,2/14,2.99%,CAPN3;CAPN15
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.4523880855594743,0.9034673587402381,0.6070901033973413,1.0,1.0,2/10,9.37%,GABRA4;GABRG1
prerank,carbohydrate kinase activity (GO:0019200),-0.35255921572109605,-0.9032180120876155,0.568904593639576,0.8631457403117841,1.0,5/11,15.40%,HK2;NAGK;GNE;FGGY;XYLB
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.3776966758732207,-0.9024017325282789,0.5464285714285714,0.8570172442351688,1.0,1/10,0.19%,CACNA1D
prerank,vitamin D receptor binding (GO:0042809),-0.3259744889986397,-0.8965527662237949,0.5931558935361216,0.8632453623163948,1.0,6/14,18.55%,THRAP3;MED12;MED4;TAF7;MED1;SNW1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3267257379149183,0.895047586916635,0.7354709418837675,1.0,1.0,35/173,19.60%,DEAF1;TBX21;SATB1;GATA3;DACH1;OTP;AEBP1;ZBTB39;MAFK;FOXP1;POU6F1;MNT;HEY2;ZBTB16;CC2D1A;KLF12;ZBTB6;GTF2IRD1;E2F6;FOXP4;ZBTB25;BCL6;MYT1L;BATF3;PRDM5;JDP2;CEBPB;ZBTB2;NFIL3;HES1;YY1;ZFP37;MLX;SNAI2;ZBTB33
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),-0.27589674846474954,-0.8939937068986898,0.6038961038961039,0.8612447121579414,1.0,15/27,34.83%,POLR3B;POLR2G;POLR3K;POLRMT;PRIM1;POLR1C;POLR3A;POLR2C;POLR2J;POLR3F;POLR2L;POLR2E;POLR2I;POLR2B;POLR1B
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.34800350220650533,0.8923946325734817,0.6538871139510117,1.0,1.0,12/53,21.50%,SLC36A3;SLC7A11;SLC3A2;SLC1A6;SLC7A1;SLC1A5;SLC7A5;SLC43A2;SLC38A1;SLC7A6;SLC25A22;SLC25A2
prerank,ligand-gated anion channel activity (GO:0099095),0.3956427403951709,0.8892671159063276,0.6040268456375839,1.0,1.0,4/17,14.74%,GABRA4;GABRB1;GABRG1;GLRB
prerank,alpha-tubulin binding (GO:0043014),0.36657628441084,0.8887702980419662,0.6236686390532544,1.0,1.0,5/31,10.63%,FAM110C;RACGAP1;DLEC1;ARL8B;ARL4C
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4136898956597265,0.8880307048527909,0.6310935441370223,1.0,1.0,7/14,27.83%,MTHFD1;PYCR2;BLVRB;ALDH1L2;QDPR;ALDH4A1;PYCR3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.3564692757459857,-0.8850030196453931,0.5740740740740741,0.8731957080941352,1.0,6/11,25.41%,CASP2;CASP3;CFLAR;CASP6;PYCARD;CASP12
prerank,ionotropic glutamate receptor activity (GO:0004970),0.40260558722949424,0.8845016811748104,0.6155810983397191,1.0,1.0,6/17,19.45%,GRIA1;GRIN3A;GRIA2;GRIK5;GRIA3;GRIK2
prerank,endonuclease activity (GO:0004519),-0.2300278864949847,-0.884291224760821,0.7926829268292683,0.8671167167220932,1.0,17/49,23.42%,LACTB2;CPSF3;AGO1;INTS11;RCL1;DIS3;EXOG;PNKP;MRE11;ZC3H12A;ZC3H12B;ZRANB3;REXO4;SMG6;YBEY;ZC3H12C;SETMAR
prerank,translation elongation factor activity (GO:0003746),0.41495361327185315,0.88426959699003,0.6391478029294274,1.0,1.0,3/14,9.10%,EEF1B2;EEF2;EEF1A1
prerank,ATP hydrolysis activity (GO:0140603),0.35766995424978787,0.8827532488702355,0.6611661166116611,1.0,1.0,7/41,15.65%,ABCA4;CLU;ABCG4;VWA8;HSP90AA1;HSPA1A;RUVBL1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.39082153149580545,0.8822422161211257,0.6484076433121019,1.0,1.0,5/19,19.45%,GABRA4;GRID2;GABRG1;GRIK5;GRIK2
prerank,WW domain binding (GO:0050699),0.36993858887206954,0.8819108975069219,0.6573170731707317,1.0,1.0,4/26,13.49%,NFE2;TCEAL9;WBP1;WBP11
prerank,pentosyltransferase activity (GO:0016763),-0.24481721159771289,-0.8804574250503678,0.7019230769230769,0.8684804520643746,1.0,6/36,9.42%,LARGE1;PARP1;LACC1;PNP;PARP2;SIRT3
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3219910458611132,0.8793255563107661,0.768920282542886,1.0,1.0,19/147,9.18%,CCDC88C;RASGRP1;THG1L;RANGRF;DENND2D;MON1A;KALRN;ARHGEF18;DOCK5;RASGRP2;SMCR8;RGP1;RIC8A;RCC1;EEF1B2;RAPGEF4;LAMTOR4;RAPGEF6;EIF2B4
prerank,3'-5' DNA helicase activity (GO:0043138),-0.3100702615931926,-0.8789014440779069,0.569672131147541,0.8641018091933849,1.0,1/16,0.01%,NAV2
prerank,poly(U) RNA binding (GO:0008266),0.38985795017411684,0.8783436789622906,0.6356877323420075,1.0,1.0,5/20,16.54%,RBM11;RBMS3;PABPC1;ATXN1;RBMS2
prerank,MAP kinase kinase activity (GO:0004708),-0.32179368067413305,-0.8774880243746426,0.614406779661017,0.8594272568560717,1.0,5/15,22.17%,PAK3;LRRK2;MAP2K7;MAP2K6;MAPK10
prerank,transmitter-gated ion channel activity (GO:0022824),0.3618113942290278,0.8750006503127156,0.6415094339622641,1.0,1.0,7/29,19.45%,GABRA4;GABRB1;GRID2;GABRG1;GRIA2;GRIK5;GRIK2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.40987610927274143,0.8739109851571681,0.6253263707571801,1.0,1.0,1/15,2.10%,PLEKHF1
prerank,hexosyltransferase activity (GO:0016758),-0.20241470885824853,-0.8736463870346943,0.8461538461538461,0.8607351044054541,1.0,23/101,18.67%,HEXB;MGAT4A;LARGE1;GCNT1;POFUT1;TMTC2;CHSY3;B3GALT5;MFNG;PIGM;PIGB;B4GALT7;POGLUT3;POMGNT1;POMT2;B3GALNT1;MTAP;POGLUT2;GBA2;DPY19L1;B3GALT2;CSGALNACT2;B4GALT4
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.34321671234409645,-0.8725045245503138,0.6050955414012739,0.8558461587497618,1.0,3/11,8.37%,MAP3K7;MAP3K5;MAP3K20
prerank,cysteine-type endopeptidase activity (GO:0004197),0.33187609620034475,0.8722756917678617,0.7114583333333333,1.0,1.0,19/78,17.52%,CTSW;USP42;MALT1;CTSZ;USP1;CASP4;USP46;ESPL1;GPAA1;USP18;USP34;CTSH;CAPNS1;USP15;CAPNS2;USP49;USP28;CAPN5;CTSC
prerank,exonuclease activity (GO:0004527),0.3485078885966532,0.8706972646985739,0.6775244299674267,1.0,1.0,16/46,23.99%,EXOSC4;ISG20;RAD1;AEN;XRN2;REXO2;EXOSC1;ERI1;POLG;REV3L;REXO5;EXOSC10;EXOSC9;DCLRE1B;WRN;ENPP2
prerank,methylation-dependent protein binding (GO:0140034),0.33919608693371334,0.868348044438278,0.7060737527114967,1.0,1.0,12/57,14.55%,ATRX;ING3;ING2;UHRF1;ING5;MSL3;TRIM24;PYGO1;L3MBTL1;NCAPD3;WDR5;MSH6
prerank,glutathione transferase activity (GO:0004364),-0.273241718140142,-0.8680192733019394,0.6939890710382514,0.8583973149069475,1.0,7/23,24.28%,HPGDS;LTC4S;GSTZ1;GSTO1;GSTM1;GSTA4;MGST3
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.3597947934225524,0.8677270110374724,0.6538461538461539,1.0,1.0,14/33,24.84%,RTRAF;PAF1;CCAR2;ELOF1;CTR9;ERCC5;AGO2;TBP;CDC73;HNRNPU;RPRD1B;WDR43;URI1;RPRD2
prerank,RNA stem-loop binding (GO:0035613),-0.33947643660849214,-0.8676302711650697,0.6591760299625468,0.85207820491091,1.0,2/12,2.23%,MYH10;METTL16
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.3645354404704815,0.866478856561846,0.6473372781065089,1.0,1.0,8/28,22.98%,DBR1;NUDT16L1;ELAC1;NUDT16;DROSHA;AGO2;POP5;RNASEH1
prerank,thyroid hormone receptor binding (GO:0046966),0.37005225063441355,0.8662805940330683,0.6828087167070218,1.0,1.0,11/28,23.43%,TRIP6;ARID5A;OASL;MED30;MED13;NCOR1;HMGN3;MED24;TRIP12;ZNHIT3;NCOA6
prerank,nucleotidyltransferase activity (GO:0016779),0.3915464898777829,0.8650271738732167,0.6624040920716112,1.0,1.0,5/19,18.59%,THG1L;TENT4A;CGAS;PAPSS2;CRPPA
prerank,cAMP binding (GO:0030552),-0.35110065359807885,-0.8627675195242984,0.6173285198555957,0.8551838341208299,1.0,2/11,5.74%,PDE10A;PDE4A
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3182761880787417,0.8593482839467026,0.7352637021716649,1.0,1.0,14/91,14.89%,SCIN;SDCBP2;PARD3;CLVS2;MYO1G;GSN;LAPTM4B;SYT7;TTPAL;MAPT;HIP1;CAPG;SDCBP;TIRAP
prerank,ankyrin binding (GO:0030506),0.38138485276969364,0.8580065008324715,0.6599749058971142,1.0,1.0,3/19,6.09%,PLEC;CDH1;SPTBN4
prerank,regulatory RNA binding (GO:0061980),-0.24041107421802743,-0.8577363346224428,0.7232142857142857,0.858404733763511,1.0,5/38,6.45%,TLR7;AGO4;PNPT1;AGO1;RBM4
prerank,microtubule minus-end binding (GO:0051011),-0.3258994810285236,-0.8541196944878612,0.6468253968253969,0.8586887131169436,1.0,6/13,32.88%,MACF1;TUBGCP2;TUBGCP5;CEP290;CAMSAP2;CAMSAP3
prerank,fibroblast growth factor binding (GO:0017134),0.37645442115383343,0.8518593308323951,0.6946182728410513,1.0,1.0,6/21,23.49%,GLG1;RPS2;RPS19;S100A13;FGFR1;FGFR3
prerank,O-methyltransferase activity (GO:0008171),0.42936545252131775,0.8515042563594657,0.648068669527897,1.0,1.0,3/10,13.63%,FTSJ3;CMTR2;COQ3
prerank,transcription coregulator binding (GO:0001221),0.3318896432090823,0.8493372483381972,0.7040261153427638,1.0,1.0,8/50,12.42%,CHD6;RPL23;FAM89B;AHR;PER2;ZBTB16;CTNNB1;CIT
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.3456586271739449,-0.8467208475277002,0.6033898305084746,0.8668059905267759,1.0,4/10,16.60%,CASP2;CASP3;CFLAR;CASP6
prerank,UDP-galactosyltransferase activity (GO:0035250),0.42466357899955925,0.8462908281790386,0.6910344827586207,1.0,1.0,1/10,3.41%,B3GALT6
prerank,ubiquitin-dependent protein binding (GO:0140036),0.41484181130778536,0.8404534657341252,0.6652173913043479,1.0,1.0,4/10,16.96%,LAPTM5;DNAJB2;USP15;ANKRD13A
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.39797309402397407,0.8382869668790982,0.6893617021276596,1.0,1.0,3/13,14.74%,GABRA4;GABRG1;GLRB
prerank,acid-thiol ligase activity (GO:0016878),0.39339252385113727,0.8380170355898662,0.6817558299039781,1.0,1.0,4/13,26.52%,ACSF3;ACSL1;AACS;ACSS2
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.3406526954890779,0.8366126115363723,0.7302857142857143,1.0,1.0,6/34,7.73%,IQGAP1;FERMT2;RACGAP1;PARD3;MYO1G;IQGAP2
prerank,phosphatase activator activity (GO:0019211),0.40276065583544246,0.8365374177101483,0.6835616438356165,1.0,1.0,6/14,22.98%,PPP1R15A;CALM1;CALM3;PPP2R5B;PPP2R5E;FRS2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3208894879276628,0.8357855884184031,0.7524219590958019,1.0,1.0,20/60,25.46%,DDR2;LMTK2;KDR;KIT;EPHB2;FLT3;EPHA7;EPHA5;IGF1R;NTRK3;EPHA3;ROR1;MET;ERBB4;DDR1;FGFR1;INSR;FGFR3;AXL;PDGFRA
prerank,ion channel activity (GO:0005216),0.31280177563003964,0.8340892395080999,0.7603305785123967,1.0,1.0,16/80,19.99%,PIEZO2;ANXA6;GABRB1;GRIA1;NALCN;GRID2;GRIN3A;TMC7;P2RX5;GRIA2;GRIK5;TMC8;TRPC1;GRIA3;GRIK2;CNGB1
prerank,protein kinase C activity (GO:0004697),0.38923743847670284,0.8327471424195143,0.6937416777629827,1.0,1.0,1/14,0.92%,PRKCQ
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.36550758475811984,0.8323347346042035,0.7174177831912302,1.0,1.0,6/21,19.13%,POLB;POLE;POLG;POLK;REV3L;POLD4
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.33132094001636586,0.8318949444121287,0.7363128491620111,1.0,1.0,8/42,20.31%,CCND2;HEXIM1;CNPPD1;CCNY;CDKN1A;CKS2;KAT2B;CCNT1
prerank,peptidase activator activity (GO:0016504),0.35853665027981296,0.831667233678587,0.6978776529338327,1.0,1.0,3/22,9.26%,PSME1;CAV1;PCOLCE2
prerank,phosphatidylinositol binding (GO:0035091),0.31095350598436955,0.8293988585143013,0.7867494824016563,1.0,1.0,14/91,11.90%,SCIN;PLEKHF1;NCF1;ITPR3;ING2;PARD3;SH3YL1;ESYT2;ITPR1;APPL1;GPAA1;MTM1;MAPT;HIP1
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4002460581895962,0.8286989586726518,0.7093333333333334,1.0,1.0,6/14,20.88%,NFU1;SDHB;RSAD2;CIAO3;IREB2;ISCU
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.29997709964568614,0.8282646270947138,0.8807615230460922,1.0,1.0,44/232,19.11%,RNF125;CBLB;RNF7;NEDD4;TRIM21;RNF14;BRAP;UHRF1;BSPRY;RNF111;MKRN1;NSMCE1;RNF157;TRIM24;ASB1;PELI1;DTX2;CDC42;NHLRC3;AMFR;FANCL;ZNRF3;MUL1;KCMF1;COP1;VPS11;TRIM68;RNF24;UBR5;RNF216;CUL3;HUWE1;SHPRH;RNFT1;AREL1;ZNRF2;PIAS1;SMURF2;CBX4;RNF152;RNF135;EGR2;UBE3D;MSL2
prerank,magnesium ion binding (GO:0000287),0.3069561571843612,0.8276927348829074,0.8222222222222222,1.0,1.0,35/135,23.95%,THG1L;FIGNL1;DUT;TKT;SRPK1;MTHFD2;ADPRH;NT5C3A;NLK;NME1;DHX36;IDH3A;CDC42BPG;SRR;SIK3;NIM1K;STK4;MSH6;RAP2A;NUDT16;RHEB;PPA2;ABL2;STK26;GNAI1;HPRT1;SNCA;STK11;MSH2;DYRK2;STK38;IDH1;ERN1;WRN;PAPOLA
prerank,death receptor binding (GO:0005123),0.3888157140978914,0.8274222617230395,0.7228116710875332,1.0,1.0,3/15,20.27%,BID;RIPK1;TMBIM1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.3576864121880618,0.8269267255829936,0.7222884386174017,1.0,1.0,7/26,23.19%,B3GNT3;B4GALNT1;EXTL2;B3GNT2;B3GALNT2;CSGALNACT1;CHPF2
prerank,sterol transfer activity (GO:0120015),0.3795536174895665,0.8261545528484976,0.6930817610062893,1.0,1.0,2/17,7.57%,STARD4;GRAMD1B
prerank,cysteine-type peptidase activity (GO:0008234),0.31389459884148535,0.8229503287095846,0.7698744769874477,1.0,1.0,20/73,20.55%,CTSW;USP42;GGH;MALT1;CTSZ;USP1;CASP4;ATG4D;USP46;ESPL1;USP18;USP34;CTSH;USP15;USP49;USP28;CTSC;USP50;ATG4B;CASP7
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.33760459691506806,0.8228569250227014,0.7394285714285714,1.0,1.0,10/35,18.30%,HDAC1;FOXP1;TAF1B;MMP12;DR1;NPM1;BAZ2A;TBPL1;AGO2;TBP
prerank,kinase activator activity (GO:0019209),0.3448192884352636,0.821654091252592,0.7272727272727273,1.0,1.0,4/30,6.35%,GPRC5C;DAXX;MALT1;RPLP1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.4036514805148697,0.8209962427001387,0.709585121602289,1.0,1.0,3/12,10.71%,HR;KDM4C;KDM3B
prerank,DNA polymerase activity (GO:0034061),0.35744892752449753,0.8208339492317746,0.7240963855421687,1.0,1.0,6/22,19.13%,POLB;POLE;POLG;POLK;REV3L;POLD4
prerank,ubiquitin protein ligase activity (GO:0061630),0.29677988137190126,0.8198712064251069,0.8897795591182365,1.0,1.0,42/228,19.11%,RNF125;CBLB;RNF7;NEDD4;TRIM21;RNF14;BRAP;UHRF1;BSPRY;RNF111;MKRN1;NSMCE1;RNF157;TRIM24;ASB1;PELI1;DTX2;CDC42;NHLRC3;AMFR;FANCL;ZNRF3;MUL1;KCMF1;COP1;VPS11;TRIM68;RNF24;UBR5;RNF216;CUL3;HUWE1;UBE4A;SHPRH;RNFT1;AREL1;ZNRF2;SMURF2;RNF152;RNF135;UBE3D;MSL2
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4136397011257451,0.8181016392776673,0.7060518731988472,1.0,1.0,4/10,22.19%,EHHADH;HADHA;HSD17B4;HADHB
prerank,voltage-gated ion channel activity (GO:0005244),0.381721130601655,0.8165248878140003,0.7250639386189258,1.0,1.0,3/14,10.26%,VDAC3;VDAC2;CACNA1H
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.30677774201578756,0.8156511073409216,0.7955742887249737,1.0,1.0,12/72,18.17%,SCIN;SDCBP2;PARD3;MYO1G;GSN;SYT7;HIP1;CAPG;SDCBP;TIRAP;TWF2;CGAS
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3354746625865212,-0.8138248850234434,0.6941580756013745,0.9235935141766409,1.0,2/10,2.85%,APOBEC1;LACC1
prerank,steroid hydroxylase activity (GO:0008395),0.3768998730076506,0.8124250770116419,0.735897435897436,1.0,1.0,1/16,2.32%,CYP2A6
prerank,histone demethylase activity (GO:0032452),0.3437486033532735,0.8114880246079583,0.7156626506024096,1.0,1.0,6/27,14.66%,HR;JARID2;KDM4C;KDM3B;JMJD6;KDM5B
prerank,voltage-gated potassium channel activity (GO:0005249),0.30177001810273835,0.8109961960357016,0.7943632567849687,1.0,1.0,8/80,13.70%,KCNJ10;KCNQ5;KCNJ15;KCNA4;KCNC4;KCNA1;HCN3;KCNT1
prerank,acetyltransferase activity (GO:0016407),-0.23437346543027093,-0.8104694757874269,0.8402777777777778,0.9224080336541092,1.0,14/31,25.88%,KAT6B;SAT1;PAFAH2;SMARCE1;NAT8L;NAT10;GTF2B;NAA10;KAT8;SAT2;NAA15;NAA80;PAFAH1B3;CREBBP
prerank,carboxy-lyase activity (GO:0016831),-0.25617578742152003,-0.8103648604300686,0.7819148936170213,0.9152647081010258,1.0,3/23,4.28%,PPCDC;CSAD;UXS1
prerank,protein serine/threonine kinase activity (GO:0004674),0.29173421485444995,0.8095579915157061,0.933,1.0,1.0,60/335,16.60%,MAPK13;MAP4K2;PRKCQ;CAMK4;PLK4;SBK1;KALRN;SRPK1;CDK6;LMTK2;MELK;NEK4;RAF1;HTATIP2;CDK8;DAPK3;PIM1;ATM;PRKD2;MAPK9;CSNK1A1;CDK1;HIPK1;STK17B;RPS6KA5;NLK;GRK6;PAK4;SRPK3;CSNK1G1;MAP3K4;FAM20A;CDK2;CDC7;TAOK3;CDC42BPG;ILK;ROCK1;SIK3;MAP3K15;MAPKAPK3;CIT;NIM1K;STK24;MASTL;MAPKAPK2;STK4;TESK2;TNIK;RIPK1;GAK;EIF2AK3;RPS6KB1;HIPK3;PKN1;PAK1;MAPK4;MAP4K5;GSK3A;CDK13
prerank,RNA cap binding (GO:0000339),-0.2822008502685071,-0.8081667693470003,0.7361702127659574,0.9120542181862938,1.0,6/16,14.32%,GEMIN5;EIF4E;SNUPN;LARP1;DCPS;NCBP2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3283937666991863,0.8060242968273298,0.7480225988700565,1.0,1.0,11/34,23.28%,UBE2H;UBE2G2;UBE2L3;BIRC6;UBE2Z;UBE2B;CDC34;UBE2F;UBE2D1;UBE2E2;UBE2W
prerank,neuropeptide hormone activity (GO:0005184),-0.25129743963378,-0.8041172091665509,0.7258064516129032,0.912419887120431,1.0,16/22,49.71%,PPY;CCK;PNOC;PENK;NPFF;NPY;CRH;GAL;NMB;VIP;SPX;ADCYAP1;CORT;NPPA;GHRH;CALCB
prerank,U6 snRNA binding (GO:0017070),0.3823393321462325,0.802893352756615,0.7282321899736148,1.0,1.0,3/14,10.74%,PRPF4;LSM3;PRPF8
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.24621416081547304,-0.801964088485576,0.8309859154929577,0.9095535952090782,1.0,8/28,23.08%,PAK3;LRRK2;PRKAA2;MAP2K7;RPS6KA1;MAP2K6;MAPK10;PRKACA
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.31040816301632523,-0.8019239798450222,0.7049808429118773,0.9026878206319734,1.0,3/13,10.20%,SLC7A7;SLC38A7;SLC15A4
prerank,double-stranded RNA binding (GO:0003725),0.3065119158993743,0.8017346119950237,0.813953488372093,1.0,1.0,23/70,24.46%,SIDT1;ILF3;SLC3A2;ACTN1;MSN;TARBP2;OASL;VIM;APTX;DHX36;ZFR;DROSHA;AGO2;MBNL1;HNRNPU;HSP90AB1;DGCR8;TUBB4B;TFRC;EIF4B;IFIH1;RC3H1;MTDH
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.39292082987762733,0.8006705518424974,0.7142857142857143,1.0,1.0,4/12,18.34%,CADM4;GREM1;CDH5;CCDC88A
prerank,ATPase regulator activity (GO:0060590),0.3239343749226038,0.7979828413390458,0.7528089887640449,1.0,1.0,10/38,19.86%,ATP1B3;DNAJB1;DNAJC15;HSPH1;DNAJB2;SIL1;KATNB1;ATP1B2;DNAJC1;BAG1
prerank,semaphorin receptor binding (GO:0030215),0.3470567093215504,0.7962579024574492,0.7374233128834355,1.0,1.0,5/23,19.79%,SEMA5A;PLXNB1;SEMA3E;SEMA5B;SEMA3D
prerank,microtubule plus-end binding (GO:0051010),0.3509833628677933,0.7960149295588932,0.7533742331288343,1.0,1.0,6/20,17.32%,STIM1;MAPRE2;CLIP4;MAPRE3;PAFAH1B1;CLIP3
prerank,tRNA binding (GO:0000049),0.31694823241031356,0.7923742307785442,0.7634529147982063,1.0,1.0,12/43,23.80%,THG1L;EIF2A;RPUSD4;AIMP1;EEF1A1;NSUN2;MRPS27;TRMT9B;KARS1;SARS1;SARS2;PSTK
prerank,phosphate ion binding (GO:0042301),0.3937675795176066,0.7891413221852097,0.7260869565217392,1.0,1.0,1/10,3.43%,MTHFD2
prerank,telomerase RNA binding (GO:0070034),0.3467441125804981,0.7851863041132481,0.7573529411764706,1.0,1.0,9/22,25.88%,DHX36;SNRPB;NAF1;EXOSC10;GAR1;HNRNPU;SMG7;HNRNPC;XRN1
prerank,ribosomal large subunit binding (GO:0043023),0.3834634248177221,0.7838259550860593,0.7272727272727273,1.0,1.0,2/11,13.11%,MALSU1;NPM1
prerank,neuropeptide receptor binding (GO:0071855),-0.29187104229027294,-0.7838081174125604,0.7388059701492538,0.9257998749245793,1.0,2/14,10.53%,PPY;SHANK1
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.332712189689901,0.7833362039691885,0.7819025522041764,1.0,1.0,5/31,12.04%,SLC12A7;KCNC4;KCNA1;SLC12A5;SLC12A4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.2272903070018235,-0.78251446133732,0.8348623853211009,0.9209731053163775,1.0,11/38,16.86%,SNX27;ZFYVE19;SNX13;SNX20;WIPI1;PLA2G4A;WDR45B;RUBCNL;LANCL2;PLA2G4E;ATG2B
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.35769399013724645,0.7816845401946437,0.7679269882659713,1.0,1.0,4/17,18.07%,EPHB2;EPHA7;EPHA5;EPHA3
prerank,ephrin receptor activity (GO:0005003),0.35769399013724645,0.7816845401946437,0.7679269882659713,1.0,1.0,4/17,18.07%,EPHB2;EPHA7;EPHA5;EPHA3
prerank,ion channel inhibitor activity (GO:0008200),0.32041403606660807,0.7809970404892007,0.7936865839909808,1.0,1.0,7/35,19.95%,NEDD4;RACK1;ITPR1;FKBP1A;CALM1;SCN3B;SCN1B
prerank,nuclease activity (GO:0004518),0.30474142292287965,0.7785959213804661,0.797644539614561,1.0,1.0,11/52,19.42%,ISG20;RNASE3;RNASE6;AEN;XRN2;NME1;DDX1;SAMHD1;ERCC5;REXO5;RNASEL
prerank,snRNA binding (GO:0017069),0.31231093308650143,0.778492938899495,0.7986798679867987,1.0,1.0,6/42,10.74%,ISG20;HEXIM1;PRPF4;LSM11;SNRPA;PRPF8
prerank,ubiquitin-protein transferase activity (GO:0004842),0.28078167105127555,0.7773153195919932,0.9679679679679679,1.0,1.0,77/346,22.16%,RNF125;TRAF1;CBLB;RNF7;NEDD4;TSPAN17;TRIM21;RNF14;BRAP;MALT1;UHRF1;UBE2H;BSPRY;BARD1;RNF103;RNF111;MKRN1;NSMCE1;UBE2G2;RNF157;TRIM24;ASB1;UBE2L3;BIRC6;PELI1;OBI1;DTX2;CDC42;NHLRC3;AMFR;FANCL;KLHL21;ZNRF3;MUL1;KCMF1;COP1;VPS11;SHARPIN;UBE2Z;TRIM68;RNF24;RSPRY1;UBR5;FBXL5;UBE2B;RNF216;CUL3;TTC3;HUWE1;CHFR;SHPRH;RNFT1;AREL1;ZNRF2;SMURF2;RNF152;DDB2;FBXO11;RNF135;CDC34;UBE3D;FBXO10;MSL2;LMO7;BIRC3;UBE2D1;TRAF3;FBXO3;UBE2E2;MKRN2;RNF220;TRIM28;BTRC;TRIP12;TMEM129;KCTD10;ERCC8
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.32283681107244194,0.7769961928475915,0.766743648960739,1.0,1.0,10/31,23.28%,UBE2H;UBE2G2;UBE2L3;BIRC6;UBE2Z;UBE2B;CDC34;UBE2D1;UBE2E2;UBE2W
prerank,voltage-gated calcium channel activity (GO:0005245),0.31598312621798313,0.7767634380924746,0.78839590443686,1.0,1.0,8/37,20.66%,CACNG7;CACNA2D3;CACNB4;CACNA1H;CACNA2D1;CACNA1I;CACHD1;CACNA1B
prerank,DNA-binding transcription factor binding (GO:0140297),0.2801928281352431,0.7750724055802545,0.9128256513026052,1.0,1.0,38/189,20.61%,EOMES;BCL2;NHLH2;RUNX1T1;HDAC9;HDAC7;HMGB1;TLE4;BBS10;DAPK3;CHCHD2;SMAD2;HDAC1;MKKS;NFYB;TCF12;HEY2;ID2;CTNNB1;ATF4;NPM1;NCOR1;SIRT1;PRDM5;PRRX1;PIAS1;CRTC2;HDAC2;DMAP1;HES1;TBP;EGR2;HDAC4;RBBP8;TXLNG;HES6;GSK3B;YWHAZ
prerank,methyl-CpG binding (GO:0008327),0.34000204191773487,0.7744962042851964,0.7713226205191595,1.0,1.0,3/22,7.01%,LHX4;UHRF1;PRMT5
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.35793765871004735,0.7735579544673651,0.7607843137254902,1.0,1.0,4/16,18.37%,ADPRH;RPS3;MACROD2;OARD1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.36060007210481515,0.7726957763267334,0.7647831800262812,1.0,1.0,2/15,3.33%,GPR171;P2RY1
prerank,anion transmembrane transporter activity (GO:0008509),0.3754572040375035,0.7682203681099229,0.7620396600566572,1.0,1.0,1/12,1.23%,SLC22A3
prerank,transcription corepressor binding (GO:0001222),0.32468316504834094,0.7679791817113399,0.7736289381563594,1.0,1.0,10/27,27.68%,FAM89B;PER2;ZBTB16;PER1;RORA;MTF2;EZH2;HDGF;ZBTB7A;THAP7
prerank,flavin adenine dinucleotide binding (GO:0050660),0.30057310703819695,0.7663228700424582,0.8221258134490239,1.0,1.0,6/53,9.62%,CYBB;STEAP4;ACADVL;ACOXL;GSR;POR
prerank,omega peptidase activity (GO:0008242),0.285171934905967,0.7648857515569952,0.8574358974358974,1.0,1.0,19/89,18.99%,USP3;USP42;GGH;USP1;MINDY3;USP46;USP18;USP34;VCPIP1;DESI2;USP45;OTUD1;USP15;USP32;USP49;USP28;UCHL3;MYSM1;USP50
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2901771997710626,0.7644075904712418,0.8381742738589212,1.0,1.0,21/69,25.43%,SOAT1;PLAAT3;MBOAT7;ZDHHC17;CERS4;NAA16;ZDHHC15;ZDHHC12;ZDHHC2;ZDHHC14;MOGAT3;ZDHHC18;KAT2B;ESCO1;SOAT2;AWAT2;ELP3;DBT;ZDHHC21;ZDHHC7;ZDHHC5
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.3667343889458472,0.7637835976676404,0.7682584269662921,1.0,1.0,8/14,30.34%,MINDY3;DESI2;USP15;MINDY4;USP9X;OTUD5;OTUD7B;ATXN3
prerank,kinesin binding (GO:0019894),-0.23635444870329458,-0.7618159204382208,0.8407643312101911,0.9475186436161658,1.0,13/27,29.57%,NEK6;PLEKHM2;KLC2;CROCC;ATCAY;PRC1;IFT88;SPTBN5;MAPK8IP3;MAPK8IP2;AP1AR;KIF1B;KIFAP3
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.2747357208569108,-0.7616670395115032,0.7887931034482759,0.9407628013644107,1.0,9/15,43.05%,ALDH3A2;ALDH3B1;ALDH2;ALDH1A2;ALDH1L1;ALDH1B1;ALDH1A1;ALDH9A1;ALDH1A3
prerank,SUMO binding (GO:0032183),0.37143680286820735,0.7569085245490368,0.7721518987341772,1.0,1.0,2/13,7.29%,USPL1;RNF111
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.27390651814863687,0.7558045707016308,0.9378134403209629,1.0,1.0,36/181,20.56%,EOMES;NCOR2;ACTB;NHLH2;BBS10;HDAC1;SMARCD3;MKKS;HEY2;ID2;CTNNB1;NFKBIA;ATF4;PSMA6;NPM1;ARNT2;NCOR1;SIRT1;NCOA7;TAF6;NCOA2;BAZ2A;NRIP1;PRRX1;PIAS1;JUP;HDAC2;DMAP1;HES1;CPNE1;TBP;EGR2;HDAC4;RBBP8;HES6;GSK3B
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.3431139123734184,0.7540998770396841,0.7909090909090909,1.0,1.0,1/16,5.43%,ADI1
prerank,GTPase activator activity (GO:0005096),0.2727052756907416,0.7526440204159439,0.972,1.0,1.0,57/313,16.28%,CCDC88C;TBC1D10C;RASGRP1;THG1L;DLC1;RANGRF;DENND2D;MON1A;RABGAP1L;KALRN;ARHGEF18;IQGAP1;DOCK5;RASGRP2;RGS3;NPRL2;SMCR8;RGS1;ASAP2;RGS8;RGPD1;RGP1;RACGAP1;ADPRH;ARHGAP15;RIC8A;RALGAPB;RCC1;TBC1D22B;SIPA1;IQGAP2;CHN1;EEF1B2;RAPGEF4;LAMTOR4;RAPGEF6;EIF2B4;RABGAP1;ARHGAP32;RGS6;TBC1D2B;SMAP1;RANBP2;TBC1D8B;AKAP13;AGAP2;ARHGAP33;DENND3;ARHGAP26;EEF1D;STXBP5L;RIC8B;ARHGAP11A;ARHGAP42;TIAM1;RINL;ARFGAP2
prerank,dipeptidyl-peptidase activity (GO:0008239),0.3834635572622405,0.7520601554326655,0.7726618705035971,1.0,1.0,4/10,22.18%,DPP4;FAP;DPP3;DPP10
prerank,DNA replication origin binding (GO:0003688),0.32128875343137137,0.7516414095738491,0.7866004962779156,1.0,1.0,5/23,21.50%,MCM7;MCM2;DDX11;MCM6;ORC2
prerank,histone methyltransferase activity (GO:0042054),0.30850355245351724,0.7470647846708269,0.8220436280137773,1.0,1.0,11/32,25.07%,TTLL12;PRMT5;FBL;SETD7;SMYD1;NSD3;PRMT7;SETDB1;KMT2E;PRDM9;EZH2
prerank,manganese ion binding (GO:0030145),0.29154303939845716,0.7466271906569784,0.8162162162162162,1.0,1.0,16/48,26.15%,NEK4;PIM1;GYG1;PPM1M;ME1;SOD2;NUDT16;ABL2;XPNPEP3;MPPE1;DYRK2;WRN;PAPOLA;XPNPEP1;ATP13A2;EXD2
prerank,CARD domain binding (GO:0050700),0.3585948394664924,0.7464919349277249,0.7909454061251664,1.0,1.0,3/14,12.36%,CASP4;NOD1;CARD16
prerank,myosin II binding (GO:0045159),0.3848774487585863,0.7457137478002331,0.7795620437956204,1.0,1.0,5/10,31.05%,GSN;STXBP5L;STXBP5;TRIOBP;SHROOM4
prerank,adenyl nucleotide binding (GO:0030554),-0.29367692953730806,-0.7456687960598143,0.8097014925373134,0.9502167877497203,1.0,5/11,18.84%,BAG3;HSPBP1;BAG4;GRPEL1;BAG5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.29367692953730806,-0.7456687960598143,0.8097014925373134,0.9502167877497203,1.0,5/11,18.84%,BAG3;HSPBP1;BAG4;GRPEL1;BAG5
prerank,bHLH transcription factor binding (GO:0043425),-0.24843545100833864,-0.7451016449498691,0.8193832599118943,0.9443320163632278,1.0,3/19,7.89%,LMO2;SMAD3;USF1
prerank,single-stranded RNA binding (GO:0003727),0.29524417348249177,0.7448514027460914,0.8228699551569507,1.0,1.0,17/43,25.64%,RBM11;ILF3;LONP1;ZFR;JMJD6;HNRNPF;DDX11;AGO2;EXOSC10;SRA1;HNRNPU;POLR2D;EIF4B;IFIH1;SNRPC;CNBP;AQR
prerank,poly-pyrimidine tract binding (GO:0008187),0.32362239118177166,0.7442592566768145,0.7859733978234583,1.0,1.0,8/23,24.55%,RBM11;RBMS3;PABPC1;ATXN1;RBMS2;HNRNPU;KHDRBS1;HNRNPC
prerank,transforming growth factor beta binding (GO:0050431),0.3231017636166811,0.7425136968441893,0.8073170731707318,1.0,1.0,4/23,13.07%,LTBP3;CD36;TGFBR3;TGFB3
prerank,GTPase regulator activity (GO:0030695),0.27080536670360245,0.7415915891166758,0.943943943943944,1.0,1.0,53/212,20.96%,TBC1D10C;DLC1;RTKN;RABGAP1L;IQGAP1;WAS;RGS3;NPRL2;RGS1;ASAP2;RGS8;RGPD1;RACGAP1;ARL2;ADPRH;ARHGAP15;RIC8A;RALGAPB;TBC1D22B;SIPA1;IQGAP2;GPSM2;CHN1;ARL2BP;RABGAP1;ARHGAP32;RGS6;TBC1D2B;SMAP1;RANBP2;TBC1D8B;AGAP2;ARHGAP33;CDC42SE1;ARHGAP26;STXBP5L;RIC8B;ARHGAP11A;ARHGAP42;ARFGAP2;GNAQ;SIPA1L3;CCDC88A;OCRL;PREB;ARHGAP30;ARFGAP1;ARFGAP3;TBC1D13;DNM1L;ARHGEF6;RIMS1;RGS12
prerank,TBP-class protein binding (GO:0017025),0.32417311162611456,0.7374278945424921,0.8105134474327629,1.0,1.0,5/21,15.65%,AHR;TAF1B;DR1;PSMC1;RUVBL1
prerank,phospholipase activity (GO:0004620),0.27896034681852167,0.733862092922996,0.8748685594111462,1.0,1.0,11/67,17.10%,PRDX6;SMPD1;PLCB3;PLAAT3;GPLD1;GDPD1;NAPEPLD;PLD3;PLBD1;PLA2G12A;GDPD3
prerank,lipid phosphatase activity (GO:0042577),0.34259817878651677,0.7329478336168302,0.7829036635006784,1.0,1.0,5/14,25.93%,PLPPR5;PLPP6;PLPPR2;SGPP1;SGPP2
prerank,exoribonuclease activity (GO:0004532),0.35357230911016574,0.7280055878095895,0.79750346740638,1.0,1.0,4/12,21.57%,EXOSC4;EXOSC1;EXOSC10;EXOSC9
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.35531161984755244,0.7275380237262961,0.7931034482758621,1.0,1.0,3/11,16.74%,AMFR;UBR5;UBE4A
prerank,O-acyltransferase activity (GO:0008374),0.30155366364995867,0.7274044061061752,0.8474970896391153,1.0,1.0,3/30,8.25%,PRDX6;SOAT1;MBOAT7
prerank,thiol-dependent deubiquitinase (GO:0004843),0.27305576194617637,0.7266952482558571,0.886576482830385,1.0,1.0,18/83,18.99%,USP3;USP42;USP1;MINDY3;USP46;USP18;USP34;VCPIP1;DESI2;USP45;OTUD1;USP15;USP32;USP49;USP28;UCHL3;MYSM1;USP50
prerank,carboxylic acid binding (GO:0031406),0.2912681757564859,0.7252269755389575,0.8437856328392246,1.0,1.0,6/38,14.74%,SHMT1;GRIN3A;SESN3;SRR;PADI4;GLRB
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.30290618209517484,0.724942931657639,0.8499399759903962,1.0,1.0,5/28,19.45%,GABRA4;GRID2;GABRG1;GRIK5;GRIK2
prerank,3'-5' exonuclease activity (GO:0008408),0.2915160122012551,0.7228710798004732,0.8651315789473685,1.0,1.0,9/45,15.88%,EXOSC4;ISG20;RAD1;XRN2;REXO2;ERI1;POLG;REV3L;ANGEL2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),-0.2839823632096165,-0.722678638025925,0.8304498269896193,0.9681137278375942,1.0,3/11,14.16%,AKR1A1;RDH11;RDH13
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.22248000924529446,-0.7219399869273913,0.9096385542168675,0.9620946792773493,1.0,6/25,20.82%,CYP27A1;CH25H;MTRR;MICAL3;KMO;NDOR1
prerank,voltage-gated cation channel activity (GO:0022843),0.266960674028286,0.721557408692856,0.9114315139031925,1.0,1.0,10/97,11.64%,KCNQ5;CACNG7;KCNA4;CACNA2D3;GRIN3A;CACNB4;KCNC4;KCNA1;CACNA2D1;HCN3
prerank,mRNA methyltransferase activity (GO:0008174),0.3541393997519904,0.7212947909699614,0.7991803278688525,1.0,1.0,4/12,16.13%,METTL3;CMTR2;METTL14;NSUN2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.29158453539311596,0.720684927416662,0.8368715083798882,1.0,1.0,7/40,15.38%,METTL9;DPH5;DNMT1;TARBP1;LCMT1;FBL;AS3MT
prerank,endodeoxyribonuclease activity (GO:0004520),0.3193759853409571,0.7205083552235692,0.8371810449574727,1.0,1.0,5/20,19.58%,ERCC4;RPS3;ERCC1;ERCC5;RBBP8
prerank,protein tyrosine phosphatase activity (GO:0004725),0.2736758397791382,0.7202940421662434,0.8984293193717278,1.0,1.0,18/71,23.17%,PTPN22;PTPN13;PTEN;PTPRN;PTPN12;PTPN9;PTPRA;PTP4A3;PTPN4;DUSP4;PTPDC1;HACD2;PTPRC;PTP4A2;CDC14A;DUSP3;PTPRD;TNS2
prerank,endopeptidase activator activity (GO:0061133),0.36187233611742464,0.7199005508785536,0.8079763663220089,1.0,1.0,1/10,5.81%,PSME1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.24856707442681764,-0.7195627579194138,0.8810572687224669,0.9581650666990421,1.0,5/18,16.66%,PIK3R1;WDR81;PIK3R6;PIK3R2;SOCS2
prerank,deubiquitinase activity (GO:0101005),0.2688875188577281,0.7175896239750242,0.9003115264797508,1.0,1.0,19/88,18.99%,USP3;USP42;USP1;MINDY3;USP46;EIF3H;USP18;USP34;VCPIP1;DESI2;USP45;OTUD1;USP15;USP32;USP49;USP28;UCHL3;MYSM1;USP50
prerank,nuclear export signal receptor activity (GO:0005049),0.3574295854633986,0.7170458759370082,0.8065843621399177,1.0,1.0,2/11,10.70%,XPO1;NUP214
prerank,nuclear receptor coactivator activity (GO:0030374),0.28005670796604865,0.714108265295775,0.868421052631579,1.0,1.0,19/52,24.28%,HELZ2;ACTN1;ETS1;SLC30A9;MED30;CCAR2;MED13;NCOA7;NCOA2;PKN1;ENY2;PPARGC1B;CALCOCO1;MED24;SRA1;PPRC1;DCAF6;NCOA6;ACTN4
prerank,chloride transmembrane transporter activity (GO:0015108),0.3274133641506834,0.712706674854475,0.8134034165571616,1.0,1.0,2/16,11.62%,SLC26A6;SLC12A5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.3287111259093377,0.7103078895049186,0.8269986893840104,0.9987678960978071,1.0,3/16,12.25%,ANO4;ANO5;ANO8
prerank,intracellular chloride channel activity (GO:0061778),0.3287111259093377,0.7103078895049186,0.8269986893840104,0.9987678960978071,1.0,3/16,12.25%,ANO4;ANO5;ANO8
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.2810032923749003,0.7100954976665554,0.8712121212121212,0.9968504190925984,1.0,5/46,10.96%,B3GNT3;PIGA;EXT2;GCNT2;EXTL2
prerank,ubiquitin-specific protease binding (GO:1990381),0.3181623823111579,0.7072827590533378,0.8254777070063695,0.9975921848474122,1.0,4/19,19.04%,PTEN;AMFR;DERL1;SELENOS
prerank,growth factor activity (GO:0008083),0.26643521647292717,0.7056263304953295,0.9137749737118822,0.9971480722420432,1.0,7/74,16.79%,NRG1;MDK;CLCF1;GRN;FGF7;CSPG5;JAG1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.27493791648570143,-0.7046946633737273,0.8527397260273972,0.9688361482605774,1.0,1/11,8.16%,HCN2
prerank,adenylyltransferase activity (GO:0070566),0.3057860287184834,0.7004671241256257,0.8488664987405542,1.0,1.0,7/21,23.95%,GPHN;OASL;PAPOLG;TENT4A;KARS1;TUT1;PAPOLA
prerank,glucuronosyltransferase activity (GO:0015020),-0.23664264528315387,-0.7002846122116977,0.9033816425120773,0.9668017715248972,1.0,1/19,0.62%,LARGE1
prerank,anion:anion antiporter activity (GO:0015301),0.3202160135404958,0.6996570689185861,0.8387096774193549,0.9992918488788437,1.0,3/17,18.40%,SLC26A6;SLC25A4;SLC19A1
prerank,protein phosphatase 2A binding (GO:0051721),0.3053036394468309,0.6963598072757657,0.8650990099009901,1.0,1.0,5/23,12.71%,PTPA;GRIN3A;MAPT;FOXO1;MASTL
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.34268641326075644,0.6957885219295188,0.8502824858757062,0.9990053850186822,1.0,3/12,18.30%,HDAC1;TBPL1;TBP
prerank,cyclic nucleotide binding (GO:0030551),-0.2286537245132854,-0.6932843917699546,0.905,0.9672771338945341,1.0,2/21,5.74%,PDE10A;PDE4A
prerank,general transcription initiation factor binding (GO:0140296),0.2951405060534304,0.6924725112963975,0.8532219570405728,1.0,1.0,6/25,18.30%,AHR;TAF1B;DR1;PSMC1;RUVBL1;TBP
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.2480176955045712,-0.6922806598005242,0.8666666666666667,0.9618384422045521,1.0,4/15,16.66%,PIK3R1;PIK3R6;PIK3R2;SOCS2
prerank,acyl-CoA hydrolase activity (GO:0047617),-0.23893590364029393,-0.692200159805238,0.9150943396226415,0.9553286190819824,1.0,2/17,3.76%,ACOT7;PPT1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3282017407624281,0.6908713576571204,0.8227146814404432,0.9995843717667279,1.0,5/14,23.44%,PTEN;MTM1;MTMR14;MTMR1;MTMR10
prerank,hydro-lyase activity (GO:0016836),0.275212066554054,0.6894066088893159,0.8808463251670379,0.9987704177369474,1.0,11/41,22.19%,ENO4;EHHADH;APIP;L3HYPDH;HADHA;HACD1;IREB2;HACD2;HSD17B4;HACD4;HADHB
prerank,potassium channel activity (GO:0005267),0.25625882153407104,0.6884455070214993,0.9387129724208376,0.9975844855644331,1.0,9/89,15.83%,KCNN4;KCNQ5;KCNMB4;KCNA4;KCNC4;KCNA1;HCN3;KCNT1;GRIK5
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.28449282769706513,-0.6860229639522639,0.8566775244299675,0.9550792883960955,1.0,3/10,15.91%,SIRPA;CD200;PKP2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.342885705451233,0.684995057271695,0.8467966573816156,0.9988338183887964,1.0,2/10,9.99%,SHANK2;NSF
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.28056225279666197,-0.6816259210566848,0.873015873015873,0.9533093334979519,1.0,4/10,23.42%,SETD3;SMYD2;ASH1L;SETMAR
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2831149568622179,0.6803487099046606,0.8915525114155252,1.0,1.0,12/33,26.15%,EXOSC4;ISG20;XRN2;REXO2;ERI1;ANGEL2;EXOSC10;EXOSC9;CNOT6L;XRN1;ANGEL1;EXD2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.33676319435629926,0.6793337079951444,0.8563458856345886,1.0,1.0,3/11,21.01%,PRMT5;FBXO11;PRMT7
prerank,NAD binding (GO:0051287),0.29262686529388443,0.6776476619895742,0.8739595719381689,0.9995082237226742,1.0,5/26,15.81%,SORD;HADH;ME1;SIRT1;ZC3HAV1
prerank,NF-kappaB binding (GO:0051059),0.2939971953335535,0.6758810232040355,0.8854679802955665,0.9990086788811304,1.0,7/24,20.56%,HDAC1;NFKBIA;PSMA6;NPM1;HDAC2;CPNE1;GSK3B
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.32568907577585,0.6742982643406559,0.8604651162790697,0.9984061707966891,1.0,5/12,23.95%,PAPOLG;TENT4A;TENT5A;TUT1;PAPOLA
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.33263499420409015,0.6732830335469038,0.8464673913043478,0.9972780085038729,1.0,2/12,11.77%,SDHB;CISD3
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.26578764777795677,0.6720201893439803,0.9066959385290889,0.9963203988841322,1.0,10/48,23.14%,PIEZO2;SLC12A7;NALCN;SLC12A4;SLC39A1;TRPC1;DMAC2L;ATP6V1F;TMEM165;ATP6V1B2
prerank,calcium channel inhibitor activity (GO:0019855),0.3313009108464667,0.6719574961231654,0.8648293963254593,0.9942833253063539,1.0,3/11,16.77%,ITPR1;FKBP1A;CALM1
prerank,hormone receptor binding (GO:0051427),0.31801849434267176,0.6719064808630261,0.8640522875816994,0.9922449280845431,1.0,3/14,23.43%,JAK2;JAK1;NCOA6
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2907895910183105,0.6632784471345068,0.8775252525252525,0.9980090116540499,1.0,2/21,14.92%,GRIA1;GRM1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.3064982806115535,0.6620995353021927,0.8814627994955864,0.9969952006421829,1.0,3/17,13.69%,LBR;BLVRA;BLVRB
prerank,methyltransferase activity (GO:0008168),0.2645571547277169,0.6616748524999626,0.8956043956043956,0.9952920688089039,1.0,9/46,16.13%,METTL3;DNMT1;PRMT5;FTSJ3;MRM2;LCMT1;COQ3;AS3MT;NSUN2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.3219034258134256,0.6578799658560931,0.8686730506155951,0.9965086227947164,1.0,6/12,25.56%,CYFIP2;EIF4E3;AGO2;CYFIP1;EIF4E2;NCBP3
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.2713473728901,0.654722440110176,0.9099201824401368,0.9972162584931495,1.0,5/34,12.11%,EXOSC4;ISG20;XRN2;REXO2;ERI1
prerank,ion gated channel activity (GO:0022839),0.2816080500482676,0.6541830205895537,0.8996282527881041,0.9956241644602392,1.0,8/24,26.07%,ANO4;ANO5;ANO8;KCNT1;ANO10;KCNT2;TMEM63B;NMUR2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.3263448622183165,0.6519687739353188,0.871301775147929,0.9953948859801277,1.0,10/10,67.39%,SLC6A11;SLC10A5;SLC10A4;SLC10A2;SLC6A13;SLC6A12;SLC6A1;SLC10A3;SLC10A6;SLC10A1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.2596501622364535,0.6497304763006247,0.9285714285714286,0.9951839509655708,1.0,11/37,23.57%,LARS2;MARS2;TARS2;TARS3;GARS1;DARS1;RARS1;KARS1;SARS1;SARS2;EPRS1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.20259999436218826,-0.6401395580644563,0.9539170506912442,0.9830545593096112,1.0,2/21,9.69%,FGF2;FGF10
prerank,RNA methyltransferase activity (GO:0008173),0.2865737233610148,0.6388541301535692,0.8842239185750637,1.0,1.0,4/19,13.42%,METTL3;FTSJ3;MRM2;FBL
prerank,acylglycerol lipase activity (GO:0047372),0.317123930609315,0.6369162368173604,0.8810511756569848,1.0,1.0,2/11,11.54%,ABHD2;FAAH
prerank,death receptor activity (GO:0005035),-0.2595080911682281,-0.6364711465866683,0.9075907590759076,0.9792463337664749,1.0,2/11,13.15%,TNFRSF11A;TNFRSF1B
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2536061596569894,0.6363347973359832,0.9297475301866082,0.9998121697140235,1.0,16/44,25.21%,TTLL12;SETD1A;SETD5;SUV39H2;WDR5;SMYD5;SETD7;SMYD1;NSD3;MECOM;CXXC1;SETDB1;KMT2E;PRDM9;EZH2;KMT2A
prerank,AMP binding (GO:0016208),0.31764910717944106,0.6322608249430972,0.8911174785100286,1.0,1.0,5/11,26.52%,PYGL;PFKP;PRKAG1;APRT;ACSS2
prerank,sialyltransferase activity (GO:0008373),0.27766100682131306,0.6308192250250155,0.907292954264524,0.9998723283958808,1.0,3/20,10.12%,ST6GALNAC3;ST3GAL1;ST8SIA5
prerank,transcription coactivator binding (GO:0001223),0.2813608554021343,0.6282533938374488,0.9156010230179028,0.9997427389310702,1.0,2/20,4.64%,RPL23;AHR
prerank,ligand-gated cation channel activity (GO:0099094),0.236713310676129,0.6279577170818178,0.9656607700312175,0.9979457991943698,1.0,9/75,19.45%,KCNJ10;KCNJ15;GRIA1;GRIN3A;P2RX5;GRIA2;GRIK5;GRIA3;GRIK2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3136848713119899,0.6263780708780796,0.8933333333333333,0.9971700414448506,1.0,11/11,68.65%,PADI4;PADI3;PADI6;ALLC;PADI1;AGMAT;ARG1;DDAH1;PADI2;ARG2;DDAH2
prerank,syntaxin-1 binding (GO:0017075),0.27602527261943877,0.6254888767448503,0.9119420989143546,0.9957766164057718,1.0,6/22,22.60%,NSF;CPLX2;SYP;SYNPR;SNPH;STXBP5
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.22107528531392562,-0.6254272658089254,0.9424778761061947,0.980103961446254,1.0,2/15,2.72%,SETD3;RBBP5
prerank,CoA hydrolase activity (GO:0016289),-0.2160240559251017,-0.6238892271099598,0.9441860465116279,0.9747313113738091,1.0,2/16,7.31%,ACOT7;NUDT7
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.27157885795166437,0.6233229272208776,0.9192399049881235,0.9953512742460167,1.0,8/25,25.74%,PARP3;PARP8;SIRT1;ZC3HAV1;PARP10;ART4;SIRT4;PARP16
prerank,leak channel activity (GO:0022840),0.28788418115575537,0.6190030119015542,0.9260651629072681,0.9964459786955879,1.0,2/18,9.88%,NALCN;PANX1
prerank,telomeric DNA binding (GO:0042162),0.25156290443238294,0.6153891485016827,0.9290617848970252,0.9970003752989572,1.0,11/32,27.26%,NCL;BLM;HMBOX1;STN1;CTC1;SMG7;WRN;HNRNPA2B1;TERF1;TERF2IP;PURA
prerank,acetylation-dependent protein binding (GO:0140033),0.2714800832408246,0.6143548258248133,0.90875,0.993691318964437,1.0,8/20,27.68%,TRIM24;ATAD2B;BAZ2A;DPF2;MLLT3;BRD4;KMT2A;THAP7
prerank,lysine-acetylated histone binding (GO:0070577),0.2714800832408246,0.6143548258248133,0.90875,0.993691318964437,1.0,8/20,27.68%,TRIM24;ATAD2B;BAZ2A;DPF2;MLLT3;BRD4;KMT2A;THAP7
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.30984735629915294,0.6127543955900033,0.8964539007092198,0.9927679104407306,1.0,4/10,22.87%,SETD5;SUV39H2;MECOM;SETDB1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3041085479410305,0.6126112880728908,0.8994413407821229,0.9908784584395044,1.0,5/11,27.23%,STN1;CTC1;HNRNPA2B1;TERF1;TERF2IP
prerank,neuropeptide receptor activity (GO:0008188),0.25616011333900673,0.6115909832573186,0.9269461077844311,0.989624260616627,1.0,3/29,15.19%,SORCS2;SORCS3;TACR1
prerank,growth factor receptor binding (GO:0070851),0.22633460775527095,0.6102300637602447,0.9732785200411099,0.9885577629512329,1.0,20/95,25.46%,IL27RA;TRIP6;TLR9;JAK2;IL6ST;HIP1;FGF7;SDCBP;SHC1;FYN;PDGFD;GLMN;CCDC88A;PIBF1;ERBB4;FRS2;ERN1;TNK2;LINGO1;PDGFRA
prerank,insulin-like growth factor I binding (GO:0031994),-0.2284649612618871,-0.6062537921013064,0.9038461538461539,0.9788951784349438,1.0,2/13,6.66%,ITGA6;ITGB3
prerank,carboxylic ester hydrolase activity (GO:0052689),0.22798175985594082,0.6057599073871277,0.9701338825952626,0.9896132279139249,1.0,17/85,23.99%,PRDX6;PGLS;PLAAT3;TARS2;ABHD2;GDPD1;NDST3;FAAH;PLA2G12A;GDPD3;CEL;AOAH;PAFAH1B2;LIPA;LYPLAL1;PGAP1;ENPP2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.26392943085973586,0.6036893686407976,0.9312424607961399,0.9890115613951379,1.0,3/24,13.03%,CAMK4;MAPKAPK3;MAPKAPK2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.23290584124001482,0.6001616984837935,0.95995670995671,0.9892945826106853,1.0,7/55,9.88%,SLC24A4;ANXA6;ATP2B4;ATP2A3;ITPR1;TRPC5;PANX1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.2590144924745461,0.5964565844884759,0.9417596034696406,0.9897725885368173,1.0,10/22,30.23%,TAB2;PRPF8;PARP10;SPRTN;ZRANB1;OTUD7A;RNF169;SQSTM1;OTUD7B;RNF168
prerank,sulfotransferase activity (GO:0008146),0.2494246995007268,0.5931753997806413,0.9544937428896473,0.9897871343762678,1.0,2/33,6.84%,UST;CHST9
prerank,semaphorin receptor activity (GO:0017154),0.2900302067492901,0.5868483249609868,0.9017980636237898,0.9915116758157645,1.0,2/11,8.71%,PLXNB1;PLXNA2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.2723455358603386,0.5856393213047553,0.9337837837837838,0.9902151467931525,1.0,1/15,8.76%,SLC26A6
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.2682331159738625,0.5808531510324441,0.9220430107526881,0.9909831538330266,1.0,5/16,23.44%,PTEN;MTM1;MTMR14;MTMR1;MTMR10
prerank,UDP-glycosyltransferase activity (GO:0008194),0.22489372125379942,0.5804039204613434,0.9830148619957537,0.9893043194792682,1.0,5/70,9.55%,B3GNT3;B3GALT6;EXT2;B4GALNT1;GCNT2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.286179826145641,0.5766507461180334,0.9301675977653632,0.9893086628579106,1.0,1/11,5.60%,RPS3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2893879402347883,0.5694774395673631,0.9245014245014245,0.9911834843487604,1.0,1/10,7.74%,MSL3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.23177628659370378,-0.5646633493434268,0.9433333333333334,0.9925167527446767,1.0,4/10,33.69%,OPLAH;CAD;DPYSL3;DPYS
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.24713386268725648,0.5635528358656767,0.952912019826518,0.9921549522004288,1.0,4/21,22.79%,P2RX5;GLRB;GRIK2;P2RX7
prerank,calcium channel activity (GO:0005262),0.20836851123368175,0.5578244886498379,0.9916926272066459,0.9928263633648408,1.0,16/84,21.19%,SLC24A4;ANXA6;CACNG7;CACNA2D3;CACNB4;TRPC5;PANX1;CACNA2D1;TRPC4;ORAI2;CACNA1I;TRPC1;CACHD1;SLC24A2;CACNA1B;MCU
prerank,sequence-specific mRNA binding (GO:1990825),0.27729919995492697,0.5571755836022061,0.940771349862259,0.9911819231856296,1.0,2/10,15.36%,ETF1;TYMS
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.26128223304139386,0.5561984730589259,0.9592105263157895,0.9897085938189871,1.0,2/15,10.14%,SLC1A6;SLC1A5
prerank,insulin-like growth factor receptor binding (GO:0005159),0.2602783910062775,0.5524818813183827,0.9629629629629629,0.9894572734677641,1.0,5/12,26.00%,IRS1;SHC1;YWHAG;INSR;IGF1
prerank,tau-protein kinase activity (GO:0050321),0.2430775201067945,0.5446369054442742,0.9628252788104089,0.9909476771808965,1.0,6/20,20.56%,ROCK1;SIK3;FYN;GSK3A;MARK3;GSK3B
prerank,NAD+ binding (GO:0070403),0.27037214275275373,0.5432784302846985,0.9431664411366711,0.9896452872822321,1.0,3/12,15.81%,HADH;SIRT1;ZC3HAV1
prerank,clathrin adaptor activity (GO:0035615),0.2563197005943646,0.5415679020530612,0.9696569920844327,0.9884413129853372,1.0,5/15,24.15%,HIP1;STON2;AP2S1;STON1;AP1G1
prerank,insulin-like growth factor binding (GO:0005520),0.24993366907260306,0.5331785170653736,0.9700910273081924,0.9898264878417551,1.0,5/15,23.39%,IGFBP2;IGF1R;IGF2R;IGFBP4;INSR
prerank,tRNA methyltransferase activity (GO:0008175),0.23916823844592594,0.5225053929166176,0.9641434262948207,0.9918186373357186,1.0,5/16,26.20%,TRMT44;TARBP1;TRMT9B;TRMT13;THUMPD3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.19367346755310424,-0.5192678929523445,0.991701244813278,0.999823063731163,1.0,2/15,16.60%,PLA2G4A;PLA2G4E
prerank,NADP binding (GO:0050661),0.21690770667580342,0.5191725274695617,0.9827387802071347,0.9910194189059145,1.0,2/32,4.87%,LBR;HSD11B1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.2022156925054594,0.5180252644188101,0.9922907488986784,0.9895116517253922,1.0,15/49,27.38%,TAB2;TNIP3;PRPF8;UBQLN1;SHARPIN;ZFAND6;TNIP1;PARP10;TNIP2;SPRTN;RAD18;ZRANB1;OTUD7A;ABRAXAS1;RNF169
prerank,histone acetyltransferase binding (GO:0035035),0.22822611155739045,0.5180005784243626,0.9711055276381909,0.9876553595221975,1.0,4/21,15.76%,GLI3;TRIM68;EPAS1;PCNA
prerank,transaminase activity (GO:0008483),-0.20207652543993457,-0.5129481807923004,0.9835526315789473,0.9947947999840235,1.0,4/11,33.87%,AGXT;GOT1;BCAT2;PSAT1
prerank,NADPH binding (GO:0070402),0.2483074377628002,0.5095365603920119,0.9758389261744966,0.9883698054517586,1.0,1/13,4.76%,LBR
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.24581670284549156,0.5079424168722461,0.9664879356568364,0.9870227323972958,1.0,2/13,14.38%,ADH5;ALDH1L2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.1975734170609973,-0.49136294432919375,0.9757785467128027,0.9926877103493918,1.0,1/11,4.06%,KCND3
prerank,neuropeptide binding (GO:0042923),0.20844377331678643,0.4628634236490511,0.9897959183673469,0.9950687489859849,1.0,4/18,27.73%,SORL1;GPR149;NMUR2;OPRL1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.2241110603129286,0.4509785703223487,0.9806362378976486,0.9949790971803776,1.0,2/12,15.53%,ARSK;SGSH
prerank,hormone activity (GO:0005179),0.10665665944921093,0.27361011386990747,1.0,0.999998236639458,1.0,49/54,68.27%,AMH;GRP;AGRP;IGF1;SST;TRH;CHGB;METRNL;NPPC;GAST;HCRT;TSHB;NPPB;OXT;QRFP;UCN;INSL6;ADIPOQ;ERFE;GPHB5;SCT;APELA;VGF;CALCB;C1QTNF12;GHRH;EDN1;POMC;NPPA;EDN2;CORT;EDN3;ADCYAP1;INHBB;GHRL;SPX;VIP;NMB;GAL;CRH;APLN;GNRH1;NPY;PTHLH;NPFF;PENK;INHA;PNOC;CCK
